Ecology of <i>Cryptococcus neoformans</i> in Vietnam by Phan, Hai-Trieu
Open Research Online
The Open University’s repository of research publications
and other research outputs
Ecology of Cryptococcus neoformans in Vietnam
Thesis
How to cite:
Phan, Hai-Trieu (2019). Ecology of Cryptococcus neoformans in Vietnam. PhD thesis The Open University.
For guidance on citations see FAQs.
c© 2018 The Author
Version: Version of Record
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright
owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies
page.
oro.open.ac.uk
ECOLOGY OF CRYPTOCOCCUS NEOFORMANS IN VIETNAM 
 
 
by 
 
PHAN HAI TRIEU 
 
 
 
 
 
A thesis submitted to the Open University U.K 
For the degree of Doctor of Philosophy in the field of Life Sciences 
 
 
 
 
Oxford University Clinical Research Unit 
Hospital for Tropical Diseases 
Ho Chi Minh City, Viet Nam 
Aug, 2018 
ii 
 
Abstract 
Cryptococcal meningitis is an infection with Cryptococcus species; almost all disease 
occurs in immunosuppressed patients due to C. neoformans.  Cryptococcus spp are 
environmental saprophytes; the ability to cause disease is considered an accident of 
adaptation to their ecological niche.  
In Southeast Asia, cryptococcal meningitis in immunocompetent individuals is well-
described and is almost always due to the C. neoformans ST5 (VNIa-5) lineage. I 
hypothesize this lineage has relative increased pathogenicity. The aims of this thesis 
were to: identify the ecological niche of C. neoformans; define the diversity of C. 
neoformans in Vietnam; compare the virulence of different genotypes, and; define 
transcriptional differences associated with virulence. 
I identified spatial clustering of lineages VNIa-4, VNIa-5 and VNIa-32. Environmental 
sampling yielded 123 cryptococci the majority of which were non-pathogenic.  
Using the G. mellonella infection model I identified an ‘ecological imprint’ on 
isolates. Within a lineage, the virulence of an isolate is determined by its source – 
environmental, immunosuppressed or immunocompetent patient. Moreover, the 
virulence of environmental C. neoformans can be upregulated by clinical strains of 
that lineage. This ‘induction’ effect is regulated by a protein/peptide signaling 
system. Comparative transcriptomics revealed 1700 genes differentially expressed 
between clinical and environmental isolates. Gene ontology (GO) terms relevant to 
metabolism and cellular biosynthesis were enriched in clinical isolates; GO terms 
relevant to cell cycle and cell division were significantly enriched in induced 
environmental isolates. Clinical and induced environmental isolates had highly 
similar transcriptomes. A number of genes previously confirmed as virulence 
determinants were upregulated in clinical and induced environmental isolates; a 
third of differentially expressed genes between the induced and `naive' isolates were 
hypothetical proteins. These are novel candidates implicated in the upregulation of 
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virulence. My findings provide insight into ecology of C. neoformans in Vietnam and 
the genetic control of virulence. 
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Chapter 1 
Introduction 
1.1 The Cryptococcus pathogens 
The Cryptococcus genus comprises 70 species of pathogenic and non-pathogenic 
basidiomycetous yeasts. The majority of them are not harmful to humans. Of all 
species, Cryptococcus neoformans and Cryptococcus gattii are the most clinically 
relevant. C. neoformans causes the vast majority of cryptococcosis in HIV/AIDS 
patients, claiming an estimated 181,000 lives annually, with a global burden of 
223,000 cases per year 1. Infection caused by the sibling species C. gattii is relatively 
rare. This pathogen mainly infects immunocompetent patients, disease being most 
frequently reported from Australasia, South America and more recently the Pacific 
Northwest of North America, where there has been a significant outbreak of disease 
since 1999. Cryptococcus pathogens are facultative intracellular fungi in 
macrophages 2. They can be found in the environment (avian excreta, soil, decaying 
wood) as saprophytes or in environmental micro-predators such as a free-living  
amoebae and nematodes) 3 4 5 
 
 
 
 
 
 2 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-1 Genotypes and serotypes of C. neoformans and C. gattii. Apdapted 
from Chaturvedi et al6 
Nomenclature of the (human) pathogenic Cryptococcus species complex is depicted 
in Figure 1-1. The conventional serotyping test, based on antigenic differences in 
major capsular glucuronoxylomannan (GXM), classifies them into 5 serotypes: 
Cryptococcus neoformans var. neoformans (serotype D), Cryptococcus neoformans 
var. grubii (serotype A), hybrid AD, and Cryptococcus gattii (serotypes B &C) 7 8. 
Serotyping is now infrequently performed, having been superceded by molecular 
methods of typing and speciation. Restriction fragment length polymorphism (RFLP) 
analysis of the orotidine monophosphate pyrophosphorylase (URA5) gene is one 
such reliable and easily performed method 9. This method divides the Cryptococcus 
complex into 9 major molecular types: C. neoformans (VNI, VNB, VNII, VNII, VNIV) 
and C. gattii (VGI, VGII, VGIII and VGIV) 9. The major genotypes differ in their 
 3 
 
epidemiology, pathogenicity, disease phenotype, in vitro antifungal susceptibility and 
geographical distribution 10 7 11 12.  
The most frequently used sequencing methodology is MultiLocus Sequence Typing 
(MLST). This is a robust sequence-based technique, which gives high discriminatory 
power and reproducible results. In 2007, the Cryptococcus Species Genotyping 
Working Group defined a consensus MLST scheme as the standardized method for 
molecular typing of C. neoformans, to enable description of the global population 
structure. Seven loci, consisting of six house-keeping genes (GPD1, CAP59, LAC1, 
SOD1, PLB1 and URA5) and the intergenic spacer IGS1 were chosen and considered 
to have sufficient discriminatory power 13. The MLST scheme for C. gattii uses slightly 
different loci; the major VGII molecular type has subsequently been subdivided into 
a, b, and c  sub-types following the Pacific Northwest outbreak (Canada and 
Northwestern USA) using this 8 loci MLST scheme. 14 
C. neoformans sex is defined by the MAT locus on chromosome 4, which is over 100 
kb long with more than 20 genes. The MAT locus encodes either the a or α allele, 
which determines the MATa or MATα mating type in haploid forms respectively. C. 
neoformans MATα cells are far more prevalent amongst both clinical and 
environmental isolates 15. The MATa mating type is largely restricted to sub-Saharan 
Africa, and notably more frequent within the VNB population 16. While mating was 
originally considered to occur between cells of opposite mating types (MATa and 
MATα), it is now clear that same-sex mating (MATα and MATα) can occur in C. 
neoformans var. neoformans 17. During the sexual cycle, yeast cells switch to a 
hyphal form, but the yeast form are predominantly found in the environment and in 
 4 
 
animal hosts. The product of mating is basidiospores. Infection is believed to occur 
through the inhalation of either these basidiospores, or desiccated yeasts. 
Basidiospores from serotype D  are more resistant to environmental stresses (high 
temperature, oxidative stress, desiccation) and this results in them being more 
infectious than yeast cells 18 19. However, while the ability to mate is clear, it is a rare 
event; C. neoformans mostly reproduces asexually by budding, producing haploid 
progeny in clinical and environmental specimens 20 (Figure 1-3).  
Mating can result in hybrid C. neoformans species. During mating, two yeast cells 
fuse but the two parental nuclei remain separated, forming dikaryotic hyphae 
(Figure 1-2). Hybridization between varieties, and even species, occurs contributing 
to the biological diversity of the Cryptococcus species complex and adaptation to 
fluctuating environments. The interspecies hybridization of C. gattii and C. 
neoformans, resulting in serotypes AB, BD and CD, has been reported from Canada 
and the Netherlands 21 22 23. The intervarietal AD hybrid exhibits increased resistance 
to ultraviolet (UV) radiation and tolerance to high temperature than the haploid 
parents and exhibits increased pathogenicity in mice compared with serotype D 24.  
 
 
 
Figure 1-2 Mating of haploid yeasts causes cell fusion. Dikaryon hyphae trigger 
filamentous growth. Once nuclear fusion occurs, blastospores are formed through 
meiosis and sporulation. Adapted from Lin et al23 
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1.1.1 Cryptococcus neoformans 
C. neoformans was first isolated from the bone of a woman suffering sarcoma in 
1894, and from the environment from peach juice later in the same year. Key to the 
ability of the organism to cause disease is its remarkable polysaccharide capsule, a 
key determinant of virulence. The capsule is easily visible when Indian ink staining is 
applied on clinical specimen (Figure 1-3).  
 
 
 
 
 
 
 
Figure 1-3 Indian ink staining of C. neoformans var. grubii isolated from Galleria 
mellonella under 1000X light microscope. Halos around spherical cells are capsule. 
Arrow shows a budding yeast with a daughter cell. Blurred objects in the background 
are hemocyte debris and body fat. 
Pigeon guano is an established ecological habitat of C. neoformans. In the laboratory, 
it can grow and mate robustly on medium containing pigeon guano 25. The pathogen 
has been isolated from the feet, beaks and fresh droppings of feral pigeons (Columba 
livia) 26. However, they do not suffer cryptococcosis because their physiological 
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temperature is too high (average 42.5oC), inhibiting fungal growth26. Instead, pigeons 
are postulated to be an important agent of dispersal for C. neoformans 7, acting as a 
mechanical vectors, particularly in densely populated urban areas. 
Cryptococcal meningitis is usually seen in immunosuppressed patients and is the 
most common fungal infection of the central nervous system. C. neoformans var. 
grubii (serotype A, molecular type VNI, now renamed C. neoformans) is the most 
important strain medically, causing the vast majority (95% worldwide) of  
cryptococcosis in HIV/AIDS patients 7. Driven by the HIV epidemic, VNI is the most 
prevalent genotype globally, except in Australia and Papua New Guinea, where 
Cryptococcus gattii, molecular group VGI prevails 27. Cryptococcus neoformans var. 
grubii VNB strains are largely restricted to Botswana 28 but have been reported from 
Brazil and Columbia 27. Studying a cohort of 230 HIV-associated cryptococcal 
meningitis cases in countries of southern Africa revealed that patients infected with 
lineage VNB suffered the highest mortality at one year compared with VNI and VNII 
29. 
Cryptococcus neoformans VNII strains can be found globally but it is rare in Europe. 
The hybrid VNIII, and Cryptococcus neoformans var. neoformans VNIV (serotype D, 
now renamed Cryptococcus deneoformans) are more frequently reported in Europe, 
( 18.5 % and 18.3 % of clinical isolates, respectively)27.  In North America, the  VNII 
and VNIII molecular groups account for approximately 5 % of human infections 27. 
The restricted distribution of VNIV to temperate regions may be attributable to the 
fact that VNIV strains are more susceptible to high temperature (above 40oC) than 
VNI 30.  
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Figure 1-4 Evolution of virulence in Cryptococcus spp. Adapted from May et al 31 
As a saprophyte, Cryptococcus does not require animal hosts to complete its life 
cycle. Despite this, it has been found to infect a wide variety of hosts: amoebae, 
insects, birds, dogs, cats, dolphins, porpoises, koalas, foxes, goats, and sheep7. The 
ability to infect animals may be a ‘bystander’ effect that has evolved as a result of 
the fungal interaction with a hostile environment and the yeasts natural predators - 
free-living amoebae, and soil nematodes. This accidentally confers human 
pathogenicity (Figure 1-4). Factors that facilitate fungal survival in the environment 
are also required for mammalian pathogenicity. An example of such bystander dual 
functionality is that of the gene laccase. Laccase is involved with acquisition of 
nutrients from decaying food and production of melanin; melanin protects cells from 
solar radiation and also protects against killing by amoeba following ingestion; in 
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animal models it is a key virulence determinant and probably enhances intra-
phagosomal survival. A further example is the capsule, which protects against 
predation by free-living amoebae and macrophages within the mammalian host 32 3. 
Consistent with this, the the yeast transcriptional profile is similar when C. 
neoformans is exposed to phagocytosis by amoeba or murine macrophages 33. Genes 
involved in non-mammalian killing  (C. elegans, Galleria mellonella) are also required 
for mammalian pathogenicity 34 4 35. Besides environmental selective pressure, 
microevolutionary events, such as DNA mutation, karyotype changes & 
chromosomal rearrangement, also contribute to driving cryptococcal pathogenesis in 
different hosts  36 37 38.  
Human infection may be acquired by inhalation of desiccated cells or basidiospores 
from the environment. There is no evidence of human-to-human, or human to 
animal transmission. Once the fungal cells colonize the lung, they are either cleared 
or enter a dormant form within the lymph node complex or macrophage and evade 
the immune system. When human immunity is impaired, the dormant forms can be 
reactivated and then disseminate with propensity for the central nervous system. 
Cryptococcal spores are as pathogenic as yeast in the murine model although lung 
fungal burden is tenfold fewer in spore-infected mice compared with yeast-infected 
mice.39 C. neoformans can cause localized infections in skin, eyes, bones, joints, 
lungs, etc. but the most common and severe clinical manifestation is 
meningoencephalitis. 20  
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1.1.2 Cryptococcus gattii 
In contrast to its sibling species C. neoformans, C. gattii mainly infects 
immunocompetent individuals. C. gattii cells, like those of C. neoformans, can be 
spherical or oval and have a polysaccharide capsule. It is associated with decaying 
wood or  hollow of various tree species (notably Eucalyptus calmadulensis, but at 
least 50 have been associated) 6. C. gattii was previously restricted to tropical and 
sub-tropical countries, mainly in Oceania and South America but it is now recognized 
that the geographical ranges have expanded notably with an outbreak of disease in 
otherwise healthy humans and animals on Vancouver Island in 1999. Spread to the 
British Columbia mainland and Pacific Northwest of the USA occurred thereafter. The 
incidence of disease in the outbreak on Vancouver Island rose up to 27 times higher 
than that seen in Northern Australia, where C. gattii cryptococcosis is endemic. The 
mortality rate has been 8.7 % 40. In the outbreak, the majority of  of disease was due 
to VGII, which has subsequently been divided into 3 types: VGIIa, VGIIb and VGIIc, 
with VGIIa causing the majority of both clinical and veterinary infections on 
Vancouver Island 41. While phylogenetically related to VGIIa, VGIIc is exclusive to the 
Northwestern United States, particularly Oregon, and does not yet appear to have 
spread to Canada 14. The enhanced virulence of the outbreak isolates correlates with 
an increased intracellular proliferation rate (IPR) within mammalian macrophages, 
and this attribute in turn is associated with significantly higher mortality rates in the  
mouse infection model42. Gene expression studies found that overrepresentation of 
mitochondrial transcripts correlated with higher IPR and increased virulence 42. 
Interestingly, hypervirulent strains were associated with changes in mitochondria 
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morphology, with a tubularized rather than globular form observed in phagocytosed 
cryptococci42. The tubular morphology may be the result of mitochondrion fusion as 
a strategy to evade mitochondrial DNA damage as a result of oxidative bursts in the 
phagosome, delivering a survival benefit following phagocytosis42.. 
It has been postulated that the emergence of hypervirulent VGIIa strains may be due 
to same-sex mating between VGIIb and a VGII isolate in Australia with spread to the 
United States due to the export of Eucalyptus camaldulensis, the major niche of C. 
gattii in Australia 43. However, another study suggests that the global VGII 
population originates in Amazon rainforest, South America 44. The original lineage of 
VGII then dispersed to Africa, followed by recombination event which introduced 
them to Australasia, Europe and North America44.  
Of the four main Cryptococcus gattii molecular types, VGI is the most prevalent 
worldwide 27. Recently, it has been proposed that the different C. gatti molecular 
types in fact represent separate species (Table 1-1). According to this idea, the VGI 
molecular type is equivalent to C. gattii 45. In Oceania, C. gattii is the most 
predominant pathogen with a ratio C. gattii/C.neoformans of 3:2 amongst clinical 
isolates 27. VGIIa accounts for 39% of all cryptococcal infection in North America due 
to the cryptococcosis outbreak on Vancouver Island46. VGIII isolates are more 
restricted in their distribution, mainly having been recovered from Latin America 
(Mexico, Southern California). VGIV is rarely reported, and has mostly been isolated 
from HIV/AIDS patients in Africa 7. The interspecies C. neoformans/C. gattii hybrid is 
extremely scarce, with just one isolate reported from each of Canada, Colombia, and 
Brazil, and three isolates from the Netherlands27. 
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Table 1-1 Current and proposed species in the C. gattii/C. neoformans species 
complex. Adapted from Hagen et al 45 
1.1.3  Other Cryptococcus species 
Like C. neoformans and C. gattii, other cryptococcal species are saprophytes. They 
are globally distributed, even having been isolated from Antarctica and the 
Himalayas 47. Non-neoformans/gattii species rarely cause human infection because 
in general they do not tolerate the normal human physiological temperatures - 
temperature dependent growth is thus an important virulence factor. While capsule 
has been clearly demonstrated to be an important determinant of virulence of C. 
neoformans, presence of capsule per se does not necessarily confer pathogenicity. 
Tremella mesenterica, closely related to C. neoformans, is encapsulated but not 
pathogenic48. Another example is C. liquefaciens, which possesses a capsule 
comparable to that of C. neoformans in terms of size, but physical chemical analysis 
reveals significant differences in viscosity and elastic properties 49.  This likely 
explains why C. liquefaciens isolates are more susceptible to amoeba phagocytosis 49. 
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1.2 Ecology of the C. gattii/C. neoformans species complex 
Cryptococci occupy a diverse range of ecological habitats, including sea, arctic, 
extreme pH and thermal springs, and even nucelar reactors 7. Animal excreta and 
arboreal sources are established habitat of the C. gattii/C. neoformans species 
complex. 
1.2.1 Trees 
The ecological niche for C. gattii was first described when an association with the red 
river gum (Eucalyptus camaldulensis) was established in Australia50. This tree species 
has been extensively exported around the world, including to southern California, 
Mexico, Africa and Southeast Asia and this trade may have contributed to the global 
dispersal of C. gattii. The first environmental isolate of C. gattii beyond Australia was 
recovered from E. camaldulensis trees in San Francisco51. One historical problem 
with environmental sampling is that there are no reports of a systematic randomized 
approach to sampling, and therefore any associations are likely driven by bias in 
choice of both sampling location and source. Isolate collections produced through 
non-randomised methods cannot be considered to necessarily be representative of 
the true population. The discovery of the eucalyptus-associated reservoir of C. gattii 
has promoted extensive sampling of arboreal sources, and the finding, perhaps not 
surprisingly, that Cryptoccocus spp can be isolated from many tree species. 
In contrast to Australia, extensive sampling of eucalyptus in India yielded very few C. 
gattii. Five C. gattii strains were isolated out of 315 plant debris samples in Punjab 
whereas none of 500 eucalyptus trees in Dehli and Uttar Pradesh gave positive result 
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26. The arboreal niche of Cryptococcus (serotype A and B) in northwestern India was 
Syzygium cumini (Java plum). They were repeatedly isolated in this tree species 7.  
In Southern California and Southwestern USA, VGIII isolates frequently infect HIV 
patients. Environmental sampling identified novel arboreal hosts of this genotype: 
Pinus canariensis (Canary Island pine), Liquidamar styraciflua (American sweet-gum), 
and Metrosideros excels (Pohutukawa tree)52. In British Columbia, environmental 
surveillence was carried out in places where cryptococcosis outbreak had occurred. 
Positive soil samples were significantly higher than positive tree swabs (65% vs 35 
%). High concentration of C. gattii in soil was associated with low moisture and low 
organic carbon content53.   
Environmental sampling in Colombia identified the most prevalence of serotype A, 
followed by B & C. Strains VGIII (serotype C) was associated with almond trees 
(Terminalia catappa). This genotype was repeatedly isolated in almond trees over 19 
months. Interestingly, 96 % of VGII strains in Colombia were MATa in contrast to 
MATα  (VGII), the most predominant  isolates in Vancouver Islands outbreak7. 
Decayed wood from  tree hollows in urban areas of Rio de Janeiro were colonised by 
C. neoformans var. neoformans7. Pink shower trees (Cassia grandis), fig trees (Ficus 
microcarpa), and November shower tree (Senna multijuga) remained positive one 
year later whereas negative trees did not become colonised54. This suggests 
perennial colonisation of C. neoformans var. neoformans in these species. A 
revealing study in Rio de Janeiro found contamination of domestic environment with 
C. neoformans var. neoformans was associated with AIDS patients with 
cryptococcosis. 824 samples including household dust, soil, avian droppings were 
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collected in 154 houses, and C. neoformans was detected in 20 % of the houses. AIDS 
patients residing in contaminated houses were more likely to develop cryptococcosis 
than those living in the ‘clean’ houses. However this result was not significant 
(OR=2.05, P value =0.61) 55. 
A recent population genetics study has found correlation between southern Africa 
strains (VNI and VNB) and the indigenous African mopane tree (Colophospermum 
mopane), whereas global VNI is frequently associated with pigeon droppings56.  
Almost a third of mopane samples were positive with VNB strains. The mopane tree 
is important in economy and culture of southern Africa. Mopane timber is widely 
used in hut construction while mopane leaves are used in traditional medicine 
56.Therefore, the widespread application of mopane may predispose HIV patients to 
cryptococcosis. 
1.2.2 Animal excreta 
There is a strong association between C. neoformans and avian excreta, suggesting 
that this is a primary habitat of the pathogen. C. neoformans was isolated in 15 % of 
excreta samples from macaws and parakeets in India, and 25.5 % of passerine and 
psittacine guano in Brazil 26 57. Data suggest that pigeon faeces can promote both 
growth and mating of Cryptococcus spp because cryptococcal fungi can assimilate 
urea and nitrogenous substances in the bird excreta 25. However, the avian body 
temperature range (41.5 to 43oC) is too high to support growth of Cryptococcus spp 
and therefore birds are unlikely to be internally colonized with Cryptococcus 7. 
Pigeons and other birds are likely to be important in the dissemination of 
Cryptococcus species, with feathers, beaks, and claws being contaminated with the 
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yeast 26. Avian habitat contaminated with C. neoformans is a plausible source of 
HIV/AIDS cryptococcosis in endemic areas 58 7. In addition to avian faeces, bat guano 
has been reported as a source of C. neoformans and C. gattii in India. 7 
In Thailand, cryptococcosis is the third most common opportunistic infections in 
AIDS patients. Environmental sampling in Chiangmai, nothern Thailand revealed C. 
neoformans was mostly associated with dove droppings samples (45 %, 45 of 100 
samples)59. Another study detected C. neoformans in 24% of weathered chicken 
dropping samples collected in suburban areas in Phayao province, northern 
Thailand57. 
Environmental isolates were also detected in USA, mostly serotype A, followed by 
serotype D and AD. Up to 762 avian excreta samples were collected in North Carolina 
with 83 % of VNI 7. In South America, bat excreta in Brazil was first reported as 
reservoir of both C. neoformans and C. gattii7.  
Of note, C. neoformans is less prevalent in Northern Russia, Canada and Scandinavia 
compared to tropical and temperate regions. Globally, VNII is rarely isolated in the 
environment7. 
1.2.3 Clinical relevance of environmental C. neoformans 
The pathogenic potential of environmentally sourced isolates is unclear with variable 
findings depending on the study. According to a study in Puerto Rico, mean lethal 
dose (LD50) of environmental C. neoformans is significantly higher than that of clinical 
isolates using intravenous murine infection model60 . In Brazil, 69 % of environmental 
isolates were significantly more lethal in mice than the rest (environmental 
isolates)61 whereas a recent study found that only 9% of environmental C. 
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neoformans var. grubii cause death 60 days post-infection in murine model62. 
Environmental isolates VGIII in Southern California exhibited increased survival time 
in murine model compared to MLST-matched VGIII clinical isolates52. 
Because Cryptococcus can cause latent infection, with periods of many years, and 
humans have are highly mobile with frequent travel and immigration, drawing 
correlations between clinical and environmental populations is complex and 
potentially cofounded by time and human factors. A more logical way to investigate 
clinical relevance of environmental isolates is to compare their genotypes with those 
of veterinary infections. 
1.3 Cryptococcal infection 
1.3.1 Cryptococcal meningitis 
The most severe symptom of cryptococcal infection is cryptococcal meningitis. The 
clinical manifestations of cryptococcal meningitis due to infection with any species 
include headache, altered mental status, nausea, vomiting and fever. Visual 
impairment is also observed both at presentation and developing during treatment. 
A study from Botswana found no differences in clinical features or in-hospital 
mortality between C. gattii and C. neoformans infection in HIV-infected patients63. 
Sparse data suggested that C. gattii is more virulent than C. neoformans because it 
causes multiple lesions in lungs and brains, although disease manifestations are 
likely complicated by the difference in underlying host immune phenotype 64. Mass 
lesions in the brain appear to be more common in C. gattii disease, and this may 
explain a higher rate of neurological sequelae in these patients 65. Inflammatory 
sequelae such as hydrocephalus are reportedly more frequent with C. gattii than 
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with C. neoformans, although an elevated cerebrospinal fluid opening pressure is 
seen in 2/3 of Vietnamese patients with cryptococcal meningitis due to C. 
neoformans66 67 64.  
Cryptococcosis due to other species has been described. The most common causes 
of non-neoformans/non-gattii disease are C. laurentii and C. albidus, which account 
for approximately 80 % of cases. The remaining 20% are due to C. adeliensis, C. 
humicolus, C. luteus, C. curvatus, and C. uniguttulatus 7. Non-neoformans/gattii 
pathogens mainly caused disease in patients with impaired cell-mediated immunity 
(immunosuppressive therapy, organ transplantation, hematologic malignancy) and 
patients co-infected with HIV47. Infection of many organ systems has been described 
including the skin, eyes, and gastrointestinal tract, with bloodstream and the central 
nervous system being the most commonly affected (39% & 32 %, respectively). The 
clinical outcomes are similar to those of C. neoformans/gattii. Amphotericin B is the 
mainstay of therapy because 94 % of isolates are susceptible to this drug, whereas 
azoles can be used for less severe or non-disseminated cases. 47 
1.3.2 Latent or acute infection 
Humans are believed to become infected with Cryptococcus species following 
inhalation of spores or desiccated yeasts. Following this, the incubation period until 
the development of overt disease is unknown, and likely variable from patient to 
patient. A case of likely nosocomial transmission of C. neoformans has been 
described between two elderly patients hospitalised in beds next to each other. The 
isolates appeared genetically identical using PCR with four random primers and 
karyotyping. While both patients might simply have been coincidentally infected 
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with the same strain, acute transmission could not be ruled out, but currently our 
understanding is that person to person spread has to be considered exceptional  68. 
The C. gattii Vancouver Island outbreak has allowed a better understanding of the 
incubation period for this particular strain. Disease occurred between 2 to 11 
months after exposure for most patients 69. However, there is growing evidence 
supporting the idea that in general most cases of disease represent reactivation of 
latent infection. A survey in immunocompetent children over 5 years old revealed 
that 70 % had serum antibodies directed against Cryptococcus, suggesting subclinical 
infection is common. Primary, self resolving pulmonary cryptococcosis could be 
confused with any number of pulmonary, including viral, infections in children 70. 
Further evidence of latency comes from transplant patients. Here, serological studies 
have shown that 52 % of transplant recipients who developed cryptococcosis (C. 
neoformans) were seropositive prior to transplantation. Moreover, they developed 
the disease significantly earlier than patients without pre-existing cryptococcal 
infection 71. In HIV infected patients, significant latency is supported by a molecular 
epidemiology study from France which used randomly amplified polymorphic DNA 
(RAPD) genotyping. Isolates from African-born patients, resident in France for a 
median of 10 years, had RAPD profiles that clustered together, away from isolates 
from patients indigenous to Europe suggesting that patients were infected with C. 
neoformans in their country of origin before migrating to France 72.  
1.3.3 Single or mixed infection 
Cryptococcus is ubiquitous in the environment, so humans are constantly exposed to 
multiple strains with different genotypes, serotypes, ploidies and mating types. 
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Mixed infection was reported to occur in 18 % of cryptococcosis patients infected 
with serotype A or D in France, however, clinical outcome did not differ significantly 
in these patients. These strains could have been acquired simultaneously or 
separately over time. Diploid strains could be co-infected environmentally or evolved 
from haploid strains through same-sex mating or endoreplication (duplication of 
nuclear DNA without mitosis) 73. Mixed populations may enable better adaptation in 
the hostile host. In contrast, a study from Brazil revealed that almost all serial 
isolates from AIDS patients had identical PCR profiles; only a minority of patients had 
mixed isolates20. The incidence of mixed infection needs consideration when 
investigating the epidemiology and developing vaccines and diagnostic tools for 
these pathogens. 
1.3.4 Cryptococcal interaction with the host immune response 
After breaching the mammalian physical barrier, cryptococcal pathogens are sensed 
by pattern-recognition receptors (PRR) on host immune cells. PRRs are a key part of 
control of the innate immune system. They are are germline encoded and detect 
molecular motifs typical of pathogens, including fungal antigens such as -glucan, 
mannan, and cell wall chitin. One examole is the C-type lectin receptors, which bind 
to carbohydrate ligands such as -glucan or mannan derived from capsule and 
spores of C. neoformans74. Another family of PRRs is the Toll-like receptors.  Toll-like 
receptor 4 is significant in fighting fungal pathogens, being able to recognize 
glucuronoxylomannan. Involvement of these receptors trigger signal transduction 
pathways that coordinate innate immunity, including phagocytosis and cytokine 
production. 
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1.3.4.1 Innate immunity 
The complement system and phagocytic cells are crucial players in the host innate 
immune response to Cryptococcus.  Complement systems opsonize cryptococcal cells 
in the bloodstream to attract immune effector cells and facilitate the uptake of the 
fungal pathogen by phagocytes. C. neoformans can be ingested by a variety of 
phagocytes. These include dendritic cells and macrophages, which following yeast 
ingestion, present cryptococcal antigens to T cells and produce mediators 
(chemokines and cytokines) to initiate adaptive immunity. Alveolar macrophages are 
the first line of defense against the pathogen. They are found to uptake cryptococci 
in murine lung74. However, following internalization by macrophages C. neoformans 
can survive and proliferate within acidic phagolysosomes and eventually lyse host 
cells. Besides lytic escape, Cryptococcus can exit macrophages without killing them 
(non-lytic exocytosis) or transfer laterally between macrophages. These mechanisms 
are thought to be important in dissemination of the pathogen to the central nervous 
system across the blood-brain barrier (the Trojan horse model)75. The interaction 
between Cryptococcus and macrophages may also explain how they remain latent 
without triggering host innate immunity. 
1.3.4.2 Adaptive immunity 
Whole C. neoformans cells or cell components (membrane, wall, proteins) trigger 
proliferation and maturation of naive T cells76. Both CD4 and CD8 T cells participate 
in inhibition of C. neoformans through direct killing or generation of cytokines that 
recruit and activate other phagocytes to kill invaders. CD4 T cells are crucial players 
of cell-mediated immunity in mice77. They mediate fungal clearance by recruiting 
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macrophages and granulocytes to murine lung. In humans CD4 T–cell deficiency (cell 
count < 100 cells/uL) is a predisposing factor for cryptococcosis. CD8 T cells are also 
involved in cryptococcal killing using granulysin. Depletion of CD8 T cells leads to 
reduction of survival in murine infection model77. Both CD4 and CD8 T cells yield Th1 
cytokines, but the former is the main producer of Th2 cytokines during cryptococcal 
infection76. Th1-type CD4 T cells play important roles in adaptive immunity. They 
produce IL-2, IL-12, IFNγ and TNF-α. IL-12, IFNγ and TNFα provide protection against 
C. neoformans in mice. Human studies confirm protective roles of IL-2, IL-12 and IFNγ 
against cryptococcal infection76. The presence of the IFNγ and/orTNFα CD4 T-cell 
response is associated with survival of HIV patients with cryptococcal meningitis. 
Prescription of IFN-γ to the standard treatment regimen increases the rate of fungal 
clearance from CSF77 in HIV infected patients. In contrast, higher levels of Th2-
associated cytokines such as IL-5 and IL-13 are associated with worse outomes from 
cryptococcosis78. They are associated with increased lung burdens and murine 
susceptibility to C. neoformans76. Absence of an IL-13 response correlated with 
higher yields of protective IL-17 and IFNγ cytokines. B-cells also play crucial roles in 
protection against cryptococcosis - deficiency of B cells and antibody increases the 
risk of cryptococcal infection in both HIV infected and uninfected patients76. This has 
been elegantly demonstrated in the mouse model where in  mice with severe 
combined immunodeficiency T-cell transfusions from B-cell-depleted mice did not 
result in effective adaptive immunity to C. neoformans in the recipients 77. 
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1.3.5 Epidemiology of cryptococcosis 
1.3.5.1 HIV-associated cryptococcosis 
Globally cryptococcal meningitis (CM) is responsible for 15 % of HIV-associated 
deaths 1. The vast majority of these cases was caused by C. neoformans var. grubii 
(serotype A). C. gattii meningitis in AIDS patients is still rare, mostly caused by VGIII 
and VGIV, accounting for 2.4% – 30 %, in South America and Southern Africa 79. The 
greatest burden of CM is in sub-Saharan Africa (73 % of total) with annual prevalence 
of an estimated 162,500 cases. The region suffering the second greatest incidence is 
Asia and the Pacific (19% of total) with an annual incidence of 43,200 cases. Clinical 
outcomes remain unacceptably poor. The mortality rate by 3 months can reach 50 to 
70 % in sub-Saharan Africa, and 15-26 % in USA and France for 10 weeks64 . 
Differences in mortality are in part due to the availability of antifungal and 
antiretroviral therapy, although incidence and mortality rates have not fallen 
significantly in South Africa over recent years despite improvements in HIV 
treatment access 1. In addition, mortality rates may exacerbated by cryptococcal 
immune reconstitution inflammatory syndrome (IRIS), occurring in 6-30 % patients 
following initiation of ARVs (antiretrovirals) in HIV co-infection. In IRIS, antiretroviral 
therapy restores cryptococcus-specific immune response; this, in turn, elicits 
paradoxical clinical worsening of preexisting infection 80.  
As an opportunistic infection, C. neoformans infection is driven by the HIV pandemic. 
When AIDS expanded since 1980s, CM emerged and infected 5-10 % AIDS patients. 
In France, incidence of HIV-associated CM increased fivefold from 1985 to 1993 
while the number of cases in HIV-negative individuals remained stable79. However, 
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the upsurge of cryptococcosis has receded in developed countries (France, UK, USA) 
since the adoption of antiretroviral therapy (ART) and uses of azoles in 1990s 80. The 
incidence of HIV-associated CM in France dropped by 46 % between 1997-2001 
period. Incidence varies with geographical regions probably due to exposure in the 
environment. For example, cryptococcal prevalence is higher in northeastern 
Thailand (24 %) than southern Thailand (7%) (P value < 0.001) 81.   
The prime risk factor for HIV-associated cryptococcosis is profoundly suppressed 
immunity (CD4 cell count < 100 cells/μL). Predictors for mortality at 2 weeks after 
beginning treatment include: abnormal mental status, high fungal burden in CSF, and 
high peripheral white blood cell count, older age (>50) and fluconazole-based 
induction treatment, suggesting fungicidal amphotericin-based and earlier diagnosis 
are important to improving outcomes 82. 
1.3.5.2 Non-HIV cryptococcosis 
Besides HIV patients, those who have other causes of defective T cell-mediated 
immunity are also at increased risk of cryptococcosis. Such conditions include: 
malignancy, solid organ transplant recipients and autoimmudiseases. Cryptococcosis 
is the third most common fungal infection in solid-organ transplant in the USA (2004-
2007), accounting for 2.8 – 8 % of transplants 83 79. The etiology is considered to be 
most likely reactivation of dormant infection. Expansion in the use of 
immunosuppressant drugs (tacrolimus, cyclosoporin, calcineurin inhibitors, cytoxic 
agents) to prevent graft rejection and cancer treatment contribute to the increased 
incidence of cryptococcosis, especially in developed countries, with the median time 
to diagnosis being 20 months after transplantation 84. In the USA, kidney transplant 
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receivers suffer the highest incidence of cryptococcosis in a retrospective study from 
1996 to 2010.85 
Other groups of non-HIV, nontransplant recipients with cryptococcosis include those 
prescribed with immunosuppressive agents & patients with hematological 
diseases84. C. gattii predominantly infects immunocompetent hosts. Molecular 
epidemiology varies with geographical regions. In Australia and Papua New Ginea 
VGI is the most prevalent with mortality whereas in North America ( British 
Columbia, Oregon and Washington state), VGII (VGIIa, VGIIb and VGIIc) is exclusivel 
detected. 
1.3.6 Epidemiology of Cryptococcosis in Vietnam 
Globally C. neoformans var. grubii VNI causes the vast majority (>90%) of 
cryptococcosis in AIDS/HIV patients. This is true in Vietnam, where it is responsible 
for 100% of disease in HIV infected patients at the Hospital for Tropical Diseases, Ho 
Chi Minh City. However, in Vietnam, this strain is also responsible for 73 % of 
infection in non-HIV infected patients 86. The majority of these patients have no clear 
underlying immunosuppressive disease. Using amplified fragment length 
polymorphism (AFLP), Vietnamese C. neoformans var. grubii strains were further 
separated into two distinct lineages: VNIϒ and VNIδ (Figure 1-6). VNIϒ strains, 
subsequently identified as multi-locus sequence type (ST5)  caused 84 % of C. 
neoformans infection in HIV-uninfected patients, but only 38% of infection in  HIV-
infection patients (odds ratio, 8.30; 95% CI, 3.04 to 26.6; P < 0.0001). Moreover, in 
HIV-uninfected patients, underlying diseases were more common in those infected 
with VNIδ (odds ratio, 6.43; 95% CI, 0.75 to 85.1; P = 0.05). Therefore, it is 
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hypothesized that VNIϒ has increased pathogenicity (ability to cause disease) 
compared to other VNI clades. This finding is consistent with those from China, the 
neighbour to the north of Vietnam. A study from 16 mainland provinces in 
predominantly HIV uninfected patients, found that most infections were due to a 
distinct cluster within the VNI clade 87.  
Since C. neoformans is primarily an environmental saprophyte, this increased 
pathogenicity presumably represents an adaptation to a particular ecological niche 
which coincidentally confers increased pathogenicity. An alternative hypothesis 
would be that these apparently immunocompetent patients may have a subtle and 
highly Cryptococcus-specific immunodeficiency which predisposes them to 
cryptococcosis. 
 
 
 
 
 
 
 
 
Figure 1-5 AFLP derived neighbour joining tree for Vietnamese VNI isolates. Gray 
bars, isolates from HIV-negative patients; white bars, C. neoformans control; black 
bars, C. gattii control. Adapted from Day et al 86 
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Comparison of clinical phenotypes by lineage in HIV patients demonstrated that 
patients infected with ST5 had significantly lower baseline fungal burden in CSF 
(P=0.01) but higher blood lymphocyte cell count (P=0.001) than those infected with 
non-ST5. ST5 strain infections were associated with worse disability outcomes for 
survivors at 70 days than non-ST5 did (P=0.046) 88 
1.3.7 Antifungal treatment 
Cryptococcal meningitis, if untreated, is invariably fatal. The standard therapy 
includes three phases: induction, consolidation and maintenance. Amphotericin B 
(AMB), a fungicidal antifungal, should be administered intravenously in 14 days for 
induction phase, with a dose of 0.7 – 1 mg/kg. AmB can be replaced with liposomal 
AmB (3-6 mg/kg) to minimize renal side effects. 
To enhance fungicidal efficacy, AMB (1 mg/kg/day) should be prescribed with 
Flucytosine (5-FC) at a dose of 100 mg/kg/day for two weeks. This regimen reduces 
mortality at 70 days compared to AMB monotherapy and significantly increases rate 
of fungal clearance in CSF.67 Omission of 5-FC has been associated with late relapse 
or treatment failure 79. Subsequently, fluconazole, a fungistatic agent, should be 
used in consolidation phase (400 mg/kg/day) for further 8 weeks. Consolidation 
phase is followed by maintenance regimen with fluconazole (200 mg/kg/day). 
Overall, the gold regimen is AmB (1mg/kg) + 5-FC (100mg/kg) for two-week 
induction, followed by  fluconazole (400 mg/day) for 8 weeks and maintained by 
fluconazole (200 mg/day) until HIV is controlled by ART 79 67. 
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There is little high quality data to guide the treatment of C. gattii infection. 
Significant differences in susceptibility of serotypes was not detected  between 
Cryptococcus spp in a study including 128 isolates ( 86 C. neoformans and 42 C. 
gattii) 89. Therefore, the Infectious Disease Society of America and WHO 
recommended the same treatment regimen for these pathogens. Because the risk of 
development of cryptococcomas is considered increased in disease due to C. gattii, it 
is recommended that duration of treatment is prolonged 79. Targets of antifungals 
are illustrated in Figure 1-6. 
Figure 1-6 Schematic image of cryptococcal cells and drug targets. AMB generates 
cell membrane pores by binding to ergosterol of cell wall. 5-FC inhibits DNA and 
protein synthesis. Fluconazole interferes with ergosterol synthesis, weakening cell 
membrane. Β-glucan, chitin and mannoprotein are component of capsule. Taken 
from Kronstad et al 90 
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1.4 Virulence factors 
Cryptococcosis occurs as a result of interaction between fungal virulence factors and 
susceptible hosts. Cryptococci do not rely on a single virulence factor for 
pathogenicity but rather require a minimum set of interacting properties for 
pathogenicity. These virulence factors necessary to cause human disease are 
complex phenotypes, selected by environmental pressures likely driven by the need 
to evade predators in the normal ecological niche such as nematodes and  amoebae 
91. Understanding virulence factors is not only interesting in elucidating 
pathogenesis; virulence factors are themselves potential drug targets. 
1.4.1 Thermotolerance 
Susceptibility to human physiological temperature is a prerequisite for any invasive 
pathogen. Only a very few of 1.5 million fungal species are thermotolerant (35-40oC) 
92. While there are phylogenetic relatives of C. neoformans which possess virulence 
determinants similar to those seen in Cryptococcus, such as capsule and melanin 
production, they are non-pathogen in humans simply because they cannot tolerate 
human body temperature 93. Such an example is C. podzolicus. Within Cryptococcus, 
there is variability within the expression of particular virulence factors. For example, 
C. neoformans var. neoformans (serotype D) is more susceptible to elevated 
environmental temperature than other species 30. This may explain its restricted 
distribution in northern Europe. The genes associated with thermotolerance are 
potential drug targets. A number of genes involved in signal transduction pathways 
are necessary for growth at 37 OC including RAS1, MPK1 and CTS1 and Calcineurin A 
(CNA1). The CNA1 site-directed mutant is not pathogenic in the rabbit model 94. 
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Different virulence factors can be closely linked. For example, the genes VHP1 and 
UGD1 are essential for the synthesis of capsular components and also important for 
thermotolerance. Other genes, such as STE20 and CPA1, are required for growth at 
elevated temperature (35-40oC) 92.  
1.4.2 Nutrient acquisition 
Following phagocytosis by macrophages or free-living amoebae, the yeast cell enters 
a highly hostile environment, being, deprived of nutrients (carbon and amino acids), 
and facing oxidative stress and antimicrobial proteins 33. The phagosome is then 
acidified and fused with lysosomes, the purpose being to destroy the invaders. To 
adapt to nutrient scarcity, C. neoformans increases uptake of host nutrients by 
expressing multiple membrane transporter genes for sugars, nitrogen and amino 
acid (DIP5, ITR1, AMT1, AMT2). This adaptation is seen in both amoebae and the 
macrophage model 33. Genes encoding for key enzymes of the glyoxylate cycle 
(isocitrate lyase, malate synthase) are also upregulated to provide substrates for 
gluconeogenesis in place of glycolysis. Iron transporter and iron permease 
expression are also induced in internalized cells 95. Overall, approximately 14 % of 
genes regulated in response to phagocytosis by murine macrophages were 
associated with nutrient transporters 33. Furthermore, C. neoformans can resort to 
autophagy, a mechanism of recycling defective organelles and cellular components, 
to circumvent nutrient starvation in the phagosome. The autophagy regulating genes 
(ATG3, ATG9) are expressed when cryptococci are ingested by murine macrophages 
95. ATG8 mutants exhibited attenuated virulence in a mouse model of infection 96. 
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1.4.3 Capsule 
As might be expected, the capsule of Cryptococcus is an important virulence factor. 
Acapsular mutants (CAP59 knockout gene) have attenuated virulence in the murine 
model 97 and acapsular cells exhibit reduced survival compared with encapsulated 
cells in both amoeba and the Galleria mellonella infection model 3 98. In the 
environment, capsule is postulated to have numerous functions. First, it is believed 
to protect cells from desiccation. However, often capsule is poorly produced in the 
environment; the resultant smaller diameter may confer an advantage in 
aerosolistaion and improve the efficacy of infection through inhalation by hosts.  
During intracellular parasitism, capsule enlargement is induced to confer protection 
against reactive oxygen species from H2O2, antimicrobial peptides (e.g. defensin) and 
Amphotericin B 99. Encapsulated cells were less sensitive to AMB (0.06 - 0.25 ug/mL) 
than smaller cells in vitro99. Capsular expression (in term of size) varies between 
strains, organs infected, and even individual isolates. The lung is particularly 
associated with highly encapsulated cells 100. Encapsulated cells are also found in CSF 
and in phagocytes (macrophages, amoebae, larval hemocytes) but capsule is almost 
invisible under microscope and is best revealed using counter-staining. When 
visualised by such staining with Indian ink, the capsule is identified as a clear halo 
around the individual yeast cells (Fig. 1-3). Experimentally, capsule production can be 
promoted by culturing cells in minimal media: DMEM (Dulbecco's Modified 
Eagle's Medium) with rich CO2 gas (5%) and bovine fetal serum.  
 Capsule composition is heterogenous, consisting of polysaccharide 
glucuronoxylomannan (GXM, 90-95 % of capsular mass), 
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glucuronoxylomannogalactan (GalXM, 5-8%) and a small proportion of 
mannoproteins (MP,) 100. GalXM is of particular interest because of its role in the 
immune response. Additional polysaccharides are chitin and β-glucan (Figure 1-5). 
When mannosylated, mannoproteins are important cryptococcal antigens implicated 
in eliciting the immune response in mice. The capsule has an antiphagocytic 
function. Encapsulated cryptococci evade phagocytosis in the absence of 
opsonization and subvert phagosome digestion. Capsular enlargement itself acts as a 
physical barrier to phagocytic ingestion. A thick capsule enhances intracellular 
survival although a thin capsule is thought to promote better traversal of the blood-
brain barrier in C. gattii 101. When internalized in the phagosome, cryptococci shed 
GXM polysaccharide into vesicles, filling the cytoplasm of the infected macrophage. 
This combines with the leaky phagosomal membrane  and eventually leads to 
rupture of the macrophage by accumulation of replicated cryptococci 102. Capsule 
can quench reactive oxygen species and other antimicrobials. The first discovered 
capsular gene was CAP59, encoding transmembrane protein involved in GXM export. 
Another capsular-associated gene is CAP64. Deletion of CAP64 gene leads to 
avirulent strains. Capsular expression of acapsular serotype A strains can be rescued 
by complementing CAP64 from serotype D 15. Other genes contributing to capsular 
formation include CAP60 and CAP10, their importance for virulence having been 
demonstrated with knock-out/complementation studies 15 103. Further genes 
important for acetylation and xylosylation of GXM include: CAS31, CAS32, CAS33, 
CAS34, CAS35, UGD1 and UXS1 15.  
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Capsule polysaccharide may be important in the pathophysiology of raised 
intracranial pressure, an important complication of cryptococcal meningitis that can 
result in visual impairment and death. This is likely mediated through shed capsule 
resulting in increased CSF osmolarity, although inflammation likely contributes 66. 
1.4.4 Melanin 
Figure 1-7 Schematic representation of melanin. (A) cross-section depiction of C. 
neoformans. Yellow line is capsule (Cap) surrounding the cell. The next layer is cell 
wall (CW). Melanin is embedded in CW and next to plasma membrane. (B) Menalin 
particles form lay layers. They allow passage of nutrients (sugar and amino acid) but 
hinder entry of antifungal aggregate (AMB). Antibody can bind to melanin and block 
entry of nutrients. Adapted from Eisenman et al104 
Melanin is a virulence factor for many microbial pathogens: C. neoformans, 
Aspergillus spp., Burkholderia cepacia 105. Melanin, localised in the cell wall, is 
produced from phenolic compounds (Figure 1-7). Laccase genes, encoded by LAC1 
and LAC2, are key in melanin production.  In the environment, melanin probably 
confers resistance to UV radiation, high temperatures, heavy metals and protects 
against predators (nematodes and amoebae)104. Melanized cells are more resistant 
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to oxidants15 and killing by antifungal drugs (caspofungin and AMB) in vitro 106. 
Melanin-deficient LAC1 mutant strains are less virulent in mice than wild type strains 
107. Together, melanin poses challenges in the antifungal treatment of cryptococcosis 
with AMB. 
Most non-neoformans cryptococci lack laccase activity (Figure 7) and are not 
pathogenic. An exception is C. podzolicus, closely related to C. gattii, which exhibits 
strong laccase activity and produces capsule, but is avirulent probaly because of high 
susceptibility to temperatures of 37 oC 93. Melanization is also variable between 
strains. A survey of C. neoformans (VNB genotype) derived from sub-Saharan Africa 
showed that VNBI isolates are more heavily melanized than VNBII, and 
environmental VNBI are significantly more melanized than clinical counterparts 16. 
 
 
 
 
 
 
Figure 1-8 Melanin production of Cryptococcus spp on L-DOPA agar, melanin-
inducing media. 2 &3, environmental C. neoformans; 1 C. laurentii; 4&5, C. 
hevanensis; 6, C. rajasthanensis 
1.4.5 Oxidative defense 
Following internalization, cryptococci are exposed to attack by oxygen radicals, 
nitrogen oxide and antimicrobial proteins. Hence oxidative defense is essential for 
fungal survival in phagocytes. Nitrous Oxide (NO) has a fungistatic effect against C. 
1   2   3 
4   5   6 
 34 
 
neoformans in vitro. Cryptococcal NO-detoxifying enzymes include flavohemoglobin 
denitrosylase and S-nitrosoglutathione (GSNO) reductase.  These enzymes are 
encoded by FHB1 and GNO1. FHB1 mutants demonstrated attenuated virulence in 
the mouse model, whereas GNO1-deficient strains did not. However, the FHB1 
GNO1 double mutant was less virulent than single mutants of these genes 108, 
suggesting GNO1 plays an ancillary role in counteracting nitrosative stress. As might 
be expected, the genes involved in oxidative and nitrosative stress are induced 
following phagocytosis in amoeba and macrophages. Catalase and cytochrome c 
peroxidase take part in detoxification of H2O2. However, four catalase isoforms are 
dispensable for virulence in murine model, suggesting there is considerable 
redundancy of the antioxidant systems in C. neoformans. The thioredoxin reductase 
enzyme (Trr1) associated with resistance to nitrosative stress is also upregulated 
upon phagocytosis 33. Other enzymes involved in counteracting the oxidative burst 
are two isoforms of superoxide dismutases (SOD), glutathione peroxidases, the 
inositol phospho- sphingolipid-phospholipase C1 (Isc1) and the protein kinase C 
(Pkc1) 109 
1.4.6 Other virulence factors 
A number of other enzymes and proteins that facilitate cryptococcal survival under 
environmental stresses have been identified. One of the most common stresses is 
alteration of extracellular pH. C. neoformans grows well at human physiological pH 
(pH 7.4) and adapts to the acidic phagolysosome (pH 5), but suffer severe growth 
impairment at alkaline pH of 8 or above. The transcriptional factor RIM101 is 
involved in regulating cryptococcal pH response. RIM101-deficient strains are more 
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susceptible to the presence of alkaline pH, elevated salt concentration, and an iron-
deprived environment 110. RIM101 mutants also exhibit remarkably defective capsule 
growth at the cell surface by secreting capsular materials rather than maintaining 
them111 .Paradoxically, unlike other capsule-deficient strains, hypocapsular RIM101 
strain is hypervirulent compared with wild type H99 in the murine inhalation model. 
Intracellular survival of RIM101 was also better than H99 within macrophages110. 
Another study found the RIM101 mutant strain maintained virulence in murine 
model compared with H99. This could be explained by the fact that RIM101 mutant 
sheds four times as much GXM into the medium as wild type 111. The increased level 
of capsular GXM causes immunosuppressive effect.  
Another virulence–associated protein called DEAD-box is encoded by VAD1 gene. 
VAD1 mutants are rapidly cleared from lung and fail to establish dissemination to the 
brain and spleen in mice. The gene facilitates cryptococcal evasion of the host innate 
immune response 112.  
The APP1 gene mediates antiphagocytic activity independent of capsule. The 
product is excreted extracellularly and can be found in patient serum. APP1 protein 
binds to complement receptors 2 and 3, thereby arresting complement-mediated 
opsonization and inhibiting phagocytosis 113 114. Another capsule-independent 
antiphagocytic protein in the GATA family of zinc-finger transcriptional factor is 
encoded by GAT201. The virulence of the GAT201 knockout mutant is attenuated in 
the murine model compared to wild type. The capsule of GAT201 mutants is not 
visible using India ink counterstaining and can be detected by GXM-specific 
monoclonal antibody only. Moreover, GAT201-deficient strains are phagocytosed 
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more profoundly than CAP gene mutant strains (CAP10, CAP60 and CAP64). Double 
mutants (CAPΔ & GAT201Δ) are internalized more dramatically than single CAP 
mutants, implying the defective evasion of phagocytosis by GAT201 mutants is 
caused by both capsule-dependant and capsule-independant mechanisms 115. 
GAT201 is a key virulence regulator and controls the induction of 1100 genes (16 % 
of the genome) with 62 genes having promoters bound to GAT201 for gene 
expression in tissue culture conditions 116 
1.4.6.1 Secreted vesicles 
GXM, a major component of capsule, is produced intracellularly and transported to 
extracellular space for capsular assembly via secretory vesicles 117. GXM is a potent 
immunosuppressant, mediating apoptosis of T cells via overexpression of FasL death 
receptor in antigen presenting cells 118. Apart form GXM, C. neoformans also secretes 
a heterogenous group of extracellular vesicles. Using proteomic and biochemical 
analyses, other virulence determinants were detected in the vesicles: laccase, 
urease, phosphatase, enzymes related to capsular production, antioxidant proteins 
(superoxide dismutase, thioredoxin reductase, catalase A) 119. Secretory vesicles are 
produced by C. neoformans during during macrophage infection, suggesting they 
have a key role in cryptococcal pathogenesis.  
1.4.6.2 Morphological switches 
Morphogenesis contributes to pathogenicity. A cryptococcal strategy to evade 
immune recognition is to change the surface presented to host immune systems. 
Morphological switches differ from spontaneous mutations, which also lead to 
divergent phenotypes, in that they are reversible and readily identified in a fraction 
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of the population 120. There are three types of morphological changes: phenotypic 
switching, pseudohyphae and titan cells. Phenotypic switching was first described in 
a strain of C. neoformans displaying three colony types (serrated, wrinkled and 
smooth) with altered virulence in the murine model 121. Mice infected with wrinkled 
colonies suffer the highest mortality. The difference in colony types  and virulence 
was associated with minor karyotype changes 120. Another study found phenotypic 
switching in mice, with smooth and mucoid colonies deriving from a strain. Mucoid 
colonies exhibited larger GXM, reduced phagocytosis compared with smooth cells 
and consequently increased virulence in mice 122. Such morphological switching has 
been observed in serotypes A, B and D and. In C. gattii (serotype B) strains, cells can 
switch reversibly in the murine host, with mucoid variants again significantly more 
virulent than smooth variants. However, only smooth variants (with thinner 
capsules) are isolated from brain homogenate.101 It has been demonstrated that 
phenotypic switching may be an important factor in relapse disease 123.  
Another type of morphological change is the development of pseudohyphae (Figure 
1-9), first detected when a subpopulation of C. neoformans with atypical forms 
survived incubation with Acanthamoeba polyphaga. However, these pseudohyphal 
strains were hypovirulent in mouse model 124. A recent study dissected 
pseudohyphal strains (serotype A and D) derived from in vitro and exposure to 
amoebae. All of them possessed a premature stop codon in the TAO3 gene, a 
component of the RAM (Regulation of Ace2p activity and cellular Morphogenesis) 
pathway. This pathway regulates cell type: it promotes polarity in the ascomycete S. 
cerevisiae but inhibits it in C. neoformans 36.  
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Figure 1-9 Pseudohyphal forms of environmental C. neoformans var. grubii were 
obtained after inoculation in Galleria mellonella for 48 hours at 37oC. White arrow 
indicates a pseudophypha. 
Another form of morphological transformation is enlargement (both body and 
capsule). This is believed to protect against host phagocytosis 125 126. These enlarged, 
so-called titan cells, which can be recovered from infected mouse lungs, reach 
diameters of up to 40-50 m compared to the 5-10 m of normal cells127. The 
proportion of titan cells can vary from 10 % to 80 % of the total cell count in the lung 
127. Titan cells can be induced in vitro in minimal media although the increase in size 
is less profound than seen in vivo. Titan cells are polyploid (e.g. tetraploid or 
octoploid) and reach their size by repeatedly replicating DNA without fission. 
RIM101, pheromone and cAMP signalling pathways are involved in regulating this 
giantism 127 128. Surprisingly, titan daughter cells have normal size but retain the 
same resistance to oxidative and nitrosative stress as their parental giant cells128. 
Thus, the enhanced survival of titan cell progeny may confer an advantage in 
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dissemination and persistence of pulmonary infection. Taken together, 
morphogenesis is important during invasion and evasion from the host immune 
response. 
1.4.7  Degradative enzymes 
1.4.7.1 Protease 
C. neoformans exhibits extracellular proteolytic activities to degrade host proteins, 
such as collagen, elastin, fibrinogen, immunoglobulins, and complement factors, 
utilizing them as sources of carbon and nitrogen 129. C. neoformans also employs 
protease and phospholipase to degrade phagosomal membrane during intracellular 
reproduction. 102 
1.4.7.2 Phospholipase 
This is a heterogenous group of enzymes whose role is to hydrolyse ester linkage of 
phospholipase, thereby destabilising cell membrane and leading to cell lysis. 
Phospholipase exhibits not only hydrolase activity of phospholipase B (PLB) but also 
lysophospholipase, and transacylase as well. PLB mediates destabilization of the 
phagosomal membrane, facilitating fungal access to nutrients in macrophage 
cytoplasma 32. PLB also takes part in antiphagocytic activity by cleaving protozoan- or 
mammalian- derived phospholipids into polar heads, which are sensed C. 
neoformans cells, inducing capsular enlargement and formation of giant cells to 
evade phagocytosis 130. PLB can enhance adhesion of C. neoformans to human lung 
epithelial cells and contribute to dissemination of cryptococcosis from the lung to 
the blood via mononuclear phagocytes in murine model 15. The PLB1 mutant (PLB 
deficient) showed remarkedly reduced virulence compared with the wild-type strain 
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in the murine and rabbit infection models 131. The PLB1-reconstituted strain can 
restore its PLB activities. 
1.4.7.3 Urease 
Urease catalyzes the hydrolysis of urea to ammonia and carbamate. Urease has been 
shown to enhance fungal dissemination to the brain 15. Mice infected with urease-
active strains have higher fungal burdens in the brain and higher mortality than 
those infected with urease-defective strains 132. Urease gene (URE1)–deficient C. 
neoformans isolates displayed increased survival of infected mice compared to the 
wild type strain H99 and the avirulent phenotype can be restored by complementing 
URE1 133. A urease-negative strain was isolated from CSF of an immunocompetent 
patient 134.Interestingly, this strain can restore urease activity and virulence in mice 
comparable to that of H99 strain by complementation of URE2 gene.  URE1 failed to 
complement the mutant phenotype in this case. This suggests urease is dispensable 
for virulence of C. neoformans if other virulence factors can compensate for it. 
Experimentally, urease activity is used to detect presumptive cryptococci 135. 
1.5 Signal transduction pathways regulating pathogenicity  
To survive saprophytic and parasitic life in nature and the animal host, Cryptococcus 
deploys virulence attributes in resistance to environmental stresses: oxidative burst, 
phagocytosis, nutrient depletion, radiation exposure, desiccation. To regulate and 
orchestrate virulence factors, cryptococci have to employ complex signaling 
networks. There are 5 or 6 signaling pathways involved in modulating morphological 
switching, virulence and stress response. These key regulatory pathways involved 
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with virulence include cAMP/Protein kinase A, MAPK, Ca2+/Calcineurin and Ras 
pathways. 
1.5.1 Cyclic AMP/Protein kinase A pathway (cAMP-PKA) 
This pathway regulates morphology and virulence including capsule formation, 
melanin production and mating. The pathway components are illustrated in Figure 1-
10. Upstream components are G protein coupled receptor (GPR4) and G subunit 
(GPA1)136. Adenyl cyclase-associated protein ACA1 functions in parallel with GPA1 to 
control CAC1137. These proteins together with HCO3
-, produced from CO2 by carbonic 
anhydrase (CAN2), regulate activity of membrane-bound adenylyl cyclase (CAC1), 
thereby generating cAMP for downstream activation. Interestingly, activity of 
catalytic subunits of PKA is serotype dependent 138. In serotype A, PKA1-deficient 
strains are avirulent with defects in capsule size, melanin formation and mating 
while PKA2 is not required for virulence. In serotype D, PKA2 mutant exhibits defects 
in synthesis of melanin and capsule. The importance of cAMP-PKA in governing 
virulence of C. neoformans is demonstrated by  finding the disruption of pathway 
components (GPA1, GPR4 and CAC1) leads to sterility, and defects in melanin and 
capsule formation, thereby reducing virulence in the mouse model of cryptococcosis 
139. In contrast, knockout of PKR1, gene encoding protein kinase A regulatory 
subunit, induced enlarged capsule and hypervirulence. A recent transcriptional 
comparison of mutants (PKA1 & PKR1) and wild type strain revealed differential 
expression of genes encoding for secretory pathway components, such as 
translocation (Sec61 and Hsp19/Kar2), vesicle formation and fusion (Bet1, syntaxin), 
Golgi transport (a-1,6-mannosyltransferase) and genes encoding chaperones, stress, 
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and phospholipid metabolism140. The role of PKA in transporting secretory 
components suggests PKA regulates expression of secretory pathway constituents to 
control expression of virulence traits at the cell surface. Moreover, GPA1, CAC1 and 
PKA1 mutants are more susceptible to Amphotericin B than wild type strains do, 
suggesting a role of the cAMP pathway in regulating resistance to polyene drugs 141. 
Deletion of GPA1, CAC1, ACA1, PKA1 also result in sensitivity to osmotic stress 
(caused by NaCl and KCl). Thus, taken together, cAMP-PKA pathway is a potential 
target for anticryptococcal therapy.  
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Figure 1-10 cAMP-PKA signal transduction pathway in the pathogenesis of C. 
neoformans. cAMP signaling responds to environmental cues (glucose & amino acid) 
through G- -. Once activated 
by GPA1, enzyme adenylyl cyclase (CAC1) releases cAMP, which subsequently 
activates Protein kinase A (PKA) by dissociating regulatory subunit Pkr1 from the two 
catalytic subunits of PKA (PKA1 &PKA2). PKA1 activates downstream proteins such as 
Nrg1. A GTPase-activating protein (Crg2) and phosphodiesterase (Pde1) negatively 
regulate Gpa1 and production of cAMP. Adapted from Kozubowski et al138 
1.5.2 Mitogen-activated protein kinase (MAPK) pathways 
Eukaryotic cells employ this pathway to sense environmental changes. Cascade 
components differ between higher mammalian and lower eukaryotic cells, but  the 
core of MAPK pathways is conserved142. The core of pathways consists of three 
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kinases. Upon environmental stimuli, MAP kinase kinase kinase (MAPKKK) 
phosphorylates MAP kinase kinase (MAPKK), which in turn triggers phosphorylation 
of MAP kinase (MAPK). The signal is eventually relayed to downstream effectors, 
activating or suppressing the corresponding target genes (Figure 1-11).  
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Figure 1-11 The general scheme of the MAPK cascade. Stimuli are perceived at the 
plasma membrane through membrane receptor. The signal is relayed by adaptor 
module to the core component of the cascade through phosphorylation. The MAPK 
pathway consists of 3 kinases: MAPKKK, MAPKK and MAPK. Upon phosphorylation, 
MAPK is transported to nucleus where it phosphorylates a transcription factor, which 
switches on or off the downstream target genes, followed by occurrence of adaptive 
response to extracellular cue.  Adapted from Roman et al.142 
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Figure 1-12 Components of MAPK signaling pathways including HOG pathway and 
Protein kinase C (PKC) pathway and their roles in regulating cryptococcal virulence 
determinants. Adapted from O’Meara and Alspaugh et al143 
In S. cerevisiae, at least five MAPK pathways regulate response to shocks (oxidative, 
nitrosative, osmotic) and pheromone during mating. MAPK is also crucial for 
cryptococcal survival during mammalian infection. Sensing and adaptation to 
environmental stresses in C. neoformans serotype A are exclusively mediated by the 
high-osmolarity glycerol (HOG) cascade. The signal transduction cascade is initiated 
when two sensor kinases (Tco1 &Tco2) are stimulated by environmental cues 144. 
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Once phosphorylated, Ypd1 histidine kinase relays signal to Skk1 response regulator. 
Under normal growth Hog1 MAPK is constitutively phosphorylated (inactivated 
form) by Pbs2, negatively inducing capsule and melanization (Figure 1-12). In 
response to stresses, Tco1 and Tco2 activate Ssk1, which in turn triggers 
phosphatase to dephosphorylate Hog1 MAPK for activation of downstream effectors 
to counteract stresses. Ssk1 is critical response regulator. Ssk1 mutation lead to 
enhanced production of melanin and capsule and defect in Hog1 MAPK constitutive 
phosphorylation in normal conditions 144. There are numerous kinase and 
transcription factors downstream of Hog1 that are still understudied. Hog1 
interferes with cAMP-PKA pathway, repressing formation of melanin and capsule in 
serotype A. Hog1 mutants produce larger capsules than wild type (H99) and restore 
melanin production in GPA1, CAC1 and PKA1 mutants 145. This provides evidence 
that there is cross-talk between cAMP-PKA and HOG pathway. In serotype A, Hog1 is 
constitutively phosphorylated under normal growth but rapidly dephosphorylated in 
response to osmotic stress. However, this occurs conversely in serotype D. Hog1 
protein sequence is identical between serotype A and D but phosphorylation pattern 
differs, suggesting upstream components of Hog1 are divergent. Hog1 and Pbs2 
mutants exhibit hypersensitivity to high temperature (40oC), UV radiation and 
osmotic stress. Disruption of Hog1 or Pbs2 lead to attenuated virulence in mice 
although both mutants significantly enhance production of melanin and capsule, 
which confirm the mutifactorial nature of C. neoformans virulence and underscore 
that the ability to cope with stress, capsule formation and melanization are 
important in pathogenesis. 
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PKC (Protein kinase C) cascade is another stress-activated pathway essential for cell 
wall integrity and thermotolerance (Figure 1-11). Pkc1 is also phosphorylated in 
response to reactive oxygen and nitrogen species but Pkc1 downstream components 
(Bck1 and Mkk2) have no role in protection against these stresses. Pkc1 mutants 
show growth defects upon exposure to 37oC incubation, oxidative and nitrosative 
stresses, cell wall inhibitors and additionally reduce melanization. Pkc1 mutants 
cause more severe defects in cell wall biogenesis than Bck1 and Mkk2 mutants, 
implying an additional role in cell wall biogenesis beyond activation of the cascade 
138. Taken together, Pkc1 is a central coordinator with multiple outputs other than 
activating the MAPK cell integrity cascade 146. Phosphorylation of Pkc1 initiates a 
transduction cascade involving downstream components: Bck1, Mkk1, Mkk2 and 
Mpk1. Bck1 and Mkk2 mutants are critical for cell wall integrity. They exhibit 
increased susceptibility to cell wall inhibitors (SDS and  
Congo red) 147. Mpk1, the terminal component of this pathway, is important for 
growth at 37oC in vitro, which, as discussed earlier, is a prerequisite for human 
infection. Thus, Mpk1 mutants display attenuated virulence in mouse 148. Mpk1 is 
phosphorylated following exposure to cell wall defect-induced antifungals (inhibitors 
of chitin synthase and b-1,3-glucan synthase ), oxidative and nitrosative stresses. A 
recent study demonstrated an interconnection between the HOG and PCK pathway 
via casein kinase I protein (Cck1). Cck1 regulates cell wall integrity and adaptation to 
osmotic shock through phosphorylation of Mpk1 and Hog1 proteins 149. 
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1.5.3 Ca2+/Calcineurin pathway 
This Ca2+ mediated signaling pathway takes part in diverse functions, including cell 
wall integrity, sexual differentiation, thermotolerance, and adaptation to cell wall 
stress, high CO2 and alkaline pH 
150. In response to environmental signals, a rise in 
levels of cytosolic Ca is sensed by Calmodulin (Cam1), which can then bind four Ca2+ 
molecules to form the Ca2+/calmodulin complex (Figure 1-13). This complex 
subsequently activates Ca/calmodulin-dependent protein kinase (CaMK) or 
calcineurin, a serine/threonine phosphatase. Calcineurin comprises two subunits: 
catalytic A subunit (Cna1) and regulatory B subunit (Cnb1). Upon activation, 
calcineurin triggers transcription of downstream genes which protect against 
environmental stresses. Activation of calcineurin can be inhibited by 
antifungals/immunosuppressive drug, such as Cyclosporine A (CsA), tacrolimus 
(FK506) and tamoxifen.  
These substances form complexes with Cyclophilin A and FK506-binding protein 
(FKBP12), respectively. The complexes inhibit growth at 37oC but not 24oC 151. 
Calmodulin can act independently of Ca2+/calcineurin to regulate morphogenesis and 
growth at 37oC 152. Calcineurin is essential for survival at 37oC. The CNA1 mutant 
suppresses growth at elevated temperature in vitro and was avirulent in the rabbit 
model of cryptococcosis 151. To survive intracellularly, Cryptococcus must adapt to 
increased levels of CO2 and physiological pH. CNA1 mutants display poorer growth at 
5% CO2 and pH 7.3 in RPMI broth compared with wild type strains. Disruption of 
Cnb1, the calcineurin regulator subunit, also impairs growth at 37oC and renders 
strains avirulent in the murine model153. Moreover, calcineurin deficiency (CNB1 
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deleted) also induces phosphorylation of Mpk1 MAPK and upregulation of the FKS1 
gene, which encodes a subunit of b-1,3-glucan synthase. This  indicates  that 
calcineurin and Mpk1 coordinately regulate cell wall integrity in response to 
increased temperature stress 148. Patients are believed to acquire cryptococcosis by 
inhaling infectious spores from these environments. Finally, calcineurin is involved in 
the mating process – drugs which inhibit it (Cyclosporin A and FK506) inhibit mating 
and haploid fruiting 154. 
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Figure 1-13 Ca2+/calcineurin signaling cascade and their roles in regulating virulence 
of C. neoformans. Cyclosporine A (CsA) and FK506, bound to cyclophilin A and 
FKBP12, respectively, inhibit calcineurin. Cbp1: calcipressin, a calcineurin effector. 
Adapted from Kozubowski et al 138 
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1.5.4 Ras pathway 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-14 Ras signaling cascade and its role in regulating thermotolerance, stress 
response and pheromone response during mating. Adapted from Shinae Maeng et 
al155 
The Ras signal transduction cascade is also a stress-triggered signaling pathway. It 
governs growth at elevated temperature and adaptations to environmental stress 
and pheromone response in mating (Figure 1-14). Ras proteins are guanine binding 
proteins. They are active in the GTP-bound from and inactive in GDP-bound form 
following GTP hydrolysis. RAS1 mutants display growth defects at 37oC and an 
avirulent phenotype in the rabbit model of cryptococcosis. Mating filaments were 
not observed when RAS1 mutants were incubated with opposite mating type strains, 
unlike the Ras1 wild type strains. However, defective mating of RAS1 was partially 
suppressed upon introduction of cAMP 156, implying potential cross-talk between Ras 
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and the cAMP signaling pathway. RAS1 has been reported to induce expression of 
pheromone response pathway genes: -pheromone gene MF1 and - pheromone 
receptor gene CPR1 157. RAS2 is expressed at much lower level than RAS1 and is not 
required for pathogenicity of C. neoformans. RAS2 mutants can grow well at 
elevated temperature, exhibit normal mating and are virulent comparable to wild 
type strains in the mouse model. However, RAS1 RAS2 double mutants display more 
severe growth defects at high temperatures than strains with either single RAS gene 
deletion, suggesting interplay of these two genes in regulating response to high 
temperature. Overexpression of RAS2 in RAS1 mutant background partially 
suppresses growth defect at elevated temperature and completely suppressed 
mating defects of RAS1 mutant strains, implying an overlapping regulatory function 
158. A recent study found Cdc24, guanine nucleotide exchange factor, functions 
downstream of Ras1 and upstream of Rho-like GTPase Cdc42 to mediate high 
temperature growth and pathogenicity 159. Besides its role in adaptation to elevated 
temperature, RAS1 mutants exhibited sensitivity to hyperosmotic stress and cell 
wall-destabilizing agents, indicating importance of Ras1 pathway for cell wall 
integrity. Both RAS1 and RAS2 mutants are more susceptible to Amphotericin B than 
wild type strains. Additionally, disruption of these genes did not change significant 
expression of ergosterol synthesis genes. This evidence implies Ras proteins can 
regulate cryptococcal resistance to AMB without interference with ergosterol 
production 141. Given Ras and cAMP/PKA signaling pathway involvement in 
susceptibility to stress response and AMB, their components are potential targets for 
discovery of potent antifungal therapy. 
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1.6 Galleria mellonella infection model 
In vitro and in vivo infection models have been used to investigate pathogenicity of 
Cryptococcus pathogens. Many cryptococcal virulence traits are only induced in 
hosts because in vitro models cannot completely mimic the stresses that cryptococci 
encounter in vivo, such as phagocytosis, nutrient deprivation, elevated temperature, 
etc. The mammalian model most frequently used is intranasal inoculation of mice 
(Mus musculus), which is expected to simulate the naturally occurring infection 
process 160. However, mammalian models using mice, rats and rabbits are costly, 
have small brood size, are time-consuming and have significant ethical 
considerations.  
The finding that pathogenesis attributes involved in cryptococcal virulence remains 
similar in both vertebrate and invertebrate hosts make the latter appealing for study 
of fungal pathogenesis in mammalian hosts. Genes associated with mamalian 
virulence (CAP59, GPA1, PKA1, RAS1, PKA1) have also been demonstrated to be 
significant virulence factors in invertebrate models including Caenorhabditis elegans, 
Drosophila melanogaster and Galleria mellonella 98 161.  
The larval stage of the greater wax moth Galleria mellonella (Figure 1-15) has been 
extensively employed as a model of the innate immune response to study the 
pathogenesis of a number of microbial pathogens, from bacteria to fungi: Bacillus 
cereus, Acinetobacter baumannii, Listeria monocytogenes, Staphylococcus aureus, 
Candida albicans, Aspergillus fumigatus, Aspergillus flavus, C. neoformans 162. The 
innate immune response is a critical component of the mammalian immune system 
response to infection, and it has been shown that comparable data are obtained 
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when both the murine and wax moth larval model are used to study pathogenesis 
163–165. Moreover, larvae are cheaper to purchase, easier to maintain, thermotolerant 
and are not subjected to the same ethical issues as mammals. Results are available 
within two weeks. Therefore, they are used to screen a large number of isolates for 
virulence or to assess efficacy of antifungal/antimicrobials. The selection of the G. 
mellonella model depends on the research question and innate immune response of 
interest. However, if the question pertains to organ dissemination or organ-specific 
fungal burden (brain, lung, spleen), then the G. mellonella is not appropriate simply 
because the larvae do not have comparable structures to such organs. 
 
 
 
 
 
 
 
Figure 1-15 Larvae of the greater wax moth Galleria mellonella 
The immune system of G. mellonella possesses a number of functional and structural 
homology to the innate immune system of vertebrates, including humoral and 
cellular defenses 162.  The humoral immune response mediates larval melanization, 
hemolymph clotting and antimicrobial peptides while the cellular response mediates 
phagocytosis and nodulation (encapsulation of pathogens within layers of 
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hemocytes). Larval hemolymph functions similarly to blood in higher animals. It 
transports nutrients, waste and immune cells called hemocytes. At least six types of 
hemocytes have been identified which function similarly to human neutrophils 
through phagocytosis and generation of superoxide to protect against pathogens 165.  
The G. mellonella model has been used to test efficacy of antifungals (Amphotericin 
B, Fluconazole, Flucytosine when used alone or in combination 98. The combination 
of Amphotericin B and Flucytosine is more effective than Amphotericin B alone in 
this model. The G. mellonella model has been shown to delineate the major 
molecular types of C. gattii strains (VGI, VGIIa, VGIIb, VGIII and VGIV) 166. In another 
study, titan cells were observed in larvae infected with C. neoformans, and G. 
mellonella extract can induce capsule enlargement when cultured with C. 
neoformans in vitro 167. One weakness of the G. mellonella model so far is that 
standardised conditions for maintenance and reproduction of larvae have not been 
established yet, which could make inter-laboratory comparisons difficult. A recent 
study demonstrated that larvae deprived of food 7 days prior to infection were more 
susceptible to C. albicans than unstarved larvae. Proteome analysis of hemolymph 
from starved larvae shown reduced expression of antimicrobial peptides and 
immune proteins, which is likely to enhance susceptibility of larvae to infection .168 
1.7 Rationale and importance of studies in this thesis 
Growing evidence underlines C. neoformans var. grubii as a prominent pathogen 
causing infection in both immunocompetent and immunosuppressed patients 1 86 87. 
In Vietnam, Day et al. identified an AFLP-defined cluster of VNI they termed VNIγ 
(later identified to be MLST sequence type 5, and genomic lineage VNIa-5 (Ashton et 
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al, https://www.biorxiv.org/content/biorxiv/early/2018/06/28/356816.full.pdf) 
responsible for the majority of infection (>80%)  in apparently immunocompetent 
patients86 88. Therefore, I hypothesize that the ST5 lineage has increased 
pathogenicity compared with other Cryptoccocus neoformans strains. The HIV 
infection prevalence rate in Vietnam is relatively low at approximately 1% of adults. 
The fact that ST5 isolates only account for ~35% of disease in the HIV infected 
population suggests it is not the dominant strain circulating in the environment, if 
they truly have increased pathogenicity. The lineage ST5 is of great interest because 
it also predominates in China and neighbouring countries in north eastern Asia 
(Japan, Korea) where disease in HIV-uninfected patients has been frequently 
reported169.  
The ability to cause human disease is likely a by-product of adaptation to a particular 
environmental niche, which accidentally confers pathogenicity. I hypothesize that 
the proposed increased pathogenicity of the ST5 isolates is a result of adaptation to 
a particular ecological niche. Identifying the ecological niches of environmentally 
required cryptococcal pathogens could enable the management of potential 
cryptococcosis outbreaks. Associations between outbreaks and ecological niches of 
Cryptococcus have been established in endemic areas around the world, with the 
identification of native trees and avian droppings as sources of infectious propagules 
26,52,53,57. However, the veracity of these findings is undermined by the fact that 
environmental sampling has never been randomised, and thus the results of 
environmental sampling cannot be assumed to be representative of the true 
environmental population. A comprehensive and randomised sampling approach to 
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interrogating the ecology of Cryptococcus is warranted, to better understand both 
the prevalences of different lineages, and to accurately describe the ecology. 
Understanding cryptococcal adaptation to ecological niches may provide insight into 
how pathogenic forms emerge. 
The globally predominant strain is the VNI, serotype A lineage, which is isolated from 
both clinical and environmental settings. Person to person spread is not considered 
to be a method of disease acquisition; therefore, competent pathogenic isolates are 
definitely present in the environment. However, there are discrepancies in virulence 
between clinical and environmental isolates, this having been described in the USA 
(North Carolina, California), Brazil, and Puerto Rico. It is not clear whether this 
discrepancy relates to microevolution within major lineages, or is some epigenetic 
effect. The wide dispersal of strains from HIV uninfected patients throughout the 
VNIa-5 lineage (Figure 1-6) suggests that all strains within this lineage have the 
potential to be highly pathogenic (cause disease in immunocompetent patients). The 
cause of variability in pathogenicity of strains identical in genotype but from 
different sources is intriguing. Understanding the mechanism that defines this 
variability could lead to the discovery of novel drug targets.  
1.8 Aims of the thesis 
a. To determine whether there is temporal-spatial clustering of C. neoformans by 
genetic lineage and HIV status in Vietnam  
b. To identify ecological niches associated with these lineages; 
c. To define the diversity of the Vietnamese C. neoformans population in the 
environment and prevalence of particular lineages; 
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d. To characterise the virulence phenotypes of environmental Cryptococcus isolates; 
e. To compare the virulence between and within different genotypes and sources 
using the G. mellonella model;   
f. To define the transcriptional differences associated with variability in virulence  
g. To identify gene candidates associated with variability in virulence between 
isolates. 
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Chapter 2  
Spatial-temporal trends in cryptococcal meningitis at the Hospital for 
Tropical Diseases, Ho Chi Minh city 
2.1 Introduction 
The estimates of the global burden of HIV-associated cryptococcal meningitis were 
revised in 2014 at 230,000 cases per year1. This human epidemic has driven a 
number of efforts to identify the spatial distribution and ecological niche of the 
responsible pathogens C. neoformans and C. gattii. The ecological niche of a species 
is defined as an area with favourable physical and biological conditions within which 
the species can survive and reproduce to maintain its population, without the need 
for immigration170. Understanding the ecological niche of a pathogen should give 
insight into the evolution of its pathogenesis and might allow control or 
interventions. For C. neoformans, the association with pigeon excreta was identified 
in North Carolina, USA by Litvintseva et al in 2004171. The importance of trees and 
the link with the eucalyptus tree was identified by Ellis et al in Australia in 199050. 
Since these seminal studies, there have been a number of efforts to identify the 
ecological niches of these species elsewhere. An association with avian guano has 
been identified in birds, including in southeast Asia, where (dried) chicken guano was 
an found to be a source in suburban areas of Phayao province, northern Thailand57. 
In South America, environmental sampling in Columbia identified C. neoformans 
serotype A to be the most prevalent type, followed by C. gattii serotypes B and C172. 
Here, the Cryptococcus gattii  VGIII molecular type (serotype C) was associated with 
almond trees (Terminalia catappa)172. In Zambia, Africa, Fisher et al found 
adaptation of environmental C. neoformans isolates lineage VNB (87%) were  almost 
found in rural areas dominated by mopane trees while the majority of clinical 
isolates (76%) belonged to lineage VNI 173.  
However, until the C. gattii outbreak in British Columbia, there has been little 
evidence of clustering of human disease. Driven by interest in the Canadian outbreak 
of C. gattii disease, Kidd et al investigated ecological determinants of C. gattii 
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colonization in British Columbia and the northwestern United States. They identified 
colonization hot spots which consisted of acidic soil associated with low moisture 
and low organic carbon content53. In Vietnam C. neoformans VNI is responsible for 
almost 100% of cryptococcosis in HIV infected patients at the Hospital for Tropical 
Diseases (HTD), Ho Chi Minh City. Disease also occurs in HIV uninfected patients, 
who usually do not appear to have associated underlying immune deficit. 
Cryptococcus gattii is responsible for about 20% of disease in these patients, and the 
rest are due to Cryptococcus neoformans molecular genotype VNI. Using AFLP, we 
previously defined 2 clusters of VNI circulating in Vietnam which we termed VNIϒ 
and VNI.  VNIϒ strains  caused 84 % of infection in HIV-uninfected patients, but only 
38% of disease in HIV-infected patients (odds ratio, 8.30; 95% CI, 3.04 to 26.6; P < 
0.0001)86. We subsequently used the consensus MLST scheme to show that the VNIϒ 
precisely corresponded to MLST ST5, and we hypothesize that the VNIϒ/ST5 cluster 
has increased pathogenicity compared to other VNI clades. Since C. neoformans is 
primarily an environmental saprophyte, this increased pathogenicity presumably 
represents an adaptation to a particular ecological niche which coincidentally 
confers increased pathogenicity. 
Statistical methods have been widely used to determine spatial variation of infection 
outbreak. One type of variation analysis is clustering analysis which examines if 
geographical cluster of disease occurs by chance alone. Detection of temporal-spatial 
cluster was important for infectious disease surveillance, such as dengue, malaria, 
hand foot mouth disease, West Nile virus, Hanta virus, typhoid fever 174–179.  
OUCRU and HTD have enrolled significant numbers of patients into cryptococcal 
meningitis trials. This represents an opportunity to identify whether there is 
clustering of cases, which should provide insights into the ecology of C. neoformans 
in the south of Vietnam. Understanding adaptation of pathogens to ecological niche 
will pave the way to understand how they emerge as pathogens. In this chapter I 
shall focus on a retrospective analysis of clinical isolates in Vietnam collected over 15 
years through our trials.  
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2.2 Aims 
My aims in this chapter are to: 
1. Identify the geographical distribution and clustering of cryptococcal meningitis 
cases in southern Vietnam due to C. neoformans seen at the Hospital for Tropical 
Diseases and Cho Ray hospital over 15 years 
2. Identify whether spatial-temporal clustering of clinical C. neoformans occurs by 
HIV status 
3. Identify whether spatial-temporal clustering of clinical C. neoformans occurs by 
lineage 
4. Identify whether there is clustering of C. neoformans sequence type 5 from HIV-
infected patients for targeted environmental sampling in chapter 3 
My analyses are limited to patients for whom I had viable Cryptococcus neoformans 
isolates. 
2.3 Methods and Materials 
2.3.1 Strains 
I used data from cases of cryptococcal meningitis who had been enrolled in clinical 
trials at the Hospital for Tropical Diseases (HTD) and Cho Ray hospital (CRH), Ho Chi 
Minh City. The studies included a prospective descriptive study of cryptococcal 
meninigitis in HIV uninfected patients, a randomised controlled trial of antifungal 
therapy for cryptococcal meningitis in HIV infected patients, and a randomised 
controlled trial of adjunctive treatment for HIV associated cryptococcal meningitis180 
67 66. A total of 409 C. neoformans isolates were available. All isolates were geocoded 
to level of the the patient’s home address. All isolates had undergone whole genome 
sequencing within OUCRU and had been assigned to one of 7 major lineages: VNIa-4, 
VNIa-5, VNIa-32, VNIa-93, VNIa-outlier, VNIa-X and VNIb (manuscript under review, 
Philip Ashton et al). Of note, because no intervention trials were running for a period 
spanning 2011 into 2012, there is a break in recruitment of HIV-assocaited 
cryptococcosis patients during this period.  The number of strains assigned to each 
lineage is presented in Table 2-1. 
 
 63 
 
 
 
 
 
 
 
 
Table 2-1 Frequency of different genomic lineages of C. neoformans in the study 
2.3.2 Spatial-temporal cluster analysis 
The discrete Poisson model was used for the retrospective space-time scan statistic 
to detect spatial-temporal clusters with high rates of cryptococcosis per 100000 
person-years181. Human population data was resolved to the district level for 15 
years (2000 to 2014). The space-time scan statistic is a cylindrical window with a 
circular geographic base and height corresponding to the time period. The cylindrical 
window is then moved in space and time to scan for each possible geographical 
location and size at each possible time period. The relative risk is calculated inside 
and outside each window as well as log likelihood ratio. The window with the 
maximum likelihood constitutes the most likely cluster. Using Monte Carlo 
hypothesis testing, a P-value was obtained by comparing the rank of the maximum 
likelihood from the study data set with the maximum likelihoods from 999 
simulations of the random data set.  
The P-values are adjusted for the multiple testing due to multiple cylinders 
corresponding to different spatial and temporal locations and sizes of potential 
clusters. Secondary clusters were ordered according to their likelihood ratio test 
statistic and were reported if they did not geographically overlap with the most likely 
cluster. The cluster is significant if its simulated p-value was <0.05. The maximum 
spatial cluster size were set as <50% of the total population.   
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2.3.3 Covariate adjustment 
In addition, I analysed clustering with adjustment for age and gender as covariates. 
These covariates were taken into account as categorical variables for the analysis181. 
I chose to adjust for these covariates because they are related to the disease. In 
Vietnam, cryptococcal meningitis is more frequently diagnosed in males compared 
with females. Age group is not randomly distributed. Young adults (26-36 years-old) 
are more prone to infection compared with other age groups (Table 2-2) 
 
 
 
 
 
 
 
 
Table 2-2 Characteristics of 409 patients included in the analysis 
2.3.3 Statistical analysis 
Statistical analyses were performed using R version 3.1.2 (R Foundation for Statistical 
Computing, Vienna, Austria). Fisher’s exact test was used to determine associations 
between ST5 and HIV-uninfected patients, and associations between ST5 and urban 
areas. The discrete Poisson model for spatial-temporal cluster analysis was 
performed using SatScan v9.4 (Maryland, USA). A P value of ≤0.05 was considered to 
be statistically significant. 
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2.3.4 Experimental workflow 
Experiment workflow for this chapter is presented below 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-1 Experimental workflow of chapter 2 
 
 
 Identify geographical distribution of cryptococcal meningitis 
cases due to C. neoformans seen at the Hospital for Tropical 
Diseases and Cho Ray hospital over 15 years 
 Identify whether spatial-temporal clustering of clinical C. 
neoformans occurs by HIV status. 
 Identify whether spatial-temporal clustering of clinical C. 
neoformans occurs by lineage 
 Identify clustering of C. neoformans sequence type 5 from HIV 
patients for target environmental sampling (in chapter 3) 
Hypothesis: Cases of cryptococcal meningitis were 
randomly distributed in southern Vietnam 
Determine geographical distribution of cryptococcal 
meningitis cases in Southern Vietnam 
 
Investigate spatial-temporal 
clustering of clinical C. 
neoformans by HIV status 
 
Investigate spatial-temporal 
clustering of clinical C. 
neoformans by lineage 
 
Identify geospatial clustering of 
C. neoformans ST5 derived from 
HIV-infected patients for target 
environmental sampling 
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2.4 Results 
2.4.1 Geographical distribution of C. neoformans 
Over the past 15 years the number of cases of cryptococcal meningitis presenting to 
HTD and CRH each year has been distributed unevenly. The number of cases 
increased slowly from 2000, peaking in 2005 (Figure 2-2). This trend then decreases 
slowly when we did not recruit HIV patients for trials in 2011-2012. The trend 
reaches another peak in 2013 when the CryptoDex trial began recruitment. 
Cases of cryptococcal meningitis seen at these hospitals had an uneven distribution 
from across the south of Vietnam, being distributed from Ca Mau at the southern tip 
of the country, to Hue in central region, with the highest number being from Ho Chi 
Minh city (207 cases, 51%) (Figures 2-3 & 2-4). Of 409 cases, 59 were isolated from 
HIV-uninfected patients. Lineage VNIa-5 was highly associated with HIV-uninfected 
patients (P value < 0.001, Fisher’s exact test). HIV-uninfected patients travelled from 
as far north as Hue in central Vietnam to access treatment in Ho Chi Minh City. There 
were no cases in HIV infected patients from further north than Binh Dinh province. 
 
 
 
 
 
 
Figure 2-2 Longitudinal number of HIV-associated (A) and non-HIV cryptococcosis (B) 
cases in Vietnam from 2004 to 2014. Cryptococcosis count represents total number 
of cryptococcosis in Vietnam by year. There are no data for HIV–associated 
cryptococcal infection in 2011-2012 (we were not recruiting into a trial in those 
years). 
 
 
A B 
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Figure 2-3 Geographical distribution of cryptococcal meningitis from HIV-infected 
and HIV-uninfected patients at the province level from 2000 to 2014. Each dot 
represents a single case. 
Figure 2-4 Number of cryptococcosis cases in Vietnam at district level from 2000 to 
2014. The darker the colour is, the more cryptococcosis cases in each district. 
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The number of cryptococcosis cases in Ho Chi Minh city for 15 years was presented 
below (Figure 2-5). There are more cases from the north of the city, likely driven by 
the higher population density compared with the south (4898 people/km2 vs 190 
people/km2). The majority of districts in southern HCMC are rural areas, covered by 
mangrove forest and sparsely inhabited. However, the highest burden of disease was 
in Binh Thanh district, which ranks only third for total population, and 12th in 
population density compared with other districts. In the Mekong delta, the largest 
number of cryptococcal meningitis cases came from An Giang province, which is the 
most populous. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-5 Number of cryptococcosis cases in Ho Chi Minh City area at the district 
level over the period 2000 to 2014. The darker the colour is, the higher the 
cryptococcal meningitis count in each district. The red cross indicates the site of HTD 
2.4.2 Clustering of C. neoformans in Vietnam 
Overall I identified two clusters of cryptococcal meningitis (Figure 2-6).  Of the two 
clusters, cluster 1 is the most likely cluster – twice as many number of cases as the 
secondary cluster (cluster 2). Cluster 1 is smaller (radius= 90 km) spanning half of Ho 
Chi Minh city, Dong Nai and Vung Tau while cluster 2 (radius=127 km) covers most of 
the Mekong delta. Cluster 1 contained 115 cases occurring over the years 2004 to 
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2007; cluster 2 contained 61 cases and occurred during the years 2004 to 2011. 
Within cluster 2, Long Xuyen had the highest burden of cryptococcosis (7 cases).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-6 Temporal–spatial clustering of C. neoformans in Vietnam. The radius of 
cluster 1 is much less smaller than that of cluster 2 (90 vs 127 km). Each dot 
represents a single isolate from a patient. The red cross indicates the site of HTD 
2.4.3 Clustering of C. neoformans in Vietnam adjusted by age and gender 
Figure 6 shows temporal-spatial clustering of C. neoformans in Vietnam after 
adjustment for age and gender. The number of cases in the most likely cluster 
(cluster 1) remained unchanged. The number of cases in the secondary cluster 
(cluster 2) drops by 234 % because the time frame shrinks and spans only three years 
(2004-2006). 
1 
2 
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 Figure 2-7 Temporal–spatial clustering of C. neoformans in Vietnam. Each dot 
represents a single isolate from a patient. 
 
 
 
 
 
 
 
 
 
 
 
2 
1 
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2.4.4 Cluster of cryptococcosis by HIV status 
Analysis of cases of cryptococcal meningitis associated with HIV revealed that there 
appeared to be two clusters (Figure 2-8). Cluster 1, the most likely cluster, contained 
more than four times as many cases as cluster 2. The time frames of these clusters 
coincided with the peaks of HIV associated cryptococcosis (Figure 2-2) 
 Figure 2-8 Temporal-spatial clustering of C. neoformans in HIV patients. The radius 
of cluster 1 is 1.8 times smaller than that of cluster 2 (88 vs 155 km) but it is more 
populous than cluster 2 (144 vs 35 cases). 
2.4.5 Cluster of cryptococcosis by HIV status adjusted by age and gender 
When I adjusted for age and gender, I identified only a single cluster of C. 
neoformans in HIV patients (Figure 2-9). This was large (r=247 km) and spanned 
more than half of Ho Chi Minh city and the whole Mekong delta. However, the 
1 
2 
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number of cases in the cluster was smaller than the result before adjustment (87 vs 
144).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-9 Temporal-Spatial clustering of C. neoformans in HIV patients after 
adjustment for age and gender. 
2.4.6 Cluster of cryptococcosis from HIV-uninfected patient 
I also analysed clustering of 59 cases from HIV-uninfected patients from 2000 to 
2014. There was no clear temporal-spatial clustering, with a distribution that 
appeared to be random (P=0.22, before adjustment and P=0.155, after adjustment 
of age and gender). VNIa-5 was the dominant lineage in HIV-uninfected patients, 
accounting for 71% (42/59) of all lineages. Additionally, VNIa-5 strains also scatter 
more widely than other strains (Figure 2-10).  
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Figure 2-10 Spatial distribution of lineages in HIV-uninfected patients. 
Dispersal of VNIa-5 isolates is wider than other lineages. 
2.4.7 Clustering of cryptococcosis by lineage 
C. neoformans  was distributed unevenly in Vietnam by lineage. Table 2-1 lists the 
number of strains of each of the major WGS -derived lineages circulating in our 
patients. VNIa-outlier and VNIb were seen only in patients from Ho Chi Minh city 
whereas infection due to VNIa-X strain was only seen in patients from the Mekong 
delta (Figure 2-11). Disease due to the lineages VNIa-32 and VNIa-93 were more 
prevalent in Ho Chi Minh city (11/19 and 25/44 cases, respectively) than other 
provinces (Figure 2-12). Lineages VNIa-4, VNIa-5 and VNIa-32 formed 3 distinct 
clusters. The lineage VNIa-4 cluster was the largest in terms of number of cases 
(Figure 2-13), and was to the west of HCMC near the border with Cambodia. Despite 
the higher frequency of disease due to lineage VNIa-93 (44 cases compared with 19 
cases of lineage VNIa-32), I could not detect any evidence of clustering (P = 0.4).  
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Figure 2-11 Geographical distribution of C. neoformans by lineage from 2000 to 
2014. Each dot indicates a single strain from a patient. 
 
The lineage VNIa-5 cluster partly overlapped both the lineage 4 and lineage VNIa-32 
clusters (Figure 2-13). HIV-uninfected cases were only found in the lineage VNIa-5 
and lineage VNIa-32 clusters. Of the three clusters, the lineage VNIa-32 cluster was 
formed in the shortest time frame (2004-2006). 
Lineages VNIa-4, VNIa-5 and VNIa-32 were the most dominant in 2005, accounting 
for 45% (30/67), 40% (27/67), and 10% (7/67) of all strains in that year (Figure 2-14). 
Overall, lineage VNIa-4 was the most abundant (179 cases), but lineage VNIa-5 was 
the most persistent being isolated every year for 15 years (Figure 2-14). In contrast, 
strains of the lineage VNIa-X, VNIb and VNIa-outlier were scarce with only one case 
detected and thus it was not possible to demonstrate clustering. Of the three main 
clusters, the lineage VNIa-4 cluster was the largest (125 km in radius compared to 
104 km for the lineage VNIa-5 cluster and 76 km for the lineage VNIa-32 cluster). 
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Figure 2-12 Spatial distribution of VNIa-32 and VNIa-93 strains from 2000-2014. The 
majority of these strains were derived from patients in Ho Chi Minh city 
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Figure 2-13 Space-time clustering of C. neoformans strains in lineage VNIa-4, VNIa-5 
and VNIa-32 from 2000 to 2014. 
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Figure 2-14 Annual distribution of C. neoformans by lineage from 2000 to 2014 in 
Vietnam. Strains of the lineage VNI-5 occurred every year, whereas strains of the 
lineage VNIb, VNIa-outier and VNIa-X were quite scarce with occurrence in one year 
for each case. 
2.4.8 Clustering of cryptococcosis by lineage after adjustment for age and gender 
Figure 2-15 shows temporal-spatial clusters of three lineages (4, 5 and 32) following 
adjustment for age and gender. The number of cases increases within the lineage 4 
cluster after adjustment although the time frame shrinks. The lineage 4 and 32 
clusters remained spatially separate but they still overlapped with the lineage 5 
cluster. The lineage 4 cluster remained the largest in terms of both cases and radius. 
Clustering of lineage 93 was not detected. 
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Figure 2-15 Space-time clustering of C. neoformans strains in lineages VNIa-4, VNIa-5 
and VNIa-32 after adjustment of age and gender from 2000 to 2014 
2.4.9 Clustering of sequence type 5 strains 
Strains of sequence type 5 (ST5) are of particular interest because they are 
associated with HIV-uninfected patients88. Cluster analysis of ST5 strains derived 
from HIV-negative patients (40 cases) was performed but gave no significant cluster, 
probably because of the wide dispersal and relatively low numbers of HIV-uninfected 
patients with cryptococcal meningitis (data not shown). Therefore, I analysed the 
cohort of HIV infected patients for this lineage (N=103). I detected a cluster of 25 
cases (relative risk 2.88, P-value=0.017), with a radius of 111km, spanning the 
southwest of Ho Chi Minh City and the adjoining part of the Mekong delta (Figure 2-
16). Within the cluster, 18 out of 25 cases (72 %) came from urbanised areas (Ho Chi 
Minh City and Vung Tau city), and the remaining 7 (32 %) from predominantly rural 
environment in the Mekong delta (P = 0.0046). The consistency of this cluster 
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suggests the prevalence of environmental C. neoformans lineage VNIa-5 is 
significantly higher in urban rather than rural areas. I use the identification of this 
VNIa-5 cluster for targeted environmental sampling in the next chapter. 
Figure 2-16 Space-time clustering of ST5 isolates from HIV-positive patients (25 
cases, time frame 2005-2006, P-value = 0.017). The inset features southern Vietnam 
and part of Cambodia. 
2.5 Discussion 
I am interested in understanding the epidemiology and ecology of Cryptococcus 
neoformans in Vietnam. As an initial step, I used data from our clinical studies 
previously performed at the Hospital for Tropical Diseases and Cho Ray hospital, to 
understand geographical and time trends in this disease in Vietnam. Mapping clinical 
data can at least give an indication of the distribution of lineages of medical 
importance. Of note clinical trials at OUCRU are designed within a pragmatic 
framework, the aim being to ensure that the results of trial findings are relevant to 
the general patient population. To achieve this, it is essential that the trial 
population is representative of the wider patient population. This is achieved by 
minimizing inclusion and exclusion criteria. Because of this, it is likely that the isolate 
populations used in my studies are essentially representative of the wider 
population, with the exception of the break in study activity in 2011-2012. People 
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are infected with C. neoformans by inhaling desiccated yeasts or basidiospores from 
their surroundings, mostly their residence, from early childhood 70. Thus the 
interpretation of mapping data from clinical cases is complicated by the fact that the 
incubation/latent period of infection with C. neoformans can be long and can be 
variable. It may even be variable between lineages, particularly if there is variability 
in the pathogenicity of lineages. I assumed that the majority of patients got infected 
with C. neoformans near their home, and that the majority of patients within my 
study set continue to live near the site of infection. However, I cannot be sure that 
this is the case since these data (migration history) were not gathered within the 
clinical trials, this not being their primary purpose. A further weakness of my study is 
that there was a break in the recruitment of HIV infected patients during 2011 and 
2012 because there was no active clinical trial at that timepoint (HIV uninfected 
patients continued to be enrolled into a prospective descriptive study of CNS 
infections). A further potential weakness of my study is that I have assumed that the 
patient referral patterns to HTD have not changed over time. I had to do this, 
because it was not possible to obtain hospital referral data by patient address over 
the 15 years of this retrospective study. However, I have no particular reason to 
suspect that referral patterns for this disease will have changed much over time. 
Despite these limitations, an ecological niche of C. gattii in British Columbia, Canada 
was successfully modeled using clinical records followed by validation using 
nontravel cases (animal and environmental samples)170 . 
2.5.1 Overall distribution of cryptococcosis in southern Vietnam 
The prevalence maps (Figure 2-3 and 2-4) show that half of the country was in the 
catchment area for our hospital (from Hue to Ca Mau). No cases in our hospital were 
from the big cities of the Central Coast, such as Da Nang and Nha Trang. This may 
reflect the fact that such patients would have received treatment in local hospitals, 
although complicated and unusual infections are usually referred on through well-
trodden and established referral paths. In provincial hospitals, tuberculosis 
meningitis (TBM) is the third most common CNS infections. Diagnosis of TBM is 
complicated due to non-specific manifestations and the need for prolonged 
specialized culture. The low sensitivity, and lack of awareness of cryptococcal disease 
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could lead to either completely missing, or late diagnosis, of cryptococcal meningitis. 
However, tuberculosis is common in Vietnam, and TBM is a diagnosis that is readily 
considered in patients not responding to treatment. There are well established inter-
hospital referral patterns in Vietnam, particularly for TB; therefore most cases of 
cryptococcal meningitis, if not diagnosed, would at least be referred to large tertiary 
centres such as the Hospital for Tropcial Diseases or Pham Ngoc Thach TB hospital, 
and the diagnosis of cryptococcal meningitis is likely to be made. Diagnoses made at 
the TB hospital are transferred to the Hospital for Tropical Diseases. Moreover, a 
well-resourced prospective surveillance study of CNS infections in district and 
provincial hsopitals (2007-2010) found only two cases cryptococcal meningitis out of 
1241 patients with syndromes consistent with CNS infection182. Therefore, for our 
region, the south of Vietnam, it is possible that my data in fact do cover the vast 
majority of cases.  
I identified a peak number of cryptococcal meningitis cases in 2005. The President’s 
Emergency Plan for AIDS Relief (PEPFAR) was instigated in Vietnam around 2005 and 
has had a dramatic effect in delivering antiretroviral therapy (ART) to patients, and 
subsequently reducing the risk of opportunistic infections. For this to be the reason 
that the number of cases of cryptococcal meningitis fell in subsequent years implies 
that the incubation period is short, in the order of a matter of months, for a 
significant number of patients. Alternatively it may represent a change in referral 
pattern or health seeking behavior by HIV infected patients around this time, 
although I have no data to support this occurring. 
Most cases of cryptococcal meningitis occurred in Ho Chi Minh city, the Mekong 
Delta and the Southeast, which are the regions with the most patients living with HIV 
183. Ho Chi Minh has an HIV prevalence of 1.25% as opposed to 0.5% for the country 
overall 183. Moreover, HCMC population density is highest in Viet Nam (General 
Statistics Office; http://www.gso.gov.vn). Taken together, these factors drive the 
highest burden of cryptococcosis and the most likely clusters of C. neoformans 
spanning HCMC and bordering well-developed provinces in the Southeast - Ba Ria 
Vung Tau and Dong Nai (Figure 2-7). In the Mekong delta, An Giang, the most 
populous province, has the highest burden of the disease (Figure 2-6). In southern 
 82 
 
Vietnam, the dry season mostly occurs from May to November wherease the 
monsoon lasts from December to April. There is no evidence about dramatic change 
of climate during the study period, so climate may not change the overall 
distribution pattern of cryptococcal meningitis.  
2.5.2 Clustering of cryptococcal meningitis in southern Vietnam 
I hypothesized that cases of cryptococcal meningitis were randomly distributed in 
southern Vietnam. However I found two temporal-spatial clusters of cryptococcal 
meningitis. The most likely cluster (cluster 1) covers half of Ho Chi Minh city and the 
Southeast (Figure 2-7). After adjustment for age and gender, the size of cluster 1 did 
not change, suggesting age and gender did not interfere with overall clustering. 
Cluster 1 may be driven by the high prevalence of HIV in HCMC, where the 
percentage of adults (age 15-49) living with HIV is the highest in the country (1.25 % 
compared with 0.51 % for Vietnam as a whole in 2005)183 
2.5.3 Clustering of C. neoformans is associated with HIV 
I identified temporal-spatial clustering of cryptococcal meningitis within HIV 
patients. However, the time frame of the cluster may be driven by the recruitment of 
cryptococcosis patients during the trial. The cluster covers half of Ho Chi Minh city 
and all of the Mekong delta. However, age and gender did appear to interact with 
this clustering (Figure 2-9). HIV-unassociated cases of cryptococcal meningitis 
appeared to be scattered randomly and more widely than HIV patients (Figure 2-3). 
HIV-uninfected patients were highly associated with lineage VNIa-5 infections (Table 
1). This association suggests that lineage VNIa-5 may have increased ability to cause 
disease (pathogenicity). Increased pathogenicity may be due to adaptation to an 
ecological niche. My observation suggests that C. neoformans VNIa-5 strains are 
better able to adapt to different ecological habitat to expand their distribution 
(Figure 2-3 & 2-10). Expansion of ecological habitats has been occuring with C. gattii 
VGIIa, which caused the cryptococcosis outbreak in Vancouver Islands10. 
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2.5.4 Lineage-specific clustering of C. neoformans 
I found three distinct clusters of VNIa-4, VNIa-5 and VNIa-93, suggesting 3 distinct 
reservoirs of these lineages in the environment. Of three lineages, the lineage VNIa-
32 cluster was formed in the shortest time frame, suggesting the outbreak of C. 
neoformans lineage VNIa-32 strains within this time (2004-2006). 
Lineage VNIa-93 strains were more prevalent than lineage VNIa-32, however only 
lineage VNIa-32 strains significantly cluster. The random distribution of lineage VNIa-
93 may indicate their wide dispersal in the environment. Lineage VNIa-93 is a highly 
clinically significant cause of disease in Africa, where it is the most frequently 
isolated strains with 61% of isolates belonging to this lineage 184, but it is a relatively 
infrequent cause of disease in Vietnam (Ashton et al, manuscript under review). The 
lack of clustering seen with this strain would be consistent with imported disease; 
however, I lack travel histories for my patients although frequent travel to and from 
Africa by Vietnamese during the time period of this study was uncommon. Instead, 
these strains could be dispersed into Vietnam either by birds or the wind. Infection 
with lineage VNIa-93 is associated with a significantly reduced risk of mortality by 10 
weeks (Hazard Ratio = 0.45, p = 0.003) (Ashton et al, manuscript under review). The 
clustering of lineage VNIa-32 around Ho Chi Minh city suggesting these isolates are 
adapted to urban area (Figure 2-13). The cluster of lineage VNIa-4 disease that I 
identified in the Mekong Delta consisted of a large number of strains over an 
extended period (6 years after adjustment of age and gender). This suggests the 
Mekong delta is a favoured ecological niche for this lineage. This cluster extends to 
the Cambodian border; in Thailand MLST types ST4 and ST6 account for the vast 
majority of infections (Thanh et al, manuscript under review), and thus clustering to 
the west of Ho Chi Minh City is perhaps not surprising. The lineage VNIa-4 cluster 
had the largest area (radius of 164 km), implying a widespread favourable habitat for 
this isolates disperse. The persistence of lineage VNIa-5 infection over 15 years, with 
consistent recovery of disease due to this lineage, implies it is well adapted and 
indigenous to the Vietnamese environment. 
Spatial clustering detection has been used to investigate the epidemiology of 
dengue, malaria, encephalitis, typhoid fever, leukemia incidence, etc. 177,185–187 .This 
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is the first study to investigate temporal-spatial clustering of cryptococcal meningitis 
caused by C. neoformans (VNI). To the best of my knowledge, my study has the 
largest sample size of any cluster detection study (409 isolates derived from 409 
locations). This has been enabled by the large number of cases of disease enrolled 
into clinical trials in a single center. Litvintseva et al found C. neoformans (VNB) is 
endemic to southern Africa and associated with the mopane tree (Colophospermum 
mopane)56. Previously, the ecological niche of the sibling species C. gattii responsible 
for the outbreak in Vancouver Island, British Columbia, Canada in 1999 was 
predicted using human and animal cases and positive environmental locations in the 
endemic area170. C. gattii isolates clustered along the central and south-eastern 
coast of Vancouver Islands. They generally colonized acidic soil with low moisture 
and low organic carbon contents 53. 
The method I used has limitations in that it is unable to detect irregular shaped 
clustering due to its circular scanning  approach 188. The circular scanning tends to 
identify a clusters that are larger than the true cluster by including surrounding areas 
without elevated risks 189. Clustering may be confounded by the fact that I assumed 
people working in Ho Chi Minh city reported their permanent addresses in their 
hometown or elsewhere, and that I did not have travel or immigration histories for 
patients. The patients’ residence may not be the place of infection, and there may be 
long latency between infection and clinical presentation72, making the identification 
of cluster uncertain. When inhaled in lung, the yeasts are likely to be in dormant 
forms for a long time before they are reactivated upon host immune deficit72. In the 
sibling species C. gattii, the duration between exposure to the pathogen and onset 
of cryptococcosis symptoms ranges from 2 to 11 months69.  
2.6 Conclusion 
I found uneven distribution of cryptococcal meningitis in Vietnam, suggesting that 
some areas are relative hot spots for disease and that there is niche adaptation by 
the organism. Ho Chi Minh city has the most cases. I also detected wide dispersal of 
lineage VNIa-5 strains, which implies either that their favourable niche is 
widespread, or that this lineage can adapt to multiple different environments. This 
increased adaptability may also confer enhanced pathogenicity, allowing adaptation 
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to the immunocompetent host. I could not detect evidence of clustering of lineage 
VNIa-5 strains in HIV uninfected patients, although clustering was detected when I 
Iooked at strains associated with HIV infected patients. The failure to show clustering 
in HIV uninfected patients may have been due to lack of power because of the 
relatively low number of cases. Three distinct clusters of lineage VNIa-4, lineage 
VNIa-5 and lineage VNIa-32 were identified, suggesting their adaptation to different 
ecological habitats.  
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Chapter 3  
Environmental sampling and characterisation of environmental 
Cryptococcus spp 
3.1 Introduction 
Cryptococcus neoformans is an environmental saprophyte, and acquisition of 
infection is believed to be the result of inhalation of an infectious propagule (spore 
or yeast) directly from the environment. The lack of person to person spread means 
that it is unlikely that the ability to infect humans has been driven from within the 
human host. Rather, the pathogenicity of Cryptococcus has been considered to be a 
‘bystander’ effect of its adaptation to its ecological niche. The emergence of 
different lineages likely reflects further adaptation to specific environmental 
conditions. Variability in pathogenicity between lineages, such as that exhibited by 
ST5 (i.e. causing disease in apparently immunocompetent hosts) is presumably a 
consequence of such specific niche adaptation.  
The ecology of Cryptococcus species is incompletely described. Established ecological 
habitats include avian droppings (particularly, chicken and pigeon), soil, and decayed 
woods of various tree species, although these have not been interrogated to the 
resolution of MLST. Concordance has been established between clinical and 
environmental isolates recovered from the same geographical areas. For example, 
clinical and environmental isolates of C. neoformans var. neoformans had identical 
RAPD profiles in Nagasaki 190. RAPD and PCR fingerprinting confirmed C. gattii (VGI) 
strains were the molecular group predominantly isolated in eucalypts (100%) and in 
clinical settings (92%) in Australia 191. In southern Africa, endemic C. neoformans var. 
grubii isolates (VNI and VNB) are associated with mopane trees (Colophospermum 
mopane) with 30 % of sampled mopane trees colonized by C. neoformans var. grubii 
56. 
 Some studies have found that the environmental recovery rate of isolates varies by 
season, (dry versus wet), and varies from region to region26,57,192. It is frequently high 
in regions with high prevalence of cryptococcosis but low in others. For example, the 
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recovery rate is up to 32 % in southern Africa but only 0.15 % in Havana, Cuba193 56. 
In northern Thailand, it has been reported that  C. neoformans is more frequently 
isolated from the environment in the dry season compared with the rainy season57. 
However, this contrasts with the situation in Bogota, where the rainy months favour 
the successful isolation of C. neoformans from the environment.194 Of note, there 
does not appear to be seasonal variability in the incidence of human disease, likely 
representing a smoothing effect of latent infection 195. 
It is not clear whether identifying the ecological niche of C. neoformans, or particular 
lineages, would have a pragmatic implication for public health. However, 
understanding the niche may provide insight into the drivers of pathogenicity. Of 
note, previous studies using environmental sampling may have been biased because 
sampling was not randomized 56 171 26. Randomised sampling protects against 
confirmation bias when attempting to define the ecological habitat of C. 
neoformans, and should identify the actual prevalence and diversity of different 
genotypes in the whole population. A potential disadvantage of randomized 
sampling is that it is resource intensive and may produce a lower yield of isolates. In 
this chapter, I aim to understand the ecology of C. neoformans in Vietnam, identify 
whether clustering occurs by species or lineage, and identify specific environmental 
niches that will provide insight into the origins of bystander pathogenesis. I use both 
random and targeted sampling, in both urban and rural areas, in an attempt to 
provide comprehensive and unbiased sample datasets. 
3.2 Aims 
My aims were: 
1. To describe the diversity of Cryptococcus spp. in the environment  
2. To determine whether geographical clustering of C. neoformans isolates 
occurs by MLST defined lineage  
3. To determine whether any association occurs between Cryptococcus 
neoformans lineages and tree species 
4. To characterize the virulence-associated phenotypes of environmental-
sourced Cryptococcus species 
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3.3 Materials and Methods 
3.3.1 Randomised sampling 
I collected environmental samples consisting of tree swabs, sub-canopy soil and air. I 
chose two main types of environment –urban and rural (consisting of mixed farming 
including rice, rubber and village environments). Each sampling area was viewed in 
quantum GIS with a Google Earth plug-in (www.qgis.org) and overlayed with a 22 by 
22 km grid (Ho Chi Minh) or 13 by 11 km grid (Nhon Trach) bisected by gridlines 100 
metres apart using quantum GIS 1.7.4. For each grid I randomly selected 500 gridline 
intersects using R 3.0.0 (Figure 3-1 & 3-2). The chosen intersects were marked as 
waypoints in a Garmin Montana 600 Global Positioning System (GPS) (Garmin Ltd, 
Kansas, USA)  to enable navigation to the precise sampling site. At each site, 
following explanation of the project and obtaining the verbal consent of the 
landowner, the nearest tree to the selected coordinate was sampled. I collected two 
tree swabs, two soil samples and one air sample at each site (1000 sites altogether). 
Tree species were identified using Northern Annamites Tree V.1.0 (National 
University of Laos). Nhon Trach was sampled in the early dry season to monsoon 
(April to August 2014) while Ho Chi Minh City was sampled from late monsoon to dry 
season (November 2014 to January 2015). 
Sterile transport swabs containing Amies medium without charcoal were used to 
swab tree hollows, and overlying bark. A single swab was wiped repeatedly until 
darkened on all sides. Air was collected under each tree canopy for 10 minutes using 
an Oxoid air sampler (Oxoid, Hampshire, UK) with a flow rate of 100 litres of air per 
minute (1000 litres in total). Soil samples was collected within the tree root zone, 
around 5 cm deep from the surface and contained in clean ziplock bags.  
Samples (soil and swab) were placed initially in a cool box for transportation and 
then stored at air conditioned room temperature (25oC) and processed as soon as 
possible but no later than one week following collection. At each sampling site, the 
global positioning system receiver (Garmin) was used to record the longitude and 
latitude of the sampling site.  
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3.3.2 Targeted sampling 
Because of the potential risk of low yield through randomized sampling, I also 
undertook targeted sampling. Targeted sampling, while not likely to deliver a set of 
isolates that are representative of the entire population of Cryptococcus in Vietnam, 
has the advantage of potential higher yield. Targeted sampling had 2 themes – 
sampling environments that I considered were potential habitats based on my 
knowledge of the biology of Cryptococcus spp, and sampling based upon my 
previously identified clusters of clinical cases (chapter 2). Targeted samples included 
tree swabs, soil and air, as described above. Each site had two tree swabs, two soil 
samples and one air sample collected. 
Biological sampling I sampled gecko (n=30) and avian droppings (N = 200; pigeon, 
chicken, wild bird, and duck), and fruits (n=25). Because Cryptococcus infection is 
thought to be due to the inhalation of airborne infectious propagules,  I sampled the 
swabs of fan blades and air conditioner filters, assuming that this machinery 
processed large volumes of air and might therefore serve as a concentration point 
for trapping airborne yeast particles or spores (n=30). In addition I sampled a more 
speculative source, potentially relevant in Vietnam - rice husk (n=20). 
 Clinical cluster sampling I also selected sampling sites based on the result of the 
cluster analysis of the 103 clinical isolates (ST5) derived from HIV patients (Chapter 
2). I went to 25 of the clinical-defined cluster sites and collected environmental 
samples as described above. 
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Figure 3-1 A gridline ( 22 x 22 km) overlaying Ho Chi Minh city satellite imagery with 
500 randomised sampling spots (yellow dots) visualised by QGIS 1.7.4 
 
 
 
 
 
 
 
 
 
Figure 3-2 A gridline (13x11 km) overlaying Nhon Trach with 500 randomised 
sampling spots (yellow dots) visualised by QGIS 1.7.4 
3.3.3  Isolation 
Soil and avian/gecko excreta 
Soil was collected within a tree’s root zone (tree canopy) at 5-10 cm depth. Samples 
were processed as described by Litvintseva et al 171. I suspended 2 - 3 grams of soil or 
guano in 15-mL sterile water by vortexing at 2500 rpm for 2 minutes. The sediment 
was settled for 5 minutes, and then 100-µL aliquot of the supernatant was plated 
onto a Benomyl Bird seed agar plate. Benomyl was added to inhibit ascomycetes 
growth (1.5 ug/mL). It has no effect on basidiomycetes196. I decant 8 mL of 
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supernatant into another 15-mL Falcon tube and centrifuge at 3220 G in 15 mins. I 
poured away 6 mL of the supernatant, resuspended the pellet by vortexing at 2500 
rpm for 2 minutes, and inoculated 100-µL of the suspension onto another modified 
Bird seed agar plate. Incubate all plates at 30oC for at least 3 days. I observed for the 
appearance of characteristic brown colonies from 3 days until 7 days after 
inoculation.  
Bark and tree hollow swabs 
Collected swabs were thoroughly agitated in 6-mL sterile water and then vortexed at 
2500 rpm for 2 minutes. 100-µL aliquot of the resulting suspension was inoculated 
onto a benomyl bird seed agar plate. I then centrifuged the remaining suspension at 
3220 G for 15 mins, poured off 4-mL of the supernatant, resuspended the pellet and 
inoculated 100 µL of the new suspension onto another benomyl bird seed agar plate. 
All plates were incubated at 30oC for at 7 days. I observed for the appearance of 
mucoid or characteristic brown colonies from 3 days until 7 days after inoculation.  
3.3.4 Bird seed agar  
Growth on bird seed agar results in the development of brown colonies due to the 
production of melanin. This medium permits selective recovery of C. neoformans but 
inhibits growth of mold and bacteria197. All mucoid colonies (white, pale or dark) 
were examined for identification of presumptive Cryptococcus species (oval to round 
encapsulated budding yeast forms). 
3.3.5 Biochemical speciation   
The ability of Cryptococcus species to assimilate carbohydrate substrate was used for 
identification using ID 32 C strips (bioMerieux, France). Kits were used according to 
the manufacturer’s instructions. Briefly, a single colony of Cryptococcus spp grown in 
Sabouraud agar was suspended in sterile water to make a suspension with a 
turbidity equivalent to 2 McFarland (compared with a turbidity of 2 McFarland 
standard). Dispensing 135 µL of the suspension into each well of the strips followed 
by incubation at 30oC for 72 hours and then growth is detected by visual reading. 
Fungal identification is obtained using the Api-web identification software 
https://apiweb.biomerieux.com 
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3.3.6 Sequence-based speciation 
3.3.6.1 DNA isolation 
Isolates were revived on Sabouraud’s agar at 30oC for 72 h. Single colonies were 
spread for confluent growth and again incubated at 30oC for 24 h. Chromosomal 
DNA was extracted in accordance with the previously described protocol by Wen et 
al. 198. The resulting DNA pellet was suspended in 100 ul of TE buffer (10 mM Tris-
HCl, 1 mM EDTA, pH 8.0) containing 10 ug of RNAse A. 
3.3.6.2 DNA sequencing 
The nuclear eukaryotic rRNA cistron has been used for fungal phylogenetics for more 
than 20 years199. It consists of 18S, 5.8S AND 28S rRNA genes (Figure 3-3). During 
post transcriptional processing, the cistron splits to remove two internal transcribed 
spacers. These two spacers and the 5.8S are called the ITS region. This highly variable 
region is the most frequently used barcode marker of fungi199. The internal 
transcribed spacer (ITS) region and the intervening 5.8S rRNA gene were amplified 
using universal fungal primers ITS1 (TCCGTAGGTGAACCTGCGG) and ITS4 
(TCCTCCGCTTATTGATATGC), as described by White et al200. These primer pairs are 
complementary to the conserved regions at the end of the 18S and 28S rRNA genes, 
respectively, leading to amplification of the ITS region and the 5.8S rRNA gene. 
Reactions were performed in a 50 ul reaction mixture containing approximately 100 
ng template DNA, 0.2 mM of each primer, 0.2 mM each dATPs, dTTP, dGTP, dCTG; 
2.1 mM MgCl2, 1 U of Taq polymerase (Bioline) and 5 µl of 10X buffer. The 
amplification reactions were performed in a Flexcycle2 (Analytik Jena), with the 
following cycling parameters: initial denaturation step (94oC for 3 mins), followed by 
35 cycles of 94 oC for 30 s, 55 oC for 30 s, 72 oC for 1 min; and a final extension step at 
72 oC for 10 min. PCR amplicons were purified by QIAquick PCR purification (QIAGEN) 
and sequenced with ITS1 and ITS4 primers using the BigDye terminator v.3.1 reagent 
kit (Applied Biosystems) in an automated sequencer (ABI PRISM 3130xL Genetic 
Analyzer, Applied Biosystem).  
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Figure 3-3 Diagram of the fungal rDNA gene cluster. The barcode region used for 
fungi identification spans ITS1, ITS2 and 5.8S regions 
3.3.7 Cluster analysis 
The case-control Bernoulli method181 integrated in SaTScan v9.4 was used for 
detecting spatial clustering of Cryptococcus species recovered from random 
sampling. The significance of any detected cluster was assessed by the likelihood 
ratio test, with a p-value obtained by 999 Monte Carlo simulations generated under 
a null hypothesis of a random spatial distribution. Detected clusters were considered 
significant where the resultant p-value was less than or equal to 0.05.  
3.3.8 Characterization of virulence-associated phenotypes 
Suspected colonies of Cryptococcus (beige to brown colonies consisting of oval to 
spherical yeast like cells)  were purified by subculturing onto Sabouraud’s agar at 
30oC for 2 days and subjected to the following virulence associated phenotypic tests: 
India ink staining for capsule presence, urease production on Urea Christensen’s 
agar, temperature dependent growth92, capsule production, melanin production and 
ex vivo CSF survival 201. The significance of these virulence factors has been described 
in section 1.5 of the introduction chapter. 
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3.3.8.1 Control strains 
Isolates used in phylogeny and phenotyping experiments are presented below 
Isolates MLST 
type 
Background Experiment used 
 
H99 ATCC 
208821 
 
2 
Isolated from male with 
Hodgkin’s disease from USA 
Phylogeny of 
environmental isolates 
Candida 
parapsilosis 
ATCC 22019 
 
 
NA 
 
 
NA 
Outgroup in 
phylogeny, Negative 
control for urease 
activity 
BK59 4 
4 
Isolated from HIV-
associated cryptococcosis 
patients in Vietnam 
CSF ex vivo survival 
and Galleria infection 
model 
 
BK48 
BK139 5 
 
ENA1 
 
     2 
Derived from H99 strain, 
growth defect in CSF 
Negative control for 
CSF ex vivo survival 
Table 3-1 Control isolates used in phylogeny and phenotyping 
3.3.8.2 Urease production 
Most Cryptococcus neoformans are urease positive135. Their growth on Christensen’s 
agar results in a characteristic pink colour due to elevated pH driven by degradation 
of urea by urease. A single colony of suspect Cryptococcus spp was streaked onto 
Christensen’s agar followed by incubation from 24 to 48 hours. Candida parapsilosis 
ATCC 22019 was used as negative control. 
3.3.8.3 Temperature-dependent growth 
Cryptococcus spp were cultured in Sabouraud agar for 2 days at 30oC. Stock 
suspension of 106 cells/mL was made using sterile water. I prepared inoculum by 
diluting the stock from 105 to 103 cells/mL. I dropped 5 µL of diluted inoculum to 
Sabouraud agar and incubated them at 30oC, 37oC and 39 oC for 72 hours. 
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3.3.8.4 Capsule production 
DMEM agar was used to induce capsule enlargement in vitro. Cryptococci inoculated 
in DMEM plate was incubated at 30oC with supplement of 5 % CO2 for 5 days. 
Suspension with Indian ink was made and visualized at 100X magnification using 
CX41 light microscope (Olympus, Japan). Images were captured using a built-in DP71 
camera (Olympus, Japan) and visualised using ImageJ 
(https://imagej.nih.gov/ij/index.html). Capsule size was calculated by subtracting cell 
body diameter from the whole cell diameter (including cell body and capsule). 40 
individual microscopic cells were measured for each isolate. Two strains of 
unidentified Cryptococcus and three strains of other Cryptococcus were selected for 
capsule enlargement induction. 
3.3.8.5 Melanin formulation 
L-DOPA agar was used to visualise melanization of cryptococci. I spotted 5 µL of cell 
suspension (106 cells/mL) onto the agar plates followed by incubation for 3 days at 
30oC. 
3.3.8.6 Ex vivo CSF survival 
I prepare pooled CSF supernatant by randomly selecting 12 tubes (baseline CSF) prior 
to filtering. Next I prepared inoculum of 107 cells/mL using Cellometer X2 
(Nexcelom). 10 uL of inoculum was added to 90 uL of CSF, YPD broth and PBS 
followed by incubation at 30oC for 3 days. Resulting culture was serially tenfold 
diluted with PBS (neat, 10-1, 10-2, 10-3, 10-4). I dispensed dilutions onto Sabouraud 
plates (5 uL/drop) and exposed for another 3 days at 30oC. Finally I calculated CFU of 
each strain post-inoculation in CSF. Tested trains were inoculated alongside ∆ENA1, 
negative control (defect in CSF survival) 
3.3.9 Sequencing analysis 
ContigExpress software was used to obtain consensus sequences from aligned 
forward and reverse sequence reads. Each resulting sequenced product was 
submitted to the Basic Local Alignment Search Tool (BLASTN) to retrieve species with 
identity values > 99 %. 
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3.3.10 Phylogenetic analysis 
Consensus sequences were aligned with the Clustal W2 algorithm 202. For neighbour-
joining analysis 203, the evolutionary distances between sequences were calculated 
using Kimura’s two-parameter model using Bioedit software203. Bootstraps analyses 
were performed with 1000 random resamplings203 . The tree was rooted using 
Candida parapsilosis ATCC22019 as the outgroup. 
3.3.11 MultiLocus sequence typing (MLST) 
I determined the MLST genotype of environmental isolates by sequencing 7 unlinked 
housekeeping genes: CAP59, GPD1, LAC1, PLB1, SOD1, URA5 and GPD1 according to 
the ISHAM MLST consensus scheme as described by Meyer et al 13. The seven loci 
were sequenced using ABI 3130xL Genetic Analyzer (Applied Biosystems, USA). 
Sequence reads (forward and reverse) were assembled using ContigExpress. Allele 
types of housekeeping genes and corresponding sequence type were assigned by the 
fungal MLST Database http://mlst.mycologylab.org/  
3.3.12 Virulence phenotype in the G. mellonella infection model 
The pathogenic potential of environmental isolates was assessed using the G. 
mellonella infection model. An inoculum of 106 cells (108 cells/mL) was injected to 
last left pro-leg of each larva and incubated at 30oC and 37oC for 10 days. Each 
isolate was infected with 15 larvae. Further details of the infection model are 
described in Chapter 4. 
3.3.13 Statistical analysis 
Statistical analyses were performed using R version 3.1.2 (R Foundation for Statistical 
Computing, Vienna, Austria) to test equality of proportions with continuity 
correction. Fisher’s exact test was used to determine associations between melanin 
production and ability to grow at 37oC. 95% confidence intervals for binomial 
proportion were estimated with Clopper-Pearson method employed to define 
associations between particular tree species and Cryptococcus spp. A P value of less 
than 0.05 was considered statistically significant. Corrections for multiple 
comparisons were performed using the Benjamini-Hochberg method. The Cox 
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proportional-hazards model was employed to compare survival of G. mellonella 
infected with other isolates. 
3.3.14 Experimental workflow 
Experimental workflow for this chapter is depicted below 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-4 Experimental workflow of chapter 3 
3.4 Results 
3.4.1 Growth on bird seed agar 
I identified 123 potential Cryptococcus species from the environmental sampling. 
Bird seed agar is used for initial differentiation of C. neoformans from other 
Cryptococcus species. Thus, of 123 presumptive Cryptococcus species, only three C. 
Hypothesis: Cryptococcus species occupy ecological niches in the environment 
Randomised and targeted environmental sampling of Cryptococcus species. 
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Aims: to describe the diversity of Cryptococcus spp in the environment, to determine 
whether geographical clustering of C. neoformans occurs by MLST-defined lineage, to 
determine whether any association between C. neoformans lineage and tree species 
occurs, to characterize virulence-associated phenotypes of environmental sourced 
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neoformans exhibit typical brown colour in this agar. The rest were white or pale 
(Figure 3-5). Under microscopes, non-neoformans cryptococci are oval while C. 
neoformans are spherical yeast-like cells 
 
 
 
 
 
 
Figure 3-5 Cryptococcus growth in bird seed agar at 30oC. Brown colonies: 
environmental C. neoformans. White or pale colonies: non-neoformans species. 
3.4.2 Speciation of Cryptococcus species 
Of the 123 presumptive cryptococci, 107 strains were obtained from random 
sampling and 16 from targeted sampling (Tables 3-2 & 3-3). All were subjected to 
carbon assimilation testing (ID32 C, Biomerieux). The speciation of the 123 isolates 
by ITS sequencing and sugar assimilation tests are shown in table 3-3. There was 
poor correlation between the 2 methods: only C. neoformans strains were 
concordantly identified by both methods. All non-neoformans cryptococci strains 
were identified as C. laurentii, C. albidus and C. humicolus by ID32 C (Table 3-4). 
Using ITS fungal barcoding primers I found that of 123 Cryptococcus spp, 3 strains 
were identified as C. neoformans var. grubii, 19 C. laurentii strains, 93 C. heveanensis 
strains, 6 C. rajasthanensis strains and 2 novel Cryptococcus sp (they were not 
previously characterised). Two isolates from Nhon Trach, previously assigned as C. 
laurentii by ID32 C, were later identified as novel Cryptococcus species by ITS 
sequencing. 86 % of strains were misidentified by ID32 C system (Table 3-5). This 
suggests biochemical testing aIone is unreliable for fungal speciation, at least for 
non-pathogenic species. 
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Table 3-2 107 Cryptococcus isolates from random sampling in Nhon Trach and Ho Chi 
Minh city 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3-3 A total of 16 Cryptococcus isolates were recovered from targeted sampling 
sites. The tree species where two isolates were isolated from air are shown in bold. 
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Table 3-4 Correlation between ITS sequencing species identification and ID32 C 
species identification. Rows represent strains identified by API ID32 C. Columns 
represent strains identified by ITS barcoding. 
 
 
 
 
Table 3-5 Comparison of cryptococcal identification using ID32 C vs ITS sequencing 
3.4.3 Distribution of environmental isolates in Nhon Trach and Ho Chi Minh city 
Overall, 1000 random sampling sites resulted in the collection of 5000 samples plus 
125 samples from 25 targeted sites. I also had 305 samples from gecko guano, avian 
guano, rice husk, swabs (fan blades, wall, air conditioner filter). 
The distribution of environmental Cryptococcus species is shown in Figure 3-6. The 
majority of isolates were C. heveanensis; this species is not known to have caused 
human disease. Of the C. neoformans strains, two were isolated from a heavily urban 
district of Ho Chi Minh city, and one from a rural area of Nhon Trach. 
Isolates were derived from both arboreal and non-arboreal sources. Non-arboreal 
sources included air conditioner filter swab, wall swab, rice husk, fruits and gecko 
guano. This finding implies cryptococci are ubiquitous in the environment. For 
random sampling, sites from Ho Chi Minh City were more likely to yield more 
Cryptococcus isolates than sites from Nhon Trach - 92/500 (18%) sites were positive 
in the city compared with just 15/500 (3%) of sites in Nhon Trach, P< 0.0001.  
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Following the identification of a cluster of 25 clinical isolates (Chapter 2), I performed 
targeted sampling at addresses of corresponding 25 patients in the cluster. I did not 
isolate C. neoformans, but interestingly 13 out of 25 sites (52%) were positive for 
non-neoformans isolates. In other words, the recovery rate of cryptococci by 
targeted sampling in the cluster of clinical isolates was 5 times higher than overall 
random sampling (13/125=10.4 % vs 107/5000=2.1 %, P value <0.001). Moreover, 
the only positive air samples were obtained in the clinical cluster sites: C. 
heveanensis and C. laurentii (Table 3).  
Table 3-3 lists strains recovered from targeted sampling.  Three Cryptococcus species 
were recovered from 12 tree species, gecko guano, air conditioner filter, and wall 
swabs. Surprisingly, none of the samples from avian droppings were positive. 
 Figure 3-6 Distribution of environmental Cryptococcus species in Ho Chi Minh city 
and Nhon Trach district. These administrative areas are separated by Saigon river. Of 
123 isolates, 15 were from Nhon Trach district. 
 
 
 
 
 
Ho Chi Minh city 
Nhon Trach 
district 
Saigon river 
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Table 3-6 Prevalence of Cryptococcus isolates in Nhon Trach and Ho Chi Minh city. All 
strains from Nhon Trach were isolated by random sampling. 
I recovered 5 species of Cryptococcus from Nhon Trach (Table 3-5), including the 
isolation of two unidentified cryptococci and 4 other species. The Nhon Trach 
sampling area was much smaller than Ho Chi Minh city (143 km2 vs 484 km2). In Ho 
Chi Minh City, I isolated 4 different species. For random sampling, the proportion of 
C. laurentii isolated in Ho Chi Minh city (11 strains, 73%) was significantly higher than 
that in Nhon Trach (4 strains, 26%), P value = 0.01, 2-sample test for equality of 
proportions). Similarly, C. heveanensis strains were more abundant in Ho Chi Minh 
city (76 strains, 92%) than in Nhon Trach (7 strains, 8%) (P value <0.001). This 
disproportion was potentially confounded by sampling seasons and difference in 
ecology of the two sampling areas. Ho Chi Minh City was mostly sampled in dry 
season while Nhon Trach was mostly sampled in rainy season. 
3.4.4 Clustering of environmental isolates 
I identified a cluster of C. heveanensis that spans the south eastern districts of Ho Chi 
Minh city. The cluster included 30 out of 81 C. heveanensis strains randomly isolated 
in Ho Chi Minh City. Districts included in the cluster cover both urban and rural areas 
and are located in the network of canals and rivers (Figure 3-7). Where the cluster 
occurred, elevation was generally lower than for the rest of Ho Chi Minh City, and 
the population density was also lower (Figure 3-8). I had insufficient numbers of 
Cryptococcus of other species to allow a geospatial clustering analysis. 
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Figure 3-7 Spatial cluster of C. heveanensis (radius = 4.84 km, P value = 0.002) was 
detected in the southeastern Ho Chi Minh city. This cluster spans both urban and 
rural areas with a network of canals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-8 Elevation map of Ho Chi Minh city with a spatial cluster of C. heveanensis. 
More than half of the circle (rural areas, dark green) have lower elevation and is less 
populated than urbanised areas of HCMC (light green). 
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3.4.5 Association between environmental isolates and arboreal sources 
Cryptococcus spp were isolated from 29 of the 79 tree species sampled.  Acacia 
auriculiformis was sampled the most frequently, but had the lowest rate of recovery 
(1.3%, 95% CI 0.16% - 5%), with just two C. neoformans strains isolated. For random 
sampling, the flamboyant tree (Delonix regia) harbours the largest number of 
Cryptococcus isolates 19/107 (18%, 95% CI 12% - 26 %) (Table 3-2).  
Hopea odorata was associated with 4 different Cryptococcus species (C. neoformans, 
C. heveanensis, C. laurentii and C. rajasthanensis); however, I lacked power to 
determine whether it truly held a diverse population. I was unable to demonstrate 
an association between any particular cryptococcus species and any particular tree 
species (Figure 3-9).  
C. heveanenesis was the dominant environmental population of cryptococci in 
Vietnam. C. heveanensis has also been found to be the most frequently recovered 
environmental isolate in Cuba, which is somewhat surprising given the geographical 
distance between each country, and points to a global population dispersal of this 
species193. I isolated C. heveanensis from both arboreal and non-arboreal sources. 
The flamboyant tree (Delonix regia) was used as reference to study association 
between this tree and C. heveanensis because flamboyants accounted for the largest 
frequency of C. heveanensis isolates by random sampling (22%, 18/83) in my study. 
Moreover, this tree was previously documented as an ecological habitat of 
Cryptococcus spp in Cuba193. However, my data did not support this association 
between C. heveanensis and Delonix regia. They did not reject the null hypothesis 
that there was no difference in the proportion of flamboyants positive for C. 
heveanensis compared with other trees, with the calculated P value not quite 
reaching conventional levels of statistical significance (P value = 0.065, Fisher’s test). 
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Figure 3-9 Probability of isolating Cryptococcus spp associated with tree species from 
random sampling. 95% confidence intervals for binomial proportion were estimated 
with Clopper-Pearson method. 
3.4.6 Phylogeny of environmental isolates 
A maximum likelihood tree was constructed to clarify the phylogenetic relationship 
of these species based on ITS sequences (Figure 3-10). C. neoformans strains 
clustered with the reference clinical isolate H99. This clustering is supported by 100% 
bootstrap value, implying environmental C. neoformans are potential pathogenic. 
The main polytomy clade of C. heveanensis strains is more closely related to C. 
neoformans than it does with the rest of Cryptococcus species. Undetermined 
Cryptococcus strains are more closely related to C. rajasthanensis than rare 
pathogens C. laurentii.  
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Figure 3-10 Maximum likelihood tree of environmental cryptococcal isolates based 
on ITS sequence (550 bp) constructed by MEGA 6. Candida parapsilosis and H99 are 
outgroup and clinical control, respectively. Numbers on the left of each node 
represent bootstrap percentages produced by 1000 replications. 
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3.4.7 Multilocus sequence typing 
Multilocus sequence typing confirmed the environmental C. neoformans isolates to 
be sequence type 5 and sequence type 4 (Table 3-7). These genotypes (5 and 4) 
account for the majority of disease in our clinical practice (97/136, 71 %)88. Sequence 
type 5 and 4 correspond to the AFLP clusters VNI and VNI, respectively86. 
 
 
 
 
 
 
Table 3-7 MLST profiles of three environmental C. neoformans var. grubii isolates 
3.4.8 Characterisation of virulence-associated phenotypes 
3.4.8.1 Urease production 
 
 
 
 
 
 
Figure 3-11 Urease Christensen agar test to detect cryptococci. Negative control 
(orange tube): Candida parapsilosis. Positive: Cryptococcus spp. 
Urea Christensen agar was used for tentative identification of cryptococci 135. All C. 
neoformans isolates turned pink, usually within 24 hours of inoculation. Other 
Cryptococcus species (120 isolates) gave positive tests 48 hours post-incubation at 30 
oC, suggesting their urease activity is lower than that of C. neoformans (Figure 3-11).  
3.4.8.2 Melanin formation 
I used L-DOPA agar to characterize the melanin production of the environmental 
Cryptococcus species. All 3 C. neoformans isolates produced melanin resulting in the 
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characteristic dark brown colonies, whereas only 7/19 (37 %) of C. laurentii strains 
exhibited melanisation by 7 days. Moreover, the colonies of non-neoformans 
melanin-producing isolates were lighter than those of C. neoformans, indicating less 
vigorous melanin production (Figure 3-12). Only one C. heveanensis isolate exhibited 
melanisation attribute (Table 3-8 & 3-9). While C. rajasthanensis melanized on L-
DOPA media, it was unable to grow at 37oC, implying it is unlikely to be able to cause 
disease in humans.  
 
 
 
 
 
 
 
Figure 3-12 Melanin formation of Cryptococcus spp in L–DOPA agar. 1&2: C. laurentii, 
3: C. rajasthanensis, 4&5: C. heveanensis. 6&7: C. neoformans. 8&9: undetermined 
Cryptococcus. 
 
Isolate 
% isolates in each species exhibiting particular phenotypes 
30oC 37oC Melanin 
C. neoformans var. grubii 100 100 100 
C. laurentii 100 47 42 
C. heveanensis 100 1 1 
C. rajasthanensis 100 0 17 
Unidentified Cryptococcus 100 0 0 
 Table 3-8 Percentage of isolates can grow above 30oC in YPD or produce melanin on 
L-DOPA agar 
 
 
1 
2 
3 
6 7 
4 5 
8 9 
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Table 3-9 Strains exhibit ability to grow above 37oC in YPD agar or to produce 
melanin in L-DOPA agar. +++: strongly grow, ++: grow well or produce melanin 
robustly, +: fairly grow or fairly produce melanin, - : fail to survive or fail to produce 
melanin 
3.4.8.3 Thermotolerance 
Susceptibility to mammalian temperature is key to pathogenicity. I exposed all 
isolates (C. neoformans, C. laurentii, C. heveanensis, C. rajasthanensis and 
undetermined Cryptococcus) to a range of temperature (30oC, 37oC, 39oC). All strains 
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had been initially selected through growth at 30oC (a typical shaded temperature in 
the south of Vietnam), and thus all grew well at this temperature following 
purification. However, at 37oC the C. neoformans isolates grew more robustly than 
the rest. Only one isolate of C. heveanensis could grow at 37oC. Potentially 
pathogenic isolates (C. neoformans & C.laurentii) can withstand 37oC and above 
better than other species. However, only C. neoformans (3 isolates) could survive at 
39oC (Figure 3-13). Interestingly, of 8 C. laurentii growing at 37oC, 7 strains were 
derived from Ho Chi Minh city and only one from Nhon Trach. The ability of C. 
laurentii strains to survive at elevated temperature was not associated with melanin 
production (P=0.63, Fisher’s exact test). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-13 Temperature-dependant growth of cryptococci at 37oC (upper panel) 
and 39oC (lower panel). At 37oC, C. heveanensis (E) and C. laurentii (F); the rest are C. 
neoformans (A,B,C) and C. laurentii (D,G,H) that grew equally well. At 39oC, C. 
neoformans (A, C, D); C. heveanensis (B) and C. laurentii (E) 
3.4.8.4 Capsule size 
The capsule size of the C. neoformans isolates was significant larger than that of all 
other Cryptococcus species post-incubation in capsule-inducing agar (DMEM) (P 
value < 0.01, multiple comparison with P value adjustment performed by Hochberg 
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method). C. neoformans also exhibited the most variation in capsule size compared 
with other species (Figure 3-14). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-14 Variation in capsule size between environmental Cryptococcus spp. 3 
strains of each species were measured for capsule size. 40 cells were measured per 
species 
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3.4.8.5 Ex vivo CSF survival 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-15 Fungal count of Cryptococcus isolates after 2 days of culture in ex vivo 
CSF. C. heveanensis (n=33), C. laurentii (n=8), C. rajasthanensis (n=3), environmental 
C. neoformans (n=3), clinical C. neoformans (n=3), Undetermined Cryptococcus (n=2). 
The ability to grow within the cerebrospinal fluid (CSF) is a pre-requisite for infection 
within the central nervous system, and specific genes associated with survival in the 
human host CSF have been identified 201. The ability to grow in CSF is considered a 
virulent characteristic. In order to define the virulence potential of the 
environmental isolates, I grew them in pooled human CSF. I used C. neoformans 
isolated from patients within our hospital as controls. I found significant differences 
in fungal counts between environmental C. neoformans vs C. heveanensis (P=0.03, 
Wilcoxon rank sum test), and clinical C. neoformans vs C. heveanensis (P=0.015). 
Surprisingly, C. rajasthanensis strains had both the most rapid growth resulting in the 
highest fungal burdens (Figure 3-15), and the highest variability in fungal counts, 
suggesting this species has a somewhat heterogenous population. 
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3.4.9 Survival analysis of Cryptococcus spp using Galleria mellonella infection 
model 
To compare the survival of Cryptococcus spp, I randomly selected two strains of each 
species: C. neoformans, C. heveanensis, C.laurentii, C. rajasthanensis and 
unidentified Cryptococcus for larva killing assays at 30oC. The virulence of 
environmental strains of C. neoformans was not significantly different from the other 
species (Figure 3-16). C. heveanensis appeared more virulent than C. laurentii (P 
value=0.01) 
 
 
 
 
 
 
 
 
 
 
Figure 3-16 Survival curves of five environmental Cryptococcus species infected with 
Galleria mellonella at 30oC. P value >0.05 obtained from the Cox proportional-
hazards model for comparison between C. neoformans and others. Each species was 
represented by two isolates (15 larvae/isolate). N=30 larvae/arm 
Human disease requires growth at 37oC. Thus I repeated the larva infection assays at 
this temperature. I used only C. neoformans and C. laurentii isolates because they 
can grow reliably at 37oC. Each species was represented by two isolates. Larvae 
challenged with C. laurentii survived significantly longer than those infected with 
either clinical or environmental isolates of C. neoformans (Figure 3-17). In fact, most 
of the larvae survived beyond the ten-day observation period, consistent with C. 
laurentii being less virulent than C. neoformans at 37oC. 
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Figure 3-17 Survival analysis of C. neoformans vs C. laurentii infected with Galleria 
mellonella at 37oC. P value < 0.001 obtained from the Cox proportional-hazards 
model for comparison between C. laurentii and others. Each species was 
represented by two isolates (15 larvae/isolate). N=30 larvae/arm 
3.4.10 Characterisation of underdetermined Cryptococcus species 
During random sampling in Nhon Trach, I isolated two isolates of underdetermined 
Cryptococcus species from Manihot esculenta and Mimosa pigra (Table 2 and Figure 
3-6). ITS-based phylogeny reveals they are closely related to C. rajasthanensis (Figure 
9). Unlike C. neoformans, they did not exhibit urease activity on Christensen’s agar or 
melanization when grown on L-DOPA agar (Figure 3-11 & 3-12). Furthermore, like 
the majority of non-medically significant Cryptococcus , they were unable to grow at 
37oC. Their production of capsule and ability to survive ex vivo CSF were statistically 
significantly different to C. neoformans (Figures 3-14 and 3-15). Taken together, 
these suggest that these Cryptococcus of undetermined species are extremely 
unlikely to be able to cause disease in humans.   
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3.5 Discussion 
3.5.1 Environmental niches of Cryptococcus spp  
I hypothesized that Cryptococcus spp occupy particular ecological niches. Overall I 
isolated 123 environmental cryptococci isolates, with 107 isolates obtained from 
random sampling and 16 derived from targeted sampling (Table 3-2 & 3-3). I isolated 
Cryptotoccus species from a wide variety of arboreal and non-arboreal sources. 
Although association between tree species and Cryptococcus was not established, 
Hopea odorata (Cengal Pasir, Vietnamese: sao đen), a native plant in southern 
Vietnam, is an interesting host for Cryptococcus species, harbouring C. neoformans 
and three other non-neoformans cryptococci species (Table 3-2 & 3-3). Hopea 
odorata is native to Southern Asia and Indochina countries, including India, 
Bangladesh, Myanmar, Thailand, Laos, Vietnam and Malaysia. This is the first time 
isolation of C. neoformans from this tree has been reported. 
I found the prevalence of Cryptococcus species in the urban area (Ho Chi Minh city) 
was significantly higher than in rural areas (Nhon Trach district). However, it is 
possible that this result is confounded by the season of sampling. I sampled the rural 
areas mostly in the rainy season (from April to August) and the urban areas in the 
dry season (from November to January). The recovery of environmental isolates of C. 
neoformans has been reported to be more efficient in the dry season in some 
tropical countries including Thailand, Zambia and India 173 57 192 . However, the 
contrary observation has also been reported in similar environments - in Colombia C. 
neoformans was recovered more frequently in the rainy season 172 204 . I was 
surprised that I failed to recover C. neoformans from avian sources (bird, pigeon, 
chicken, duck guano and soil contaminated with avian droppings) although these 
sources were common habitats of C. neoformans as previously reported in Africa, 
Thailand, India, USA, Columbia 26,56,57,171,205. More Cryptoccus species are found in 
Nhon Trach although the sampling area is much smaller than Ho Chi Minh city (143 
km2 vs 484 km2). 12 out of 15 isolates in Nhon Trach were derived from samples 
collected in the field where trees predominate (rural areas) (Figure 3-6). 
My data showed that non-neoformans strains were ubiquitous and were able to be 
isolated from a wide spectrum of sources including trees, guano, soil, air, dust (air 
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filter, inanimate objects such as a wall). The recovery rate of C. neoformans in my 
study was low (0.06%, 3/5125). The literature suggests that the percentage of 
positive environmental samples can vary from 0 to 10 % with a likely higher rate of 
isolation in endemic areas 56 52 7. I used randomized sampling, which can explain my 
relatively low recovery rate of C. neoformans (0.06%, 3/5000). I may simply have 
missed the most important ecological niche for C. neoformans in Vietnam, although 
at each sampling point I used a diverse approach to harvest samples including air, 
soil, and tree swabs. One practical problem was the size and inaccessibility of 
branches of trees in Vietnam – I mostly had to sample the lower trunks of trees, so 
could have missed Cryptococcus that was colonising upper trunks/branches or even 
in flowers. In Thailand, 2 % of environmental C. neoformans was isolated in 
eucalyptus flowers59. A further possibility is that environmental C. neoformans in 
Vietnam produce melanin poorly, making it difficult to detect them on birdseed agar. 
While melanin production is usually obvious in Vietnamese clinical isolates, Pereira 
et al compared the melanin intensity of 15 clinical vs 15 environmental C. 
neoformans and C. gattii and found a wide variation in melanin production in 
environmental isolates, which may reflect their different exposure to environmental 
stresses206. A further explanation for my low recovery of C. neoformans is that it 
simply grows very slowly in the environment, and is mainly quiescent, and my 
culturing techniques were insufficiently sensitive to detect it. A final explanation 
could be failure to detect because of overgrowth of filamentous molds post-
inoculation. However, I processed samples as soon as possible, mostly within 2 days 
of collection to minimize this risk. Moreover, mold overgrowth did not seem to 
impair the growth of other Cryptococcus species. The methods I used were 
consistent with Litvintseva et al’s validated protocol; like me, they processed 
samples within 3 days of collection171. 
3.5.2 Speciation of Cryptococcus species 
According to the manufacturer Biomerieux, the ID32 C system covers 62 yeast taxa 
including 7 Cryptococcus species which are medically important. A previous study 
using this system identified correctly 87% of Candida strains 207. Here, I found the 
ID32 C only correctly identified only 14% of Cryptococcus spp (Table 3-5). However, 
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this method can detect 100% of C. neoformans in agreement with ITS sequencing 
(Table 3-5). The misidentification of C. heveanensis, C. rajasthanensis and the 
unidentified Cryptococcus species is likely a consequence of these species not being 
included in the ID32 database, and a result of a ‘best fit’ approach. Efficiency of ID32 
C was also lower than Vitek MS208 for identification of a variety of clinical yeasts. My 
finding suggests ID 32C can be used for screening presumptive C. neoformans, but 
additional confirmation should be followed by culture on bird seed agar, a selective 
medium for C. neoformans, and ITS sequencing.  
In terms of accuracy, the sequence-based method, e.g. ITS barcode, in combination 
with phenotypic assays was superior to ID32 C alone. The former should be 
employed along with phenotypic assays because of the (small) possibility of DNA 
contamination from other fungal species. This has been reported to occur (during 
DNA extraction or PCR assay) as frequently as 3.3 % in negative controls and 4.7 % in 
PCR mixture209. Commercial products such as zymolyase powder, PCR buffer, 
TaqMan probes and master mix solutions can contain traces of fungal DNA210. 
In contrast to C. neoformans, C. laurentii is a rare causative agent of opportunistic 
infections in humans. C. laurentii mostly infects skin, bloodstream and the central 
nervous system. Patients with impaired cell-mediated immunity, such as HIV 
infection (CD4 count<100), organ transplant, and immunosuppressant use, or 
patients with exposure to azoles or invasive catheter devices are predisposed to C. 
laurentii infection 47 211.  
C. heveanensis was the most abundant species (76%) in my environmental 
cryptococcal population. C. heveanensis has a diverse global distribution, having 
previously been recovered from trees and cacti in Havana, Cuba 193, tropical forests 
in Thailand, and glacial meltwater in Argentina212 213. However, human disease due 
to this species has not been reported because they are not frequently tolerant to 
human temperature. 
Another non-pathogenic cryptococcus is C. rajasthanensis, which was first isolated 
from tree flowers in Rajasthan state, India214 and later from hollow trees in Brazil, 
Thailand, and China215. This isolate is closely related to C. laurentii using ITS sequence 
analysis as previously reported215. 
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I also isolated an unidentified Cryptococcus species, whose ITS sequence was 
deposited in the Genbank but its phenotype was not characterised previously. 
3.5.3 Spectrum of tree species hosting Cryptococcus spp 
I sampled  79 tree species -  somewhat more than the number examined in other 
studies (for example, India (17 species) or Colombia (35 species))216 172. Nearly 40% 
(29/79) of tree species that I examined were positive for Cryptococcus spp. A number 
of tree species that I sampled in Vietnam have been shown to harbour C. 
neoformans and C. gattii in India, including Cassia fistula, Mimusops elengi, 
Azadirachta indica, Tamarindus indica and Alstonia scholaris26 . However, I found 
only non-neoformans species on these trees in my study (Table 3-2). Notably, the 
tropical almond tree Terminalia catappa and rain tree Samanea saman host non-
neoformans cryptococci in Vietnam but have been shown to host the C. neoformans 
species complex in Colombia172. Terminalia catappa was notable as this tree is 
associated with C. gattii serotype C in Colombia172. I found no C. gattii in my 
sampling although we see 5-10 cases of this infection each year at the Hospital for 
Tropical Diseases, HCMC.  
My study is the first time that C. neoformans has been isolated from Acacia 
auriculiformis and Hopea odorata. A. auriculiformes has previously been associated 
with fungi of importance to humans – it is the ecological niche of rust fungi of the 
genus Endoraecium spp in Australia217. A number of my Cryptococcus isolates were 
associated with Cassia fistula. This species is an important host of C. neoformans in 
India 216 although I isolated only non-neoformans species from this tree. Similarly, 
while 15 % of Mimusops elengi samples were found to be colonized with C. 
neoformans in India, I had a recovery rate of 12% of non-neoformans Cryptococcus 
from this tree in Vietnam (Tables 3-2 & 3-3). It is not clear why I had such low rates 
of recovery of C. neoformans from these trees given the Indian experience. Possible 
explanations include different sampling sites from the trees in the different studies, 
different sensitivities within the laboratories, or failure of reporting of non-medically 
important species from the published studies. However, it is likely that the botanical 
niches of C. neoformans vary from country to country. 
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Figure 3-18 The 30 April park in Ho Chi Minh city, with predominance of golden oak 
(Hopea odorata), where two environmental C. neoformans strains were isolated. 
Hopea odorata is of great interest, with a wider variety of species of Cryptococcus in 
my study. 24 % of samples from this tree are positive with both C. neoformans and 
three other Cryptococcus species (Table 3-2 & 3-3). Were I to have the resources to 
repeat my study, I would focus on this species. However, it represents particular 
challenges to sample, being exceptionally tall with height commonly greater than 
45m and a paucity of low branches (Figure 3-18). 
3.5.4 Clustering of Cryptococcus spp 
I found a spatial cluster of randomly isolated C. heveanensis strains in Ho Chi Minh 
city. This cluster overlapped with the cluster of cases of meningitis due to ST5 strains 
described in Chapter 2. Interestingly, the recovery rate of non-neoformans 
cryptococci in the cluster sites of clinical C. neoformans ST5 was five times higher 
than that of random sites, and two air samples of cluster sites contained non-
neoformans cryptococci. Taken together, these data suggests the ecological niche of 
C. neoformans and non-neoformans isolates overlaps in Vietnam. 
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Given that cryptococcal meningitis occurs with reasonable frequency in Vietnam, I 
was surprised (and disappointed) not to recover more isolates of C. neoformans.  
Discrepancies between the predominant clinical cause and the apparent dominant 
environment isolate have been documented in other studies. Extensive sampling in 
Zambia revealed that the majority of environmental isolates were of the VNB group 
(83%), whereas VNI strains predominate in human infection (76%) 173.  A study from 
Bostwana similarly found that VNI strains accounted for 30% of clinical isolates but 
only 6.5% of the environmental population218. Ecological sampling in Havana, Cuba 
recovered only one C. neoformans out of 660 samples 193. A recent study from South 
Africa performed in the densely populated townships around Cape Town where 
human disease is common recovered only 2 C. neoformans isolates from 248 
samples collected from trees, soil and pigeon guano 219. A possible explanation for 
the low recovery rate of C. neoformans from the environment may be that the 
human adapted species have low rates of growth in the environment – other species 
are better adapted to growth as saprophytes on trees. 
3.5.5 Phenotypic assays of Cryptococcus spp 
I tested environmental isolates of different species using standard virulence assays 
including temperature-dependent growth, melanin production, capsule size, and 
urease activity to determine whether such environmental isolates could potentially 
cause human disease. As expected, C. neoformans isolates had the most robust 
expression of such phenotypes. My data suggest that thermotolerance is probably 
the single most important virulence factor. All species grew similarly at 30oC; at 37oC 
there was a fall in the viability of C. heveanensis and some C. laurentii strains; at 
39oC, the growth of both C. heveanensis and C. laurentii was markedly inhibited. C. 
neoformans strains, both clinical and environmental in source, grew well at all 
temperatures.   
This variability in thermotolerance was also manifest in the Galleria model. At 30oC, 
the virulence of Cryptococcus spp was indistinguishable. However, incubation at 37oC 
revealed differences in virulence between Cryptococcus neoformans and 
Cryptococcus laurentii. Clearly the ability to grow at 37oC is critical for human 
infection and a good indicator of the likelihood that a species can be a human 
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pathogen.  A recent case report described cryptococcal meningitis in an HIV patient 
in Guatemala, due to infection with Cryptococcus liquefaciens complicated by co-
infection with Mycobacterium tuberculosis220. C. liquefaciens was previously 
considered as non-pathogenic yeast because of its poor growth at mammalian 
temperatures. Moreover, this species did not produce melanin in L-DOPA agar. Its 
capsule was visible using India ink staining and survival of G. mellonella infected with 
C. liquefaciens was comparable to larvae infected with C. neoformans at 25oC 221. It is 
feasible that rises in average global temperatures could drive the 
development/selection of thermotolerance in environmental fungal species which 
may have a bystander effect of increaseing their pathogenic potential222. In my 
environmental cryptococcus population, it was interesting to see that there was 
evidence of variability within species - 1 % of C. heveanensis and 47 % of C. laurentii 
strains could grow at 37oC. This is consistent with the occasional reports of C. 
laurentii as a human pathogen211; I am unaware of any reports of disease due to C. 
heveanensis, but presumably this is a possible rare event. 
In this study, I found that C. neoformans was more virulent than C. laurentii in the 
Galleria larvae although both species grew well at 37oC, given that C. neoformans 
strains were significantly more melanised than C. laurentii when grown on bird seed 
agar and L-DOPA agar. So far there has been no study investigating correlation 
between virulence of C. neoformans in G. mellonella and pathogenicity in humans. 
This suggests the important role of melanisation in cryptococcal virulence. G. 
mellonella infection model was previously used to identify the hyperpathogenic C. 
gattii strains causing Vancouver Island outbreak (VGIIa) and other major molecular 
types (VGI, VGII, VGIII and VGIV)166. A number of C. gattii strains (VGI, VGII, VGIII and 
VGIV) were significantly less virulent than the highly pathogenic Vancouver Island 
outbreak strain CDCR265 (VGIIa) 166.  
Finally, the failure of my novel species to grow at 37 or 39oC suggests that it is 
unlikely to be able to cause human disease. 
3.6 Conclusion 
In conclusion, I isolated 123 cryptococci in the environment with 22 potential 
pathogens (3 C. neoformans isolates and 19 C. laurentii isolates). I did not identify 
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species-specific niches because I lacked power for C. neoformans. However, the 
association between increased recovery rates of non-neoformans Cryptococcus 
species from sites of clinical disease suggests that habitats for different species are 
highly similar and would require high resolution ecological techniques to tease apart. 
Of note, I could not associate any particular tree species with cryptococcal species. 
More sensitive environmental recovery techniques are needed to better understand 
the ecology of Cryptococcus species of medical importance. 
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Chapter 4  
Understanding pathogenicity of C. neoformans var. grubii using the 
Galleria mellonella infection model 
4.1 Introduction 
We previously reported that cryptococcal meningitis occurring in HIV-uninfected 
patients in Vietnam was caused almost exclusively by isolates from an AFLP-defined 
cluster of C. neoformans var. grubii which we named VNI 86. We subsequently 
showed that this cluster corresponded precisely with multi-locus sequence type 5 
(ST5) 88. The ST5 strain predominates in China, and neighbouring countries such as 
Japan, South Korea and Vietnam, where disease in HIV uninfected patients has been 
frequently reported 169 223 224. Given this host distribution, I hypothesize that ST5 
strains have increased pathogenicity – ability to cause disease - compared with non-
ST5 strains. To explore this in the laboratory setting requires a suitable model of 
infection. The mouse model of cryptococcal infection is well established but has 
some significant disadvantages in that it is expensive, involves use of a sensate 
vertebrate, and is not practical for higher throughput applications  160.  
More than one decade ago, the larvae of the wax worm Galleria mellonella were first 
employed to study the virulence of Candida albicans 164. The demonstration of 
correlation between the virulence of this clinically important pathogen in G. 
mellonella with that in mice was established, which triggered the widespread use of 
this model in other fungal pathogens including Candida krusei, Aspergillus fumigatus, 
A. flavus, C. neoformans and C. gattii 166 162. The popularity of the G. mellonella 
model is driven by multiple advantages over mammalian hosts. The larvae are cheap 
to grow and maintain, suitable to high-throughput studies and there are no current 
ethical concerns. The larval immune system is similar to the innate immune system 
of vertebrates with both humoral and cellular responses. Humoral immune 
responses of the insect include melanization and production of antimicrobial 
peptides. The cellular components consist of hemocytes, which function similarly to 
macrophages and neutrophils in vertebrates 162 225.  
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The validity of the G. mellonella infection model in interrogating the pathogenesis of 
human cryptococcal disease is supported by concordance between the Galleria and 
mouse infection models. Mylonakis et al was the first to use this model to study 
cryptococcal virulence, host response to infection and in vivo susceptibility to 
antifungals. They found that several cryptococcal genes involved in mammalian 
virulence are also important in in larval infection, including CAP59, GPA1, RAS1 and 
PKA1 98. They also found the antifungal combination of amphotericin B and 
flucytosine was significantly more effective than amphotericin B alone in treating 
infection in Galleria. This is consistent with data from humans where the 
combination has been associated both with better rates of fungal clearance and 
reduced mortality.67 
Liu et al used the Galleria model to perform systematic genetic analysis of virulence 
genes in C. neoformans. Using knockout mutants they discovered novel genes 
regulating melanization and capsule production and identified a capsule-
independent antiphagocytic pathway regulated by Gat201 transcription factors226. G. 
mellonella killing assays have also contributed significantly to investigating multiple 
kinase and transcription factor genes associated with virulence 227 34.  
The morphogenesis of C. neoformans has previously been studied using the mouse 
lung infection model228. Zaragoza et al demonstrated that the Galleria model can 
also be used for this purpose, with capsule enlargement occurring within 2 hours 
post-infection, and induction of a sub-population of giant (Titan) cells accounting for 
up to 5 % of all cells by 4 days post-infection167.  
In addition to significant work interrogating virulence using type strains, the Galleria 
model has been used to compare the virulence of the major molecular types of C. 
gattii, notably the highly pathogenic Vancouver Island outbreak strain VGIIa166. 
Firacative et al found variation in virulence between G. gattii major molecular types 
(VGI, VGII, VGIII and VGIV); perhaps surprisingly the Vancouver outbreak strain VGIIa 
was not the most virulent.  Together, these studies support the versatility and 
validity of the G. mellonella infection model in elucidating cryptococcal 
pathogenesis. However, the relative virulence of different clinical isolates of C. 
neoformans var. grubii of different lineages is largely unstudied in model systems – 
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most studies of virulence focus on the H99 type strain. The purpose of this part of 
the thesis was to use the Galleria infection model to interrogate the relative 
virulence of different lineages of C. neoformans from Vietnam, because of the 
different host distributions we have observed in clinical practice.86 88  
4.2 Aims 
The aims of the chapter are to use the Galleria mellonella infection model to 
determine whether it can detect differences in the virulence of isolates of C. 
neoformans according to their lineages and source (HIV uninfected or infected 
patients, clinical or environmental), and between Vietnamese C. gattii and C. 
neoformans ST5 strains.  
4.3 Methods 
4.3.1 Strains 
Clinical isolates: The isolate characteristics are presented in Table 1. Strains were 
randomly selected from those archived within the mycology research laboratory at 
OUCRU. Isolates from HIV infected patients were from patients enrolled into a 
randomized controlled trial of antifungal therapy performed at the Hospital for 
Tropical Diseases 67. Strains from HIV uninfected patients were randomly selected 
from those from a prospective descriptive study of CNS infections performed at the 
Hospital for Tropical Diseases, Ho Chi Minh City 180.  
Environmental isolates: Environmental isolates were the 3 C. neoformans isolates 
described in chapter 2 - LD1, LD2 and NT7533.  
Typing  
All isolates were typed using MLST described in the chapter 2. The STs are described 
in Table 1.  
C. gattii strains: BMD873, BMD1377, BMD800 isolated from HIV-negative patients 
enrolled in BMD study180  
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Table 4-1 Clinical and environmental isolates of C. neoformans for comparison of 
pathogenicity according to lineage and source 
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4.3.2 Galleria mellonella infection model 
The detailed procedure for maintaining and infecting larvae is presented in Appendix 
D. The procedure was based on the methods described by Firacative and Kavanagh 
et al166, 229.  
4.3.2.1 Preparation of larvae 
Late instar isogenic wild type Galleria mellonella larvae (30 days from oviposition of 
the adult moth) were sourced from U U Pet Shop (Ho Chi Minh city, Vietnam). All 
larvae were kept in air porous containers at 16oC in bran in the dark. Larvae for 
experimentation were selected according to the following criteria: weight 250-300 
mg, healthy colour (beige). Grey larvae (indicating poor health) were discarded. All 
larvae were moved to room temperature for 2 hours prior to inoculation. 
To control for potential variation in larval phenotype between batches, all survival 
experiments were internally controlled – that is I never used historical data regarding 
survival with a particular lineage. All infection experiments consisted of the strain of 
interested and simultaneous infection of Galleria from the same batch with the 
comparator strain of interest.  
4.3.2.2 Identification of Galleria mellonella larvae 
The larva species was confirmed morphologically. The greater wax moth larva (G. 
mellonella) is easily distinguished from the lesser wax moth larva (Achroia grisella) 
using a magnifier. The former have 4 stemmata on each side of the head while the 
latter do not have this characteristic. 
4.3.2.3 Inoculum preparation 
Yeasts were revived from frozen stock (Microbank Beads) on SDA plates for 72 
hours. Single colonies were picked and cultured in YPD broth for 24 to 48 hours in a 
shaking incubator (SI-300, Jeio Tech), at 150 rpm at 30 oC until the concentration of 
cells was as at least 108 cells/mL (titrated using  a Cellometer X2 (Nexcelom 
Bioscience, USA). The culture was spun at 8000 rpm for 1 minute to form a pellet, 
subsequently washed twice with PBS. It was resuspended in PBS for quantitation 
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using the cellometer. I adjusted the suspension to a density of 108 cells/mL. Ten μL of 
inoculum (106 cells/larva) was used for injection per larva. All inocula were relabeled 
by an independent person such that I was blind to the nature of the inoculum used 
in each batch of larvae (i.e. the survival experiments were blinded). 
4.3.2.4 Infection 
Hamilton syringes were cleaned using 10% bleach by drawing and pushing out for 3 
times followed by 100% ethanol and 1X PBS. The needle and syringe were cleaned 
between fungal strains. I used a cotton bud soaked in 70 % ethanol to swab the larva 
pro-legs prior to injection. Infection was performed by injecting 10 μL of inoculum 
(106 cells per larvae) into the last left pro-leg. Each cryptococcal strain was injected 
into 15 or 20 larvae. After injection, larvae were put into a petri dish covered with 
tissue for a few minutes to stop hemolymph leakage. I also injected 10 μL of PBS as 
control for sterility for every batch with the same number of larvae for each tested 
arm. Larvae infected with the same cryptococcal isolate were put into a petri dish 
and incubated at 37oC for ten days. Larvae were checked twice daily for survival 
using physical stimulation with forceps. Larvae that did not respond to touch were 
considered to have died. 
4.3.2.5 Blinding 
To reduce any risk of bias in performing the experiment and assessing outcome, all 
inocula were relabeled by a third party such that I was unaware of which isolate was 
in use. 
4.3.2.6 Controls 
All experimental sets used the same batch of Galleria. PBS controls were included 
with all experimental sets. 
4.3.2.7 Statistical analysis 
Kaplan-Meyer survival curves were plotted using ggplot2 and survminer package (R 
version 3.4.2). The Log-rank test was used to compare differences in survival. Hazard 
Ratios were estimated using the Cox proportional-hazards model. Logistic regression 
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was used to investigate the change in the risk of larva death per every log10 increase 
in inoculum. The Wilcoxon rank sum test was used to compare fungal burden 
between isolates. Capsule size was compared using the Kruskal-Wallis test with P 
value adjusted for multiple comparisons by the Benjamini-Hochberg method. 
4.3.3 Induction of C. neoformans var. grubii pathogenicity  
Preparation of culture filtrate 
Clinical isolates were grown to stationary phase (48 hours) followed by 
centrifugation at 8000 rpm for 1 min. The resulting supernatant was filtered using a 
Millipore membrane filter 0.45 m (Merck), and was then checked for sterility by 
plating onto Sabouraud’s agar and BHI  broth and incubated at 30oC for three days.  
Preparation of inducing broth  
Inducing broth consisted of 5 mL of fresh sterile YPD to which 2.5 mL of sterile 
culture filtrate was added (see above). Naive strains were inoculated into inducing 
broth and incubated for 48 hours in shaking incubator at 30oC. Pellet was collected 
by centrifuging culture at 8000 rpm and washed with PBS twice prior to infection. I 
prepared an inoculum of 108 cells/mL in PBS and 10 L was injected into larvae. The 
workflow of inducing pathogenicity of naïve C. neoformans is described in the Figure 
4-1. 
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Figure 4-1 Inducing pathogenicity of naive environmental C. neoformans. Culture 
filtrate of clinical isolates was collected 48 hours post-inoculation. Naive 
environmental strains were then grown in fresh YPD plus the culture filtrate for 
another 48 hours. Pellet was washed and resuspended in PBS followed by 
adjustment to 108 cells/mL for larval infection. 
4.3.4 Treatment of filtrate with freezing, heat, protease, and nuclease 
To check the stability of culture filtrate exposed to prolonged frozen storage, the 
culture filtrate of BMD761 was kept at -20 oC for 33 days. The filtrate was brought to 
room temperature prior to induction experiments. Denaturation of filtrate was 
performed as described previously230. To denature protein by heat, filtrate of 
BMD761 was boiled at 97 oC for 2 minutes. To denature protein chemically, filtrate 
was incubated with Proteinase K (Sigma) at the concentration of 100 g/mL in the 
presence of 30 mM Tris.HCl (pH=8) and 5 mM CaCl2 at 37 
oC for 1.5 hours. To 
degrade DNA, 28 L DNAse I (Ambion) was added to 700 L DNAse I buffer and 7 mL 
filtrate for 1 hour at 37oC. To remove RNA, 2.5 mL filtrate was incubated with 50 L 
RNAse cocktail of RNAse A and RNAse T1 (Thermo Fisher Scientific) for 1 hour at 
37oC. 
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4.3.5 Quantification of fungal burden in larvae 
I collected dead larvae infected with strains of interest (5 dead larvae/biological 
replicate). Larvae were gently squeezed to collect hemolymph and fat body (about 1 
gram) using a sterile knife. Hemolymph and fat body were collected into a 1.5 mL 
tube. I added sterile glass beads and 1mL of sterile water followed by homogenizing 
the mix at the frequency of 30 times/second for 10 minutes (TissueLyser II, Qiagen). I 
divided a Sabouraud agar plate into two equal sides then inoculated 100 L of 
homogenate onto each side of the plate and incubated for 3 days at 30oC. Finally I 
counted the number of colonies and calculated the CFU/gram/larvae. 
4.3.6 Passage of C. neoformans through G. mellonella larvae 
Following infection of Galleria as described previously yeast cells were harvested 
from the hemolymph of fresh (within 24 hours) dead larvae by inoculating 
hemolymph onto Sabouraud’s agar plates and incubated at 30oC for 3 days. Purified 
colonies were suspended in PBS and adjusted to 108 cells/mL. 10 L was reinfected 
into fresh Galleria larvae (20 larvae infected each generation) and incubated at 37 oC 
for 10 days. This cycle was repeated for 6 generations for each strain. Pathogenicity 
of the 6th generation C. neoformans and naive strain were compared using the larva 
killing assay as described above. 
4.3.7 Capsule size measurement 
Following infection with 106 cells, larvae were sacrificed 48 hours post-infection and 
hemolymph extracted as in section 4.3.5 above. Hemolymph was stained with India 
ink to visualise capsule using light microscopy (at 1000X magnification). The 
diameter of the whole yeast cell and internal cell body were measured using ImageJ 
(https://imagej.nih.gov) based on the ruler bar embedded into each image. Capsule 
thickness was estimated by subtracting the internal cell diameter from the whole 
yeast cell diameter. Capsule size was calculated by subtracting the diameter of the 
cell body from the whole cell.  
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4.3.8 Experimental workflow 
Experimental workflow for this chapter is depicted below 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-2 Experimental workflow for chapter 4 
Hypothesis: ST5 isolates are more 
virulent than non-ST5 isolates. 
Comparison of relative virulence 
between ST5 derived from HIV-
uninfected patients and ST4 from HIV 
patients. 
Hypothesis: Environmental isolates are 
as virulent as clinical isolates 
Comparison of relative virulence between 
clinical and environmental isolates (ST4 & 
ST5) 
Hypothesis: the inoculum size 
of C. neoformans correlates 
with mortality of larvae 
Dose-dependency for clinical 
and environmental isolates 
  
Hypothesis: Virulence of naive 
isolates increase through 
incubation in hosts. 
Passage of environmental 
isolates through generations 
of larvae 
Hypothesis: intercellular signaling 
enables up-regulation of virulence 
of environmental isolates 
Inducing virulence of naive isolates 
using culture filtrate of pathogenic 
clinical isolates (ST4 & ST5) 
Induced isolates can maintain 
upregulated virulence over 
generations 
  
Induced isolates themselves 
can induce naive isolates 
  
Hypothesis: difference in virulence of 
clinical isolates, naive isolates and induced 
isolates are driven by virulence traits 
Characterisation of in vitro virulence phenotypes 
of C. neoformans isolates  
  
Fungal burden of C. neoformans isolates 
is associated with mortality of larvae 
  
Identify biochemical 
determinants of 
culture filtrate 
responsible for 
induction of virulence 
  
Investigating 
if induction 
effect is 
independent 
of medium 
  
Aims: to use the Galleria mellonella infection model to determine whether it can 
detect differences in the virulence of isolates of C. neoformans according to their 
lineages and sources (HIV uninfected or infected patients, clinical or 
environmental) 
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4.4 Results 
4.4.1 ST5 isolates derived from HIV uninfected patients are more virulent than ST4 
isolates derived from HIV infected patients 
Each of the 20 ST4 or ST5 strains was inoculated into 15 larvae (N=600, 300 per arm). 
C. neoformans ST5 strains derived from HIV-uninfected patients were significantly 
more virulent than C. neoformans ST4 strains from HIV patients (HR 1.4, 95% CI 1.2 - 
1.6, P value <0.001) (Figure 4-3). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-3 Survival curves of G. mellonella infected with C. neoformans strains: ST4 
from HIV patients (20 isolates) vs ST5 from HIV-uninfected patients (20 isolates). P 
value was obtained from Log-rank test. The sample size is 600 larvae (15 
larvae/strain) 
4.4.2 ST4 and ST5 isolates derived from human patients are more virulent than 
strains derived from the environment. 
Cryptococcosis is acquired from the environment and is not spread from person to 
person. Therefore, all strains are ultimately of environmental source and all strains 
of the same lineage would be expected to have the same ability to cause human 
disease. Moreover, ST5 strains derived from HIV-uninfected patient are interspersed 
in the whole-genome phylogeny of lineage 5, suggesting all ST5 strains have the 
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potential to cause disease in HIV-uninfected patients (Ashton P et al, unpublished 
data). Therefore I hypothesized that the pathogenicity of clinical and environmental 
isolates are indistinguishable, and tested this in the Galleria model. The isolates 
tested, and their sources and sequence types, are shown in Table 4-1. BK224 and 
LD1 are clinical and environmental isolates of ST4, respectively. BK42 plus BK139 and 
LD2 plus NT7533 are clinical and environmental isolates of ST5, respectively. I tested 
strains with MLST-matched genotypes. 
The Kaplan Meier survival curves are shown in Figure 4-4. Clinically derived isolates 
were significantly more virulent than strains derived from the environment (HR 11.3, 
95% CI 6.7-18.8, P value <0.0001). All Galleria larvae infected with clinically-derived 
strains died by day 8 regardless of sequence type, whereas a number of Galleria 
larvae infected with environmental isolates survived longer than 10 days.  
I quantified the fungal burden in larvae infected with clinical isolates (BK139, BK224 
and BK42) and those infected with environmental isolates (LD1, LD2 and NT7533). 
Fungal burden was significantly higher in the former (P value < 0.001, Wilcoxon test) 
(Figure 4-4).  
 
 
 
 
 
 
 
 
 
 
Figure 4-4 Survival analysis of clinical and environmental isolates. Six ST4 and ST5 
isolates of clinical and environmental origin were infected with larva. Sample size is 
72 larvae/arm. P value < 0.001, Log-rank test. 
 
 
 135 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-5 Fungal burden in larvae infected with clinical (BK224, BK42, BK139) and 
environmental isolates (LD1, LD2 and NT7533). P < 0.001 (Wilcoxon test). Sample 
size is 24. Each strain was quantified for fungal burden with 4 biological replicates. 
4.4.3 Dose-dependent pathogenicity 
I hypothesized that size of the inoculum of C. neoformans correlates with mortality 
of larvae. I chose two strains of the same sequence type 5 but derived from different 
sources: environmental LD2 and clinical BMD761. Each strain was infected into 
larvae with an inoculum varying from 103 to 106 (40 larvae/inoculum size) and larval 
survival was observed for 10 days at 37oC. I found that for every log10-cells increase 
in inoculum size of the LD2 isolate, the odds of larval death increased by 3.4 (OR 3.4, 
95% CI 2.3-5.4, P value < 0.001). For the clinical BMD761 isolate, for every log10 
increase in inoculum size, the odds of larval death increased by 7.3 (OR 7.3, 95% CI 
4.3-14.1, P value < 0.001). Predicted probabilities of larval death are illustrated in the 
figure 4-6 and 4-7 below.  
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Figure 4-6 Logistic regression model of the risk of death in relation to inoculum size 
for the environmental C. neoformans isolate LD2. Predicted probabilities and 95% CI 
are blue line and dot line, respectively. Doses vary from 103 to 106 cells/inoculum. X 
axis indicates inoculum (log10 cells). Y axis indicates probability of death of larvae 
infected with LD2. 
 
 
 
 
 
 
 
 
 
 
Figure 4-7 Logistic regression model of the risk of death in relation to inoculum size 
for the clinical C. neoformans isolate BMD761. Predicted probabilities and 95% CI are 
shown by the blue and dotted lines, respectively. Doses vary from 103 to 106 
cells/inoculum. X axis indicates inoculum (log10 cells). Y axis indicates probability of 
death of larvae infected with BMD761. 
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4.4.4 Virulence of environmental C. neoformans is fixed following passage through 
the larvae. 
Cryptococcosis in most cases is considered to occur as the result of reactivation of 
latent infection. Latent infection follows an initial infection that is asymptomatic in 
the vast majority of cases72. I hypothesized that C. neoformans ‘learns’ increased 
virulence through adaptation to the host following infection, as a result of low level 
growth. To determine whether virulence can be upregulated within the host I 
repeatedly passaged environmental strains in Galleria larvae and compared 
virulence with the baseline status of the strain. Naive environmental C. neoformans 
strains (LD1 and NT7533 representing ST4 and ST5, respectively) were passed 
through 6 generations of larvae and then subjected them to the G. mellonella killing 
assay. However, I found no change in virulence between the index and F6 strains 
(Figure 4-8). 
 
 
 
  
 
 
 
 
 
 
 
Figure 4-8 Survival curves of G. mellonella infected with naive vs larvae-passed 
environmental isolates. Sample size is 80 (40 larvae/arm). P value was obtained from 
Log-rank test. 
4.4.5 Pathogenicity induction of environmental C. neoformans var. grubii isolate 
In the following experiments, I tested if pooled filtrate of ST5 isolates derived from 
HIV-patients (BK139 and BK142 isolates) or non-HIV patients (BMD854, BMD761, 
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BMD494 and BMD973 isolates) can induced ST5 environmental isolates (LD2 and 
NT7533). Then I investigated if individual ST5 clinical isolates above can induce naive 
environmental isolates. 
4.4.5.1 Isolates derived from HIV uninfected patients can upregulate the virulence 
of environmental isolates of C. neoformans ST5. 
AFLP data previously published from our lab suggest that strains derived from HIV 
uninfected apparently immunocompetent patients are spread throughout the entire 
VNIg (ST5) lineage. This implies that all strains have the potential to infect 
immunocompetent patients, despite the differences I saw between environmentally 
and clinically derived strains, and that virulence may be up (or down) regulable. 
Presumably all cells of a particular isolate must behave similarly in order to deliver a 
specific virulence phenotype; maintenance of this phenotype amongst cells may be 
driven by intercellular signaling. To test this hypothesis that intercellular signaling 
may enable up-regulation of virulence, I cultured naive environmental isolates (NEI) 
ST5 strains in pooled culture filtrate from clinical isolates (BK139 and BK42 
representing ST5) derived from HIV patients. The resulting strains were injected into 
larvae in the usual manner. There was a separation of the survival curves for these 
‘induced’ and NEI isolates, but the effect was modest and did not reach conventional 
levels of statistical significance (Hazard ratio 1.4, 95% CI 0.8-2.3, P=0.2) (Figure 8A). I 
repeated the experiment but used culture filtrate from ST5 strains derived from HIV-
uninfected patients (BMD854, BMD761, BMD494 and BMD973). This resulted in a 
highly significant increase in Galleria mortality (Hazard ratio 4.1, 95% CI 2.9-5.8, P 
value <0.001) (Figure 8B).    
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Figure 4-9 Survival curves of larvae infected with clinical, naive environmental and 
induced environmental isolates. Environmental isolates (LD2 and NT7533) were 
induced using pooled culture filtrate from ST5 strains (n=2) from HIV patients (A) or 
ST5 isolates (n=4) from HIV uninfected patients (B). P values were obtained from Cox 
proportional-hazards model for comparison between induced and naive isolates.  
4.4.5.2 All ST5 strains derived from HIV-uninfected patients can induced the naive 
environmental strain LD2 
To test the individual ‘inducing’ effect of each clinical strain, I used individual culture 
filtrates from BMD854, BMD761, BMD494 and BMD973 to induce environmental 
isolates LD2 (ST5) and NT7533 (ST5) individually. All four strains exhibited the ability 
to upregulate the virulence of LD2 (Figure 9). In contrast none of NT7533 strains 
were induced. Surprisingly, NT7533 strains grown in culture filtrate from BMD494 or 
BMD854 were significantly less pathogenic than naive NT7533 (Figure 10). 
 
 
P=0.2, 
N=36/arm 
 
P<0.0001 
N=80/arm 
B 
A 
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Figure 4-10 Survival curves of larvae infected with clinical, naive environmental and 
induced environmental isolates. Environmental isolates (LD2) were induced by 
individual culture filtrates of clinical BMD854, BMD761, BMD494 and BMD973 
isolates. P values and hazard ratios obtained from Cox proportional-hazard model, 
were applied for induced isolates and naive ones. Sample size is 40 larvae/arm 
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Figure 4-11 Survival curves of larvae infected with clinical, naïve environmental and 
induced environmental isolates. Environmental isolates (NT7533) were induced by 
individual culture filtrates of clinical BMD854, BMD761, BMD973 and BMD494 
isolates. P values and hazard ratios obtained from Cox proportional-hazard model, 
were applied for induced isolates and naive ones. Sample size is 40 larvae/arm. 
4.4.5.3 ST4 strain-derived culture filtrate is unable to upregulate the pathogenicity 
of ST5 environmental strains 
To test the ability of clinically derived ST4 strains to upregulate the pathogenicity of 
environmental strains, I used the culture filtrate of BK80 strains to grow LD2 strains 
as described previously. The virulence of naive LD2 and ST4-induced LD2 was not  
significantly different (HR 0.8, 95% CI 0.3-2.2, P value=0.7) (Figure 4-12). I repeated 
induction of LD2 using pooled supernatant from both BK80 and BK224. However, 
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there was still no effect. The survival rate of larvae infected with induced LD2 was 
not significantly different from those infected with naive LD2 (HR 1.5, 95% CI 0.5-4.8, 
P value=0.5). ST4 strains are necessarily from HIV infected patients since this lineage 
does not infect apparently immunocompetent patients. Therefore I could not 
perform this experiment with culture filtrate derived from ST4 strains from 
apparently immunocompetent patients. 
Figure 4-12 Survival curves of larvae infected with clinical, naïve environmental and 
induced environmental isolates. LD2, environmental isolate, was induced by 
individual filtrate (BK80) or pooled filtrate (BK224 + BK80). Sample size is 40 
larvae/arm 
4.4.6 Upregulated virulence is persistent over generations 
To test if induced isolates maintain their up-regulated virulence over one generation, 
I extracted induced isolates from larvae, cultured on Sabouraud agar and then 
repeated the infection experiments. The BMD761-induced LD2 strain clearly 
maintained its upregulated virulence; however, LD2 induced by BMD854 appeared 
to lose some virulence, although the survival curves remained separated (Figure 4-
13).  Hence the BMD761 strain is used for downstream experiments. The ability of 
BMD761 to induce LD2 was confirmed by repeating the experiment on 6 
independent occasions. The results was presented in the appendix E. 
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Figure 4-13 Survival curves of clinical isolates, naive environmental isolates and 
induced environmental isolates revived from larvae infected with induced isolates. 
BMD761 and BMD854 are clinical isolates while LD2 is derived from the 
environment. N= 40 larvae /arm 
4.4.7 Induced isolates can induce naive isolates 
I next tested whether the induced LD2 isolate could transform its naive self.  I grew 
the naive LD2 in culture filtrate of a previously BMD761-induced LD2 strain. The 
virulence of the LD2-induced LD2 strain significant increased compared to naive LD2 
(Hazard ratio 2.8, 95% CI 1.7-4.4, P value <0.001) (see Figure 4-14) 
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Figure 4-14 Survival curves of clinical (BMD761), environmental (LD2), induced 
isolates (Induced LD2 and LD2-induced LD2). Induced LD2 indicates BMD761-induced 
LD2. LD2-induced LD2 indicates naive LD2 transformed by BMD761-induced LD2. P 
value for comparison of L2-induced LD2 vs naive LD2 was obtained from the Cox 
proportional-hazards model. 
4.4.8 Virulence induction is not a consequence of growth in nutrient depleted 
media 
To test whether virulence induction was an artefact of growing a strain in a 
somewhat nutrient depleted medium, I cultured the naive isolate in nutrient-deplete 
culture filtrate. Here, instead of culturing naive LD2 in culture filtrate from BMD761, 
I grew it in culture filtrate from naive LD2. Nutrient-deplete culture filtrate was 
obtained by inoculating LD2 strains into YPD broth for 48 hours followed by 
centrifuge and filtration (i.e the same method as used for the induction experiments 
described above). The virulence of self-induced LD2 strains was not significantly 
different to the naive strain (HR 1.2, 95% CI 0.8-1.9, P value=0.3) (Figure 4-15). 
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Figure 4-15 Survival curves of larvae infected with naive LD2 and self-induced LD2 
strains. P value was generated using  the log-rank test. 
4.4.9 Hypervirulent isolates can induce upregulation of virulence of other clinical 
strains 
I tested whether BMD761 could upregulate the virulence of other clinical strains. 
Using the methods already described I added BMD761 culture filtrate to broth 
cultures of strains BMD973 (ST5), BK80 & BK224 (ST4). Larvae infected with 
BMD761-induced strains exhibited worse survival than naive clinical strains (Figure 4-
16). While the baseline virulence of BK224 was similar to that of BMD761 (HR 1.2, 
95% CI 0.7-1.9, P=0.5), BMD761-induced BK224 was even more pathogenic than 
BMD761 (P=0.02). 
 
 
 
 
 
 
 
 
P=0.3 
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Figure 4-16 Survival curves of BK80, BK224 and BMD973 and corresponding 
BMD761-induced isolates. P values are derived from Cox’s proportional-hazards 
model for comparison between induced isolates and naive ones. Sample size was 40 
larvae/arm 
4.4.10 The induction capacity of culture filtrate is lost by boiling and protease 
treatment 
To test the stability of BMD761 culture filtrate activity under freezing for prolonged 
storage, I froze culture filtrate at -20oC for 33 days. Frozen filtrate maintained its 
induction effect (Figure 4-17) 
To understand whether nucleic acids or protein/peptide mediated the induction 
effect, BMD761 culture filtrate was incubated with RNAse, DNAse and protease 
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(proteinase K) and heat prior to induction. The results show that culture filtrate lost 
its effect when exposed to heat (Figure 4-17) or protease treatment (Figure 4-18).  
 
 
 
 
 
 
 
 
Figure 4-17 Survival curves of larvae infected with clinical (BMD761), environmental 
(LD2) and induced isolated. LD2 was induced with either frozen (left plot) or boiled 
(right plot) culture filtrate. P values and HR were calculated using Cox proportional-
hazards model. 
 
 
 
 
 
 
 
 
 
 
Figure 4-18 Survival curves of larvae infected with clinical (BMD761), environmental 
(LD2) and induced isolated. Culture filtrates were treated with nuclease or protease 
prior to induction. P values and HR obtained from the Cox proportional-hazards 
model are presented in the table above 
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4.4.11 Upregulated virulence is associated with larger fungal burdens in infected 
Galleria  
 
Figure 4-19 Fungal burden of C. neoformans isolates (clinical BMD761, 
environmental LD2 and induced LD2) recovered from larval hemolymph  48 hours 
post-inoculation. P value (Wilcoxon test) is 0.025 for comparison between LD2 and 
Induced LD2. N=48, 16 biological replicates/strain. 
After inoculation for 48 hours, larvae were sacrificed to extract hemolymph and fat 
body which were cultured to quantify CFU/gram of larva. Fungal burden was 
significantly higher in larvae infected with induced LD2 compared with those 
infected with naive LD2 (P=0.025). The fungal burden in BMD761-infected larvae was 
more variable than that of LD2 and Induced LD2 (Figure 4-19). 
4.4.12 Virulence upregulation is not associated with measurable differences in 
classical virulence traits 
Thermotolerance, capsule size, melanin formation and CSF ex vivo survival are 
phenotypes previously associated with virulence in C. neoformans as mentioned in 
the introduction chapter. I tested whether larval virulence was associated with 
changes in phenotype by comparing phenotypes of induced LD2 with naive LD2. The 
methods of phenotypic assays were described in the chapter 3. There were no 
differences between induced and naive isolates across any of these parameters (P 
values for difference in growth at 30oC and 37oC were 0.2 and 0.4, respectively). CSF 
ex vivo survival testing for 72 hours at 37oC was indistinguishable (P value =1). 
Similarly, no difference was seen in melanin production by visual observation using 
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Candida parapsilosis as control for negative melanization. Contrary to my 
expectation, the capsule size of naive LD2 isolates (extracted from larval 
hemolymph) was significantly thicker than induced LD2 (Figure 4-20). Both capsule 
size of LD2 and Induced LD2 were significantly smaller than that of BMD761 
(Adjusted P value = 0.03 and < 0.001, respectively) 
 
Figure 4-20 Capsular size comparison of C. neoformans (clinical BMD761, 
environmental LD2 and Induced LD2) recovered from larval hemolymph 48 hours 
post-inoculation. Adjusted P value = 0.03 obtained from Kruskal-Wallis test with 
Benjamini-Hochberg method (Induced LD2 vs LD2) 
4.4.12 Morphology of C. neoformans post-inoculation in larvae 
C. neoformans were extracted from hemolymph of living larvae 48 hours post-
inoculation. All cells were highly encapsulated with pseudophyphae cells detected in 
induced LD2 strains (Figure 4-21). However, pseudophyphae cells were not 
frequently observed. Titan cells were observed in both LD2 and induced LD2 strains 
but not in BMD761 strains 96 hours post-inoculation. Titan cells are classified as 
those with cell body diameter greater 15 m128. Titan cells were first described in the 
mouse lung. They are resistant to phagocytosis and oxidative and nitrosative 
stresses, and are believed to enhance cryptococcal survival in vivo126 125. 
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Figure 4-21 Morphology of C. neoformans extracted from larva 48 hours post 
inoculation at 1000X magnification under light microscope: clinical BMD761, naïve 
LD2 and Induced LD2, and 96 hours post-inoculation: naïve LD2 and Induced LD2. 
Titan cells and pseudohyphae cells are denoted with ** and *, respectively. 
4.4.13 ST5 strains derived from HIV-uninfected patients appear more virulent than 
Vietnamese C. gattii strains in the Galleria model 
Disease in immunocompetent people due to infection with C. gattii is well-described, 
and a small number of cases (2-6) are seen each year in our hospital. It is rare to 
BMD761-48H 
** 
* 
* 
** 
LD2-48H 
Induced LD2-48H 
LD2-96H 
Induced LD2-96H 
** 
** 
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encounter a C. gattii strain in HIV infected patients in Vietnam.  Given the fact that 
almost all disease in HIV uninfected patients due to C. neoformans in Vietnam is 
caused by ST5 strains, I was interested in whether the ST5 strain has comparable 
virulence to Vietnamese C. gattii isolates.  I compared survival in the Galleria model 
using three C. neoformans ST5 strains (BMD1592, BMD367, BMD494) vs three C. 
gattii strains (BMD873, BMD1377, BMD800) - all derived from HIV-negative patients. 
The survival rate of larvae infected with C. neoformans ST5 strains derived from HIV 
negative patients was significantly lower than C. gattii (P value <0.0001, Figure 4-22). 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-22 Survival curves of larvae infected with C. gattii and C. neoformans ST5 
derived from HIV-uninfected patients. P value < 0 obtained from Log-rank test, n=90 
4.4.14 Medium-dependent induction effect 
I hypothesize that the induction effect is independent of medium. I employed RPMI 
instead of YPD to culture BMD761 and used the culture filtrate, both fresh and 
frozen, to induce LD2 strain. The induction effect was maintained when using RPMI, 
but only when fresh (as opposed to frozen) culture filtrate was used (Figure 4-23). 
However, the induction effect was not as robust as in the case of YPD-based culture.  
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Figure 4-23 Survival analysis of larvae infected with clinical BMD761, naïve LD2 and 
LD2 induced with fresh and frozen RPMI-base culture filtrate. P value and HR were 
obtained from pairwise comparison between naïve LD2 and induced LD2 using Cox 
proportional-hazards model. N= 120 
4.5 Discussion 
4.5.1 Comparative survival of ST4 strains derived from HIV-infected and ST5 strains 
derived from HIV-uninfected patients 
The mouse is an established model for studying pathogenicity of C. neoformans 
because it shares some similarity with humans, with regard to general anatomy, 
physiological temperature and immune system. However, it has the disadvantage of 
being expensive, low throughput, and sentient. Moreover, with regard to 
cryptococcosis, it may represent more a model of disease in HIV infection rather 
than immunocompetent infection 231.  
In recent years, there has been increased interest in the G. mellonella infection 
model because of its relative ease of use, reduced bioethical issues, lower costs and 
potential for higher throughput. Despite being an invertebrate, Galleria has an 
immune system that shares considerable similarities with the mammalian innate 
immune system. Galleria hemocytes phagocytose bacterial and fungal cells in a 
P = 1 P = 0.04 
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similar way to human neutrophils through the oxidative burst pathway. Proteins 
mediating generation of reactive oxygen species in Galleria larvae are homologous 
to proteins involved in superoxide production by human neutrophils 232. Following 
these discoveries, G. mellonella has been widely adopted to study the pathogenesis 
of bacteria (Bacillus cereus, B. thuringiensis & E. coli) and fungi (Candida albicans, C. 
krusei, Aspergillus fumigatus, A. flavus & Cryptococcus gattii)229 166. The G. mellonella 
infection model was previously used to distinguish the hyperpathogenic C. gattii 
strain causing Vancouver Island outbreak (VGIIa) and other major molecular types 
(VGII, VGIII and VGIV)166. Moreover, correlation between virulence of C. albicans and 
Pseudomonas aeruginosa in mice and larvae has been established164 163. This 
supports the use of Galleria mellonella as a model of innate immunity for high-
throughput pathogenicity assays instead of mammalian models.  
I hypothesized that ST5 isolates are more virulent than non-ST5 isolates. Here, I 
found that C. neoformans ST5 isolates derived from HIV uninfected patients are 
significantly more virulent than non-ST5 strains (which are necessarily derived from 
HIV infected patients). I believe that enhanced virulence, when detected in a model 
of the innate immune system (ie. the Galleria model), is consistent with my 
hypothesis that ST5 strains have increased pathogenicity, where pathogenicity 
means the ability to cause infection/disease86. The innate immune response is the 
first line of barrier against cryptococcal infection with two major players –
complement and phagocytic effector cells. The complement system is responsible 
for opsonising cryptococcal cells and attracting phagocytic effector cells. 
Phagocytosis is performed by macrophages and neutrophils in humans. Neutrophils 
are an integral component of the innate immune response to cryptococci 233. They 
kill pathogens by exerting the oxidative burst and producing antimicrobial peptides 
(e.g. defensins). 
4.5.2 Clinical C. neoformans are significantly more virulent than environmental 
isolates 
I hypothesized that environmental isolates are as virulent as clinical isolates. The 
difference I identified in the pathogenicity of clinical isolates compared with 
environmental isolates of the same MLST is consistent with observations that clinical 
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isolates are more virulent than environmental isolates in the mouse model 52 62. 
Ngamkulrungroj et al observed a similar effect with  C. gattii strains (VGIIb) 234. The 
increased virulence of clinical strains compared with environmental strains could be 
explained by within-host microevolution235, driven by selective pressures that are 
absent in the environment outside of the animal host. Infection results from the 
inhalation of (possibly dormant) yeasts or spores. During the prolonged incubation in 
human hosts, there may be low level yeast growth that stimulates a conversion to a 
raised virulence state, driven by mutation, or more likely epigenetic/transcriptional, 
factors. I identified greater fungal burdens in larvae infected with clinical strains 
compared with those infected with environmental strains; this suggests the 
increased virulence of clinical isolates is driven by increased growth rate or better 
survival against phagocytosis in vivo.  
Differences in the pathogenicity of fungal species by source (clinical versus 
environmental) has been observed in other fungal pathogens including Aspergillus 
fumigatus236 .  
However, it is also possible that adaptation to infection in the human occurs 
somewhere in the environment – for example through infection in soil microfauna 
(free-living amoebae, nematodes etc) or in animals. Cryptococcal infection in animals 
is well described, although it is not clear how frequently this occurs, and there is not 
such a strong relationship with a particular species as has been described for 
Talaromyces20 237  
Differences in the phenotypes of clinical and environmental isolates have also been 
observed in the C. neoformans VNI population in Zambia and South Africa173. Clinical 
isolates produced larger capsules and grew more rapidly at 37oC than environmental 
isolates. However, laccase activity (involved in melanin production) was slightly 
higher in environmental isolates (VNI and VNB molecular types) compared with 
clinical isolates219. A study using Brazilian C. neoformans also found differences in in 
vitro thermotolerance between clinical and environmental isolates. Clinical C. 
neoformans grew significantly more rapidly at 42oC than environmental 
counterparts238. I speculate that my clinical isolates survive at elevated temperature 
better than environmental isolates too because the fungal burden of clinical isolates 
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was significantly higher than that of environmental isolates in larvae incubated at 
37oC. 
4.5.3 Dose-dependent pathogenicity 
I hypothesized that the inoculum size of C. neoformans correlates with mortality of 
larvae. I found denser inoculums of C. neoformans resulted in increased probabilities 
of larval death (Figure 4-4 & 4-5). This effect was more marked in the clinical isolate 
compared with the environmental isolate. The clinical isolate BMD761 was around 
30-fold as potent as the naive environmental strain LD2 in relation to the dose that 
was associated with a 50% probability of larval death. My finding in larvae is 
consistent with that in mice. A dose-dependent effect of C. neoformans var. 
neoformans in the mouse model has been observed before using clinical isolates, 
with median survival time negatively correlating with dose 122. Inoculum size –
dependent mortality has also been observed with C. neoformans var. grubii and C. 
gattii infections in the mouse model with dose varying from 103 to 106 CFU 239. An 
increasing mortality with increasing dose of yeast seems biologically plausible, and is 
consistent with my findings of higher fungal burdens in larvae infected with more 
virulent strains. 
4.5.4 Larvae-passaged C. neoformans 
Previously it has been suggested that passaging isolates through the mouse or even 
in the laboratory can increase virulence of C. neoformans H99 strain 240 241. I 
hypothesized that environmental isolates were less virulent than the clinically 
derived isolates because they had not experienced the immune environment before, 
and that they would upregulate their virulence if they had sufficient exposure to 
Galleria. Therefore I repeatedly passaged naive isolates through the Galleria larvae. 
However, I found that the virulence characteristics of my strains, both clinical and 
environmental, were fixed and unaltered by repeated passage through Galleria or on 
agar. This is consistent with a more recent publication that passage of two 
environmental C. neoformans up to three times in mice in fact has little effect on 
virulence 62. While I couldn’t demonstrate upregulation of virulence solely as a result 
of passage through Galleria, it may be that the period within the Galleria was 
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insufficient to allow such adaptation to occur. C. neoformans is likely to be dormant 
in humans for years before reactivation72 62. An alternative explanation is that the 
virulence up-regulation is driven by interactions with the adaptive immune system in 
more complex hosts than Galleria. However, my experiments certainly suggest that 
at some point there is an inter-yeast signaling pathway that becomes active and is 
likely responsible for maintaining or further enhancing virulence.  
4.5.5 Intercellular signaling regulates virulence of C. neoformans 
I hypothesized that intercellular signaling enables up-regulation of virulence of 
environmental isolates. My experiments appear to suggest the presence of an inter-
yeast signaling pathway that regulates the virulence of C. neoformans. Experiments 
with heat, proteases and nucleases imply that this is likely mediated by secreted 
peptides/proteins. Previously, it has been reported that secretory vesicles are 
produced by C. neoformans (serotype A and D) strain, and that they contain a 
number of proteins, many of which are relevant to virulence (growth at 37oC, 
protection against oxidative stress, capsule synthesis, cell cycle regulation)119. More 
recently, such vesicles have been described for C. gattii where they appear to 
mediate virulence, although the exact mechanism is unclear230. Such vesicles are a 
plausible explanation for the transmissible upregulation I have described here. 
Just as quorum sensing has been described in other micro-organisms, signaling 
peptides that have auto-inducing properties and regulate density-dependent growth 
have been described in C. neoformans242. Quorum sensing is the phenomenon 
whereby microbes coordinate their behaviour by adjusting gene expression in 
response to population density. In bacteria, this coordination ensures that 
metabolically expensive virulence factors/processes are only synthesized in 
synchrony to maximize bacterial survival /advantages243. In fungi, the first quorum-
sensing molecule (QSM) characterised was farnesol, which mediates morphology 
switching of Candida albicans244. C. albicans is dimorphic. At densities lower than 106 
cells/mL, the fungi develop as mycelium; they switch into yeast forms when the 
density >106 cells/mL. Interestingly, farnesol has detrimental effects on other 
species. It inhibits growth of Saccharomyces cerevisiae and induces apoptosis in 
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Aspergillus nidulans and A. fumigatus242. Quorum sensing has also been described in 
Histoplasma capsulatum and Neurospora crassa242.  
Quorum sensing (QS)-like molecules were first detected in TUP1 mutants of C. 
neoformans serotype D when it was observed that inocula of less than 103 cells 
failed to form colonies on agar. This density-dependent growth phenotype could be 
rescued when TUP1 mutants were grow in media supplemented with high cell 
density TUP1 culture filtrate.245 This lead to the discovery of an 11-amino acid 
peptide Qsp1 (quorum sensing-like peptide 1) acting as a signaling molecule in high-
density TUP1 cultures. However, this effect was not observed in TUP1 strains 
(serotype A). Ten years after the discovery of Qsp1, the molecular mechanism of this 
peptide in C. neoformans was identified. The QSP1 gene encodes a peptide precursor 
consisting of a signal sequence and 24-amino acid pro-peptide (proQsp1). proQsp1 is 
synthesized intracellularly. Once exported outside, it matures through cleavage 
mediated by the cell-associated protease Pqp1. The mature Qsp1 enters surrounding 
cells via peptide transporter Opt1, where it initiates morphological and virulence 
changes. The virulence of QSP1-deficient mutants was attenuated in the mouse 
inhalation model compared to wild-type H99. The QSP1 mutants formed wrinkled 
colonies while H99 strains formed smooth colonies. Moreover the mutant strains 
were hypomelanized in saturated culture. These defects can be rescued by adding 
synthetic Qsp1 or placing mutants near WT cells. In saturated culture, transcriptome 
profiles were significantly different between WT and QSP1 mutants. Qsp1-regulated 
genes were enriched for genes associated with cell wall biosynthesis 246. However, it 
is not clear that the observation I see here in my experiments is quorum sensing in 
the sense of being driven by the yeast population density. The exact stimulant that 
first initiates upregulation of pathogenicity is beyond the scope of this thesis but 
would be an exciting area for future study. 
As mentioned above, a recent report related to the Vancouver Island outbreak strain 
C. gattii (R265) revealed that the strain can accelerate intracellular proliferation rate 
of non-outbreak strains in murine macrophages. This is regulated by extracellular 
vesicles (EV) derived from the outbreak strain. EVs are taken up by the host 
macrophage, then transported to the fungal phagosome where they trigger 
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proliferation of non-outbreak cells. The two EV components essential for inducing 
virulence of non-outbreak strains are protein and RNA230. However, in my 
experiments, only protease treatment, rather than nuclease treatment, resulted in 
loss of the inducing property of culture filtrate. 
I examined four ST5 strains derived from HIV-uninfected patients. All of them 
exhibited induction effects, in contrast to ST5 strains derived from HIV infected 
patients, where the change in virulence did not meet conventional levels of 
statistical significance, although the HR was in the direction of an increase. Given 
that ST5 strains from HIV uninfected patients are distributed throughout the lineage 
in the phylogenetic tree, I would expect all ST5 isolates to have the potential to 
infect immunocompetent patients and to be able to be induced, or induce, further 
strains. Induction effect of some ST5 strains can be explained by phenotypic 
heterogeneity of ST5 lineage. The ST5 lineage displayed variation of virulence 
phenotypes in vitro compared to non-ST5 strains247. Phenotypic heterogeneity 
facilitates adaptation to environmental fluctuations248. I found only the BMD761-
induced LD2 strain was able to maintain significantly induced virulence over 
generations. Moreover, the exclusively hypervirulent BMD761 was able to induce 
other hypovirulent clinical isolates, including of other sequence types, suggesting 
virulence is not necessarily associated with sequence type but rather related to 
distinct attributes of individual strains.  
BMD761 in larvae displayed wider variation in fungal burden than LD2 and induced 
LD2 (Figure 4-19). The burden of induced LD2 in Galleria at death was significantly 
higher than naive LD2. Possible explanations include that induced LD2 grew faster, 
more efficiently, or evaded phagocytosis better than naive LD2. 
 Explanations other than peptide/protein signaling could drive the phenomenon of 
induction. These include viral infection – mycoviruses are described amongst fungal 
plant pathogens249, or even prions. Fungal prions are self-propagating and 
transmissible proteins isoforms, acting as epigenetic determinants by changing their 
conformations. Prions are proposed to create heritable phenotypic diversity to 
enable yeast adaptation to fluctuating environments250 251. However, the fact that 
the induction effect was inhibited by boiling and protease treatments suggests that 
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these latter explanations are unlikely. Hence, the effect of heat and protease 
treatment suggests that one or more proteins are implicated. Regulation of protein 
expression can be investigated through transcriptional profiling of protein-coding 
genes. Regulated genes involved in upregulation of virulence can be validated using 
real-time reverse transcription PCR. Then potential virulence genes could be 
precisely knocked-out using CRISPR-Cas9 and validated in animal models. Secretome 
profiling of the culture filtrate (naive strains, induced strains and knockout strains) 
could be achieved using liquid chromatography-tandem mass spectrometry. 
The changes in virulence phenotype seen in induced isolates cannot be due to 
recombination. First, I used culture filtrate from the donor inducing strain. Yeasts are 
too large to pass through the filter. I confirmed the sterility of all culture filtrates  for 
every experiment. Second, I used only purified clonal isolates for every experiment, 
and finally all culture was done in YPD medium which does not induce mating. 
Mating in Cryptococcus is a rare event that requires specific media252.  Reversibility 
of induction can be tested by growing virulent isolates into culture filtrate of naive 
isolates to see if their virulence phenotypes are suppressed. 
Other innate immunity models could be used to test induction of virulence is 
amoeba, nematode, macrophage and neutrophils. The macrophage model has been 
widely used as an in vitro cellular model of cryptococcal infection160. For example, 
the intracellular proliferation rate in murine macrophages of the non-outbreak C. 
gattii isolate was enhanced by co-culture with the outbreak C. gattii isolate230. Other 
animal models that could be utilised include the rat and mouse. Both these species 
have innate and adaptive immunity, and thus in theory are more similar to humans. 
Infection is achieved via nasal inhalation or intravenous or intraperitoneal injection. 
My experimental approach would be essentially the same, first demonstrating that 
the virulence phenotype is fixed over repeated passage, followed by comparative 
survival experiments with induced and naïve strains as performed in the Galleria 
model. Rats were reported to develop chronic pulmonary cryptococcosis in the wild, 
similar to disease due to C. gattii in immunocompetnt humans, so it is potentially a 
realistic model160. However, a significant drawback is the relatively large numbers 
(N=20 per arm) of animals that would be needed. 
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4.5.6 Morphology of C. neoformans post-inoculation in larvae 
Surprisingly, I observed pseudohyphae in the induced LD2 population but not in the 
highly virulent BMD761 isolate. Moreover, pseudohyphae cells were not frequent. 
They were not always observed in induced LD2 strains. Pseudohyphae have been 
reported to enhance cryptococcal survival in amoebae, a presumed natural predator 
of Cryptococcus found in soil. The pseudohyphae enable survival by resisting 
phagocytosis 124 23. However, the clinical significance of pseudophyphae is not clear. 
They failed to kill mice when injected intracranially253. No viable cells were revived 
28 days post-inoculation. This suggests pseudohyphae are unable to survive within 
the CNS 253. Pseudohyphae may not mediate the increased virulence of induced LD2 
in G. mellonella because they were not always observed in induced LD2 strains, nor 
did I see them in BMD761 infections.  
C. neoformans manifests morphological changes including capsular enlargement and 
formation of giant cells during mouse pulmonary infection 254 127. Cell wall thickness 
and capsule size increase as a function of infection time in this model. I found that  a 
heterogeneous population (in terms of encapsulated yeast cell, titan cells and 
pseudohyphae) also develops during infection of Galleria, supporting the validity of 
using this model to study morphogenesis of C. neoformans 167. I found that induced 
LD2 isolates had significantly less capsule than naive LD2. However, while large 
capsule size inhibits phagocytosis by hemocytes, it does not predict survival - survival 
of larvae infected with large-capsule cells was not significantly different from those 
infected with small-capsule cells167. In my case, the faster growth rate of induced 
isolates potentially played a vital role in enhanced virulence compared to naive LD2. 
Rather, the mortality rate of larvae is correlated with fungal load 98- the higher 
fungal burden, the higher the mortality rate. 
Unexpectedly, I did not find differences in classical virulence traits (thermotolerance, 
melanin production, CSF ex vivo survival) between naive LD2 and Induced LD2, 
suggestimg that these are virulence rates necessary across all lineages of C. 
neoformans. However, the (probable) faster growth rate of induced LD2, manifest as 
increased fungal burden, may play a central role in increased virulence, 
compensating for expression of classical virulence factors. 
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4.5.7 Comparative pathogenicity of C. neoformans and C. gattii 
Using the G. mellonella infection model, I found C. neoformans strains derived from 
immunocompetent individuals were more pathogenic than C. gattii. This somewhat 
surprising result agrees with the finding by Capilla et al, and perhaps represents the 
relative importance of the innate immune system for each of these two infections. 
Capilla et al compared the pathogenicity of both Cryptococcus species in both 
immunosuppressed and immunocompetent BALB/c mice, finding that C. neoformans 
are more virulent than C. gattii in both immune states of that mouse239.  The same 
result was also seen in the mouse model of severe combined immunodeficiency 
(SCID).  
4.6 Conclusions 
My data shows that G. mellonella is a good model to compare the pathogenicity of C. 
neoformans strains derived from both HIV-uninfected and HIV patients. My finding 
supports the hypothesis that ST5 strains, at least those derived from HIV uninfected 
patients, have increased virulence compared with non-ST5 strains. I also found that 
environmental isolates are significantly less virulent than clinical isolates.  
I found that the virulence of C. neoformans, at least for ST5 strains, seems to be 
regulated by a protein or peptide based signaling system, but the exact nature of this 
remains unclear. Peptides/proteins may mediate this signaling pathway to enhance 
virulence of naive environmental isolates, and to coordinate yeast growth during 
infections. While having a dramatic effect on ST5 strains with lower virulence 
phenotypes, exemplified by environmental strains, the hypervirulent BMD761 strains 
also seemed to be able to upregulate the virulence phenotype of strains of different 
lineages – namely ST4. The enhanced pathogenicity of clinical isolates or induced 
isolates compared to environmental isolates is associated with higher fungal load in 
larvae, rather than increase in capsule size or other previously recognised virulence 
factors. Further experiments with ST5 induced ST4 strains are warranted to identify 
whether such strains could also upregulate virulence. However, since ST4 strains are 
rarely found in apparently immunocompetent patients, this is unlikely.   
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Chapter 5  
Comparative transcriptome analysis of environmental and clinical C. 
neoformans var. grubii in Vietnam  
5.1 Introduction 
In chapter 4 I found that:  
1. Clinical C. neoformans strains are significantly more virulent than MLST-
matched environmental isolates in the G. mellonella infection model.  
2. ST5 clinical strains are more virulent than ST4 clinical strains 
3. The virulence state of an isolate is relatively fixed and not altered by 
repeated culture in Galleria or on agar 
4. Culture filtrate from ST5 strains from HIV uninfected patients can upregulate 
the virulence of environmental ST5 strains 
5. Culture filtrate from such upregulated (‘induced’) environmental strains can 
itself upregulate naïve environmental strains 
6. The upregulated virulence state is stable over generations. 
7. The inducing property of culture filtrate is inhibited by heat and protease, but 
not nucleases 
8. Culture filtrate from naive environmental strains themselves (i.e never 
induced) does not upregulate the virulence of naive environmental strains. 
This phenomenon of induction of virulence phenotype in Galleria may explain the 
ability of the ST5 lineage to cause disease in the apparently immunocompetent host. 
There are a number of possible explanations for how the phenomenon of induction 
is mediated. My experiments in the previous chapter suggest that the effect is 
mediated by one or more soluble factors; these are unlikely to be nucleases since 
the effect of induction was not affected by nuclease-treated culture filtrate. 
Involvement of prion was excluded because the culture filtrate lost effect when 
exposed to heat or protease. However, the effect of heat and protease treatment 
suggests that one or more proteins are implicated. In this part of the thesis I use 
RNA-Seq to answer the following questions: 
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1. What are the differences in gene expression between environmental and 
clinical isolates? 
2. Is induction associated with upregulation of recognized virulence 
determinants? 
3. What are processes/pathways associated with enhanced virulence of clinical 
and induced strains?  
4. What are gene candidates that may drive the induction? 
5. What are their likely functions? 
Investigating virulence factors, potential therapeutic targets, of C. neoformans is of 
great interest. Steen et al were interested in transcriptional response to survival and 
progression during rabbit cryptococcal meningitis.255 They employed the serial 
analysis of gene expression (SAGE) to characterise transcriptomic profiles of C. 
neoformans isolated from rabbit CSF. SAGE involves constructing and sequencing a 
library of 10-14 bp tags, whose sequences correspond to unique transcripts. 
Therefore, the abundance of tags corresponds to the expression level of genes in the 
cells under specified experimental conditions. Steen et al identified several 
functional pathways important for pathogenicity in rabbit hosts compared to in vitro 
conditions by quantifying tags assigned to genes encoding proteins responsible for 
protein synthesis and catabolism, stress response, cellular respiration, signal 
transduction, and transportation as well as carbohydrate, amino acid and lipid 
metabolism. Cryptococcal cells require these functions to adapt to the rabbit central 
nervous system. 
Hybridization-based microarrays have been used to investigate the transcriptome of 
C. neoformans. Fan et al were interested in the transcriptional response of C. 
neoformans to phagocytosis in murine macrophages 95. They identified that multiple 
transmembrane transporter genes associated with hexose, amino acids, lipids and 
iron were induced upon phagocytosis. This increased production of transporters may 
facilitate the uptake of nutrients by the yeast in the relatively nutrient-depleted 
phagosome. Macrophage internalization also triggers upregulation of genes related 
to oxidative and nitrosative stresses. Genes encoding oxidoreductase, peroxidase 
and denitrosylase were found to be enriched. Interestingly, autophagy genes were 
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upregulated. Autophagy drives degradation of cytoplasmic components to supply 
ingredients for recycling of cellular components in the case of nutrient starvation. 
Furthermore, the association between virulence and mating type was confirmed 
with the finding that 50 % of MATα locus genes present in the microarray were up-
regulated at least twofold. However, further genes related to translation were 
repressed, such as those encoding ribosomal proteins, translation initiation factors, 
translation elongation factors and tRNA synthetases. The repression of translation 
apparatus has also been described in Candida albicans following phagocytosis 256. 
The response likely reflects a reaction to the nutrient-poor phagosome. 
The ability of C. neoformans to survive mammalian macrophages has likely been 
selected through their interaction with soil predators including amoeba, slime molds, 
and nematodes. This postulation is supported by Derengowski et al’s study 33 using 
DNA microarray. They compared transcriptome profiles of C. neoformans cells after 
ingestion by the amoeba A. castellani, and murine macrophages. 111 common genes 
were similarly modulated in both intracellular environments, suggesting their 
conserved adaptation to evading phagocytosis. 
Hybridization-based and sequence-based approaches have been widely used to 
elucidate transcriptome and explore virulence attributes of C. neoformans. However, 
they have several limitations. Hybridization-based methods require a priori 
knowledge of sequences of interest, are prone to cross-hybridization artefacts and 
have limited ability to detect highly induced or lowly expressed genes due to 
saturation signals 257. Unlike microarrays, tag-based methods can quantify 
expression level more precisely. However such methods are constrained by the 
laborious bacterial cloning of sequence tags, the high cost of Sanger sequencing and 
the requirement for large amounts of RNA input. Furthermore,  DNA microarray and 
tag-based methods cannot detect alternative splicing events or novel transcripts 257. 
RNA-Seq (RNA sequencing) is a high-throughput next-generation sequencing (NGS) 
technology that has revolutionized the field of transcriptomics. RNA-Seq consists of 
serial experiments including extracting mRNA, reverse transcription to from cDNA, 
ligation of adapters and construction of a sequence library prior to entry to the NGS 
platform (Figure 1). It has been widely used to profile the transcriptomes of a variety 
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of organisms: S. cerevisiae, Pseudomonas spp, dog, mouse and human cells 258–260. In 
addition to its high sensitivity and accurate measurement of gene expression, RNA-
Seq has the ability to detect novel transcripts, alternative splice sites and allele-
specific expression.261 
Figure 5-1 Overview of RNA-Seq. First mRNA is fragmented and converted to cDNA 
by reverse transcription. Second, sequencing adapters (blue) are ligated to each 
cDNA fragment ends. Next, they are subjected to NGS platform to produce short 
reads (single end or pair pair end), ranging from 30-400 bp. These reads, including 
junction reads, exonic reads and polyA-containing reads, are aligned to reference 
genome or transcriptome. Their alignment to genomic features is counted. 
Recently RNA-Seq was used to compare transcriptional profiles of C. neoformans var. 
grubii of molecular types VNI and VNII isolated from the CSF of HIV patients with 
cryptococcal meningitis262. These strains were exposed to three environmental 
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conditions: in vivo CSF, ex vivo CSF and YPD broth. Surprisingly, the transcriptome 
profiles of strains grown in in vivo CSF and nutritionally replete medium (YPD) were 
more similar to each other than to those from strains cultured in ex vivo CSF. The 
authors identified 6 genes uniquely upregulated in in vivo CSF in both strains. Of 20 
genes significantly induced in CSF conditions compared to YPD, some had been 
previously identified as virulence factors, such as CFO1, ENA1, RIM101. 
Janbon et al employed RNA-Seq to improve annotation of the H99 reference genome 
259. They found that the C. neoformans genome is intron-rich  263 - almost all 
expressed genes harboured at least one with an average of six introns per gene, 
resulting in a total of 42,000 introns. Introns are important regulators of gene 
expression in C. neoformans, with the accumulation of mRNA of some genes (for 
example, CAS3, CAP10, UGE1, CAS4) being highly intron dependent264. The more 
introns there are in CAS3, the greater the gene induction. Alternative splicing events 
were also common, identified in 741 genes (more than 10%).  
My identification of a difference in virulence between clinical and environmental 
isolates of C. neoformans is not unique – a similar phenomenon has been described 
before in the mouse model for both C. neoformans and C. gattii 62 52. However, these 
studies did not identify the induction of upregulation of virulence that I have shown 
in the previous chapter. The induction phenomenon provides me with an elegant 
biological model where I have congenic strains in the before and after induction 
state. This offers a unique opportunity to define the transcriptional drivers and 
markers of virulence using RNAseq.  
5.2 Aims 
The aims of this chapter are: 
- To define the transcriptional differences associated with variability in virulence  
- To identify gene candidates associated with variability in virulence between 
isolates. 
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5.3 Methods and Material 
5.3.1 Strains and culture 
The strains used in this chapter are the same strains for the experiment of virulence 
induction (section 4.4.5.2). I used BMD761, a strain from an HIV uninfected 
apparently immunocompetent patient of MLST ST5. This patient had been enrolled 
in a prospective descriptive study of patients with CNS infections 180. The 
environmental strain used was LD2, isolated from the bark of a Hopea odorata tree 
from central Ho Chi Minh City during my environmental sampling study. In this 
chapter I refer to the uninduced environmental strains as naive LD2. Following 
upregulation of pathogenicity through growth in culture filtrate from BMD761, I 
refer to it as induced LD2. Self-induced LD2 is naive LD2 that has been grown in 
culture filtrate that had naive LD2 cultured in it (Table 5-1). 
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ID 
MLST type 
 
Background 
 
Experiment 
 
BK80 
 
4 
 
Isolate from HIV 
patient 
 
Comparative transcriptome 
(clinical vs environmental) 
 
BMD761 
 
5 
 
Isolated from HIV-
uninfected patient 
Comparative transcriptome: 
clinical vs environmental, 
induced vs naive 
 
NT7533 
 
5 
 
 
Isolated from 
trees 
 
Comparative transcriptome: 
clinical vs environmental 
 
LD2 
 
5 
 
Isolated from 
trees 
Comparative transcriptome: 
clinical vs environmental, 
induced vs naive 
Induced 
LD2 
 
5 
 
LD2 cultured in 
BMD761 filtrate 
Comparative transcriptome: 
induced vs naive 
Self-
induced 
LD2 
 
5 
LD2 cultured in its 
own culture 
filtrate 
Comparative transcriptome: 
induced vs naive 
Table 5-1 Strains used for comparative transcriptional profiling 
Phylogenetic relationship of clinical and environmental C. neoformans can be found 
in the appendix B. 
5.3.2 Growth curves of strains used 
Three replicates of each strain were cultured in YPD broth for 96 hours at 30oC to 
determine log phase for RNA extraction. An inoculum of approximately 106 cells was 
grown in 7.5 mL of YPD broth by agitating (200 rpm). At interval time point post-
inoculation (0, 6, 20, 24, 30, 44, 54, 68, 72 and 96 hours), an aliquot of 50 uL was 
taken for quantification by plating in Sabouraud agar plates. These plates were 
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exposed to incubation at 30oC for 48 hours. Growth curves were plotted using ggplot 
package and R version 3.4.0 software (R Foundation for Statistical Computing, 
Vienna, Austria). Growth rates were determined using the formula growth 
rate=(log10Nt-log10No)*2.303/t-to, where N indicates cell concentration at a 
particular time point; and t indicates the time point). The growth curves are 
presented in appendix C. 
5.3.3 Revival, culture and RNA extraction 
Single colonies of each isolate were revived from beads (Microbank, UK) stored at -
80oC. Revived isolates (approximately 106 cells, counted using a Cellometer) were 
grown in 7.5 ml of YPD broth by agitating for 18 hours at 30oC. My previous kinetic 
growth experiments indicated C. neoformans isolates of interest are in mid-log phase 
at this time post-inoculation. RNA was harvested using the RiboPure™-Yeast RNA 
Isolation Kit (Ambion, USA) according to the manufacturer’s instructions. Extracted 
RNA samples were subjected to quality control using an Agilent 2100 Bioanalyzer 
(Agilent, USA). The integrity of total RNA was estimated using the RIN (RNA Integrity 
Number), which ranges from 1 to 10, with 1 being the most degraded. Samples with 
RIN greater than 7 qualified for RNA-Seq. I prepared 6 biological replicates of every 
experimental condition; all were sent for sequencing 265. RNA was eluted in 
isopropanol and shipped at room temperature to Macrogen (Seoul, Korea) for library 
preparation and sequencing. 
5.3.4 Library preparation and Illumina sequencing 
In Korea Paired-end RNA-Seq libraries were constructed using the TruSeq stranded 
mRNA preparation kit (Illumina, USA). Next, cDNA were ligated with sequencing 
adaptors and were sequenced on an Illumina HiSeq 2000 platform, generating about 
11.2 million reads of 150 bp per sample, equivalent to an estimated coverage of 177-
fold. Raw data files were downloaded to the OUCRU server. 
5.3.5 RNA-Seq analysis 
Raw reads were checked for quality using FastQC 
(https://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Adapters were 
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removed using scythe (https://github.com/vsbuffalo/scythe). The resulting reads 
were further checked based on Phred score and read length to trim low quality 
regions using Trimmomatic (http://www.usadellab.org/cms/?page=trimmomatic). 
Sequenced reads were aligned with the C. neoformans var. grubii H99 reference 
genome using HISAT2 (https://ccb.jhu.edu/software/hisat2/index.shtml). SAM 
(Sequences Alignment Map) files, output of read alignment, was converted to BAM 
(Binary Alignment Map) files using SAMtools (http://www.htslib.org). Finally 
featureCounts was used to count reads assigned to genomic features (genes, exons, 
chromosome locations) on the reference genome266. The output table of raw counts 
per gene for each sample was imported for gene expression analysis using DESeq2 
267. Library size differences were normalized internally268.  The overview of the RNA-
seq workflow is featured below in Figure 5-2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-2 Overview of bioinformatic workflow of RNA-Seq data analysis. Following 
sequencing, raw short reads was subjected to quality control. Next, they were 
aligned to H99 reference genome. Then abundance of reads assigned to genomic 
features was determined. Downstreams analyses include differential expression and 
gene ontology enrichment. Adapted from Kukurba et al257  
FastQC and aligned to 
reference genome 
(HISAT2) 
Gene-based read count 
(featureCounts) 
 Gene A      Gene B    
Gene C 
Differential expression analysis 
DESeq2 
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5.3.6 Gene ontology (GO) enrichment analysis 
Differential gene expression analyses frequently generate datasets with large 
numbers of genes up- or down-regulated in response to a particular experimental 
condition. These sets of genes may coordinate to cause system-level changes in the 
experimental model. To facilitate meaningful biological interpretation for sets of 
genes, the Gene Ontology Consortium constructed a set of hierarchical controlled 
vocabulary, allowing the systematic linkage of genes with functions across species 
269. The Gene Ontology vocabularies are constantly curated and updated with over 
87,000 species having GO annotations270. GO terms have three domains: 
- Biological process: represents biological objectives to which genes or their 
products contribute, such as DNA recombination, immune response, signal 
transduction. 
- Molecular function: defines biochemical activity of gene products. A product 
may perform many functions. A set of functions builds up a biological 
process. Examples of function terms are: catalytic activity, transporter, 
ligand, DNA binding, signaling. 
- Cellular component: describes where a gene or a gene product acts within 
the cell. Examples of this term are nuclear membrane and Golgi apparatus. 
Multiple gene products can be found in a single cellular component, such as 
the nucleus or ribosome. This domain reflects understanding of eukaryotic 
cellular structure, so not every term is applicable to all organisms. 
Gene ontology is an important asset in interpreting RNA-Seq data. To this end, I used 
the R package topGO (available at 
https://bioconductor.org/packages/release/bioc/html/topGO.html) to test if 
enrichment of GO terms associated with a set of genes was significantly different 
from that which would be expected by chance. TopGO uses Fisher’s exact test and 
the Kolmogorov-Smirnov test to test whether GO terms annotated to a set of genes 
are statistically overrepresented. TopGO takes the GO hierarchy into account to 
minimize false positive results271. The resulting list of significant GO terms was 
visualised by REVIGO (available at http://revigo.irb.hr). REVIGO reduces functional 
redundancy and the clustering of semantically similar GO terms272. 
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5.3.7 Identification of virulence-associated genes and prediction of hypothetical 
protein 
A list of virulence-associated genes was retrieved from the web page 
http://www.phidias.us/victors/search_process.php?c_mc_pathogen_id=211 
developed by University of Michigan Medical School (USA). Another source for C. 
neoformans virulence genes and prediction of hypothetical protein is the fungal 
functional genomic database FungiDB (http://www.fungidb.org/fungidb/). 
Differentially expressed genes are represented by log2 Fold Change which is 
calculated by averaging for all replicates (treated vs untreated condition). 
5.3.8 Experimental workflow 
Experimental workflow in this chapter is depicted below 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-3 Experimental workflow of chapter 5 
Aims: To define the transcriptional differences 
associated with variability in virulence 
To identify gene candidates associated with 
variability in virulence between isolates. 
 
 
 
Hierarchical cluster analysis of differentially 
expressed genes  
Global transcriptomic profiles between isolates 
using PCA 
Comparative analysis of transcriptional profiles 
of isolates  
 
Functional analysis of differentially 
expressed genes using gene 
ontology enrichment analysis 
 
Investigate differentially 
expressed genes associated 
with virulence 
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5.4 Result 
5.4.1 RNA-Seq sequencing result 
The Illumina HiSeq 2000 platform generated 6.4 to 12.2 million paired-end reads 
with the length of 150 bp per sample, totaling 331 million reads (Table 5-2). The 
sequencing depth ranges from 100 to 194X. More than 97% of total reads were 
mapped to the C. neoformans var. grubii H99 reference genome, of which at least 94 
% were uniquely mapped and taken into account for digital transcriptome analysis. 
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Experimental condition Total reads Mapping (%) Unique mapping (%) 
BK80-1 9694924 98.21 95.76 
BK80-2 9345272 99.31 96.75 
BK80-3 7828385 99.22 96.67 
BK80-4 7906881 99.28 95.33 
BK80-5 8895059 99.31 97.03 
BK80-6 8288584 99.35 95.11 
BMD716-1 10566932 99.07 96.56 
BMD716-2 10209953 99.22 94.11 
BMD716-3 8026923 99.16 96.47 
BMD716-4 8389000 99.02 96.63 
BMD716-5 7992309 99.07 96.82 
BMD716-6 10283111 99.08 96.75 
NT7533-1 6411961 98.68 96.37 
NT7533-2 10948992 99.15 96.49 
NT7533-3 9427071 99.00 96.53 
NT7533-4 11626846 99.04 96.33 
NT7533-5 6871780 99.09 96.77 
NT7533-6 6467683 99.07 96.73 
LD2-1 9483009 99.01 96.63 
LD2-2 11023417 99.13 96.81 
LD2-3 10871841 98.94 96.49 
LD2-4 9038152 97.23 94.84 
LD2-5 11368845 99.07 96.60 
LD2-6 6879322 99.11 96.90 
Induced LD2-1 10297952 99.17 96.96 
Induced LD2-2 8650109 99.19 96.76 
Induced LD2-3 9502629 99.19 96.33 
Induced LD2-4 10857524 99.06 96.67 
Induced LD2-5 10559163 99.20 97.13 
Induced LD2-6 10979132 99.24 95.95 
Self-induced LD2-1 8345534 98.94 96.18 
Self-induced LD2-2 7389997 99.31 96.73 
Self-induced LD2-3 6901251 99.22 96.54 
Self-induced LD2-4 8314394 99.27 96.51 
Self-induced LD2-5 9311518 99.00 96.10 
Self-induced LD2-6 12251864 99.22 96.42 
Table 5-2 Mapping statistics for C. neoformans var. grubii RNA-seq data. Each isolate 
was performed in six biological replicates. Total reads: number of short read 
generated; Mapping: percentage of reads mapped to C. neoformans var. grubii H99 
reference genome. Unique mapping: percentage of reads uniquely mapped to 
genomic features in the reference genome. 
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5.4.2 Global transcriptomic profiles between clinical and environmental isolates 
are different 
To examine overall similarity and difference in transcriptome between samples, I 
used principle component analysis (PCA) to analyse clustering of clinical isolates 
(BK80 and BMD761) vs environmental isolates (NT7533 and LD2). The data points 
(24 biological isolates) were projected onto a 2D plane such that they spread out in 
two dimensions to reveal the most variance. PC1 represents the direction that data 
points separate the most. In this case, PC1 (principle component 1) explains 62% of 
the variance in transcriptional profiles between samples (Figure 5-4). In the plot, 
three groups form 3 clusters by source and MLST genotypes: clinical isolates (ST4), 
clinical isolates (ST5) and environmental isolates (ST5). Strikingly, the majority of 
environmental isolates are separated from clinical isolates (regardless of genotype), 
which agrees with the significant difference in survival phenotype seen on infection 
of Galleria (Chapter 4). There appeared to be two outliers in my dataset: two from 
the environmental isolate LD2 and one from the clinical isolate BMD761. The reason 
for these outliers is unclear but may reflect technical variations and/or population 
heterogeneity. Given that these outliers may have represented a technical variation, 
and because I could not be certain that the phenotype of the strains in the Galleria 
model had changed, I removed these outliers from further analyses.  
After removal of the 3 outliers, clustering was still maintained (Figure 5-5). Clinical 
isolates were grouped by genotype and were separated from a cluster of 
environmental replicates. PC1 now explained 65 % of the variance in transcriptome 
profiles between samples. 
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Figure 5-4 Principle component analysis of transcriptional profiles. 4 isolates with 6 
biological replicates each are included: BK80, BMD761, NT7533 and LD2. NT7533 and 
LD2 are environmental isolates. The biological replicates are separated well by 
genotype (ST4 vs ST5) and source (clinical vs environmental) except three outliers 
(one BMD761 and two LD2 replicates). 
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Figure 5-5 Principle component analysis of transcriptional profiles after removal of 3 
outliers. Red dots and blue dots indicate environmental isolates and clinical isolates, 
respectively. The biological replicates are separated well by genotype (ST4 vs ST5) 
and source (clinical vs environmental). 
5.4.3 Comparative analysis of transcriptome between clinical and environmental 
isolates 
Comparative analysis of clinical vs environmental isolates (BK80 plus BMD761 vs LD2 
plus NT7533) was performed to test for differentially expressed genes. A total of 
1701 genes were differentially expressed between the two isolate groups (Wald test, 
Benjamini-Hochberg adjusted P value < 0.05, log2 fold change  1 and  -1). A 
hierarchical clustering of 1701 differentially expressed genes based on normalised 
read count per gene reveals two source-specific gene clusters. The gene expression 
patterns of clinical isolates is different from that of environmental isolates (Figure 5-
6) with 977 genes induced and 724 genes repressed in clinical isolates relative to 
environmental isolates. In addition, differences in gene expression by sequence type 
were evident in clinical isolates (BK80 (ST4) vs BMD761 (ST5)). NT7533 and LD2 are 
all sequence type 5, but their transcriptome patterns differ. The heat map also 
shows some variation (technical and/or biological) in expression pattern within 
biological isolates (BK80 and BMD761, Figure 5-6). 
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Figure 5-6 Hierarchical cluster analysis of gene expression based on 
nomalised read counts per gene. The heat map displays expression patterns 
for 21 samples. Each sample corresponds to 1 column and each single gene 
to a single row. The colour key ranges from red for up-regulated gene to 
green for down-regulated genes across samples. 
5.4.4 Functional analysis using gene ontology 
5.4.4.1 Biological process terms relevant to cellular biosynthesis and metabolism 
were enriched in clinical isolates vs environmental isolates 
The set of up-regulated genes in clinical isolates relative to environmental isolates 
was investigated for overrepresentation of GO term annotations in three domains 
(biological process, molecular function and cellular component). A list of significantly 
enriched GO terms associated with biological process was summarised and visualised 
using the semantic similarity REVIGO scatterplot (Figure 5-7 & Table 2). In the 
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bubbles representing GO terms, the colours correspond to the significance level (P 
value < 0.05) and the size indicates the frequency of GO terms in the underlying 
Gene Ontology annotation database (UniProt). The smaller the bubble, the more 
specific the GO terms. The shorter the distance between bubbles, the more the 
semantic similarity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-7 Biological process–associated GO terms of upregulated genes in clinical 
isolates. Bubble size represents frequency of GO terms in the GO annotation 
database (UniProt). Colour indicates significant level. Bubble proximity implies their 
semantic similarity. 
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Strikingly, the most significantly enriched GO terms were related to cell metabolism: 
purine ribonucleotide metabolism (GO:0009150), coenzyme metabolism 
(GO:0006732), and DNA metabolism (GO:0006259). Upregulated genes involved in 
biosynthesis were frequently enriched: cellular macromolecule biosynthesis 
(GO:0034645), organic substance biosynthesis (GO:1901576) and cellular 
biosynthesis (GO:0044249) (Table 5-3). A gene participating in protein modification is 
also upregulated (GO:0006457, protein folding).  
Table 5-3 Enriched biological process–associated GO terms of upregulated genes in 
clinical isolates. Given are GO term ID, term descriptions, frequency of GO terms in 
the underlying GO (UniProt) and log10 P value. 
5.4.4.2 Molecular function terms relevant to protein biosynthesis and cell division 
were enriched in clinical isolates 
Figure 5-8 displays enriched GO terms associated with molecular function. The most 
significantly enriched GO term related to protein synthesis machinery: structural 
constituent of ribosome (GO:0003735) (Table 5-4). Other significantly enriched GO 
terms were those associated with microtubules (microtubule motor activity and 
microtubule binding). Moreover, genes involved in the synthesis of DNA and 
polypeptides were enriched: DNA-directed DNA polymerase activity (GO:0003887) 
and translation elongation factor activity (GO:0003746).  
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I also analysed enrichment of GO terms for the cellular component domain. Only one 
GO term was significantly enriched: GO:0000922 spindle pole. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-8 Molecular function–associated GO terms of upregulated genes in clinical 
isolates. Bubble size is proportional to frequency of GO terms in the underlying GO 
annotation database (UniProt). Colour indicates significant level. Bubble proximity 
implies their semantic similarity. 
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Table 5-4 Enriched molecular function–associated GO terms of upregulated genes in 
clinical isolates. 
5.4.4.3 Gene ontology analysis of down-regulated genes in clinical isolates  
In contrast to up-regulated genes, there were fewer enriched GO terms due to the 
low number of down-regulated genes in clinical isolates. For the biological process 
domain, only two GO terms were significantly enriched: GO:0009152 purine 
ribonucleotide biosynthesis and GO:0055114 oxidation-reduction process with the 
latter being more statistically significant  than the former (Table 5-5 and Figure 5-9). 
Notably, half of the molecular-function GO terms were related to transporter 
activity: transporter activity, nucleobase transmembrane transporter activity, active 
ion transmembrane transporter activity, and carboxylic acid transmembrane 
transporter activity (Figure 5-10 & Table 5-5). Additionally, genes involved in 
catalysis were down-regulated: hydrolase activity and acid phosphatase activity. No 
genes annotated to the cellular component GO domain were enriched. 
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 Figure 5-9 Enriched biological process–associated GO terms of downregulated genes 
in clinical isolates. Bubble size is proportional to frequency of GO terms in the 
underlying GO annotation database (UniProt). Colour indicates significant level. 
Bubble proximity implies their semantic similarity. 
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Table 5-5 Overrepresented GO terms associated with biological process and 
molecular function in clinical isolates 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-10 Enriched molecular function–associated GO terms of down-regulated 
genes in clinical isolates. Bubble size represents frequency of GO terms in the GO 
annotation database (UniProt). Colour indicates significant level. Bubble proximity 
implies their semantic similarity. 
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5.4.5 Differentially expressed genes associated with virulence between clinical and 
environmental isolates 
5.4.5.1 Regulation of Gat201 target genes between clinical and environmental 
isolates 
The pleiotropic virulence determinant Gat201, a GATA-family zinc finger DNA 
transcription factor, is a key regulator of virulence and capsule-independent 
antiphagocytosis. The virulence of the GAT201 knockout mutant is attenuated in the 
murine infection model compared to wild type226. Chun et al showed that GAT201 
controls the induction of ~1100 genes (16 % of the genome) and can affect a twofold 
difference in transcript level. Of 1100 genes, 62 genes have promoters bound to 
GAT201 for regulation of gene expression in tissue culture conditions116. Table 5-6 
displays the Gat201-bound genes that are differentially regulated in my clinical 
compared with environmental C. neoformans isolates. Of 19 Gat201 target genes 
with differential expression, 4 were upregulated and 15 were down regulated at 
least 2 fold in clinical isolates (Table 5-6). 
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Table 5-6 Gat201 target genes differentially expressed in Clinical vs environmental C. 
neoformans 
 
5.4.5.2 Regulation of genes associated with murine lung infectivity between clinical 
and environmental isolates 
A number of genes have been identified in C. neoformans that are virulence factors 
in terms of ability to infect and proliferate in murine lungs226. I found some of these 
genes differentially expressed in clinical versus environmental strains (Table 5-7).   
Two of them – PDR802 and LIV10 - were induced in clinical isolates, and 4 were 
down-regulated (Table 5-7) 
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Table 5-7 Regulation of genes associated with murine lung infectivity in 
clinical vs environmental isolates. 
5.4.5.3 Multiple kinase genes were upregulated in clinical isolates  
Kinases play vital roles in regulating multiple  processes (growth and cell cycle, 
nutrient metabolism, stress response and adaptation, cell signaling and many other 
cellular functions), phosphorylating 30 % of cellular proteins 227.Kinases are 
important candidates for therapeutic targets as they are possibly inhibited by small 
molecules or antibodies. A set of kinase encoding genes has been demonstrated 
pathogenicity in the G. mellonella killing assay and murine infection model 227. Here I 
detected differential expression of these genes in clinical vs environmental isolates. 
Seven out of eight of these genes were up-regulated in clinical isolates (Table 5-8). 
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Table 5-8 Regulation of pathogenicity-related kinase genes in clinical vs 
environmental isolates 
5.4.5.4 Regulation of transcription factors between clinical and environmental 
isolates 
Transcription factors govern general biology and pathogenicity of C. neoformans 
through activating or repressing effectors of multiple signaling pathways, including 
Ras, calcineurin, MAP kinase, and RIM101 ,29–31. Such transcription factors have been 
shown to be enriched when C. neoformans isolates grown in pigeon guano were 
compared with those cultured under starvation or rich medium conditions (YPD). 
This suggests transcription factors are important in cryptococcal adaptation to 
different ecological niches259. I identified differences in the expression of 
transcription factor genes between environmental and clinical strains. Of note, the 
pleiotropic virulent gene GAT201 (CNAG_01551) was down-regulated in clinical 
isolates (Table 5-9) 
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Table 5-9 Regulation of transcription factors in clinical vs environmental isolates 
5.4.5.5 Established virulence-associated genes are upregulated in clinical isolates 
C. neoformans can survive and proliferate in animal hosts through interaction 
between fungal virulence factors and host susceptibility. Virulence factors are all 
mechanisms that enable the pathogen to survive and evade the host immunity. 
Cryptococci do not rely on a single virulence factor for pathogenicity but rather 
require a minimum set of interacting attributes for pathogenicity32,274,275. Established 
virulence factors include genes controlling thermotolerance, capsule enlargement, 
melanin production, phospholipase activity, oxidative defense, antiphagocytic 
proteins, nutrient acquisition, morphological switching, etc. I retrieved a list of 186 
genes encoding established virulence factors (available at 
http://www.phidias.us/victors/index.php). From this list, 28 genes were differentially 
regulated in clinical vs environmental C. neoformans; 19 of these genes were 
upregulated in clinical strains (Table 5-10). 
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Table 5-10 Regulation of virulence-associated genes in clinical vs environmental 
isolates 
5.4.5.6 Multiple transporter genes were induced in clinical isolates 
Transporters plays important roles in yeast pathobiology262. Some are responsible 
for multiple drug resistance to fungus: major facilitator superfamily (MFS) 
transporters and ATP-binding cassette (ABC) transporter276 277. Others enable 
Cryptococcus to adapt to different ecological niches, such as pigeon excreta, murine 
lung and human CSF 259 278 201. Table 5-11 and 5-12 list the up- and down-regulated 
genes seen in clinical isolates. Twice as many transporter genes were up-regulated as 
were down regulated in clinical isolates. In particular, multiple genes encoding sugar, 
zinc ion, amino acid and monosaccharide transporters were exclusively enriched in 
clinical isolates (Table 5-11). Some MFS and ABC genes were upregulated in clinical 
isolates (CNAG_00792, CNAG_00869, CNAG_04416, CNAG_01674 & CNAG_05982) 
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whereas others were upregulated in environmental isolates (CNAG_07799, 
CNAG_00905 & CNAG_01690) (Table 5-11 & 5-12). Of upregulated transporters in 
clinical isolates, the monosaccharide transporter (CNAG_02733) was the most highly 
induced. 
 
Table 5-11 Up-regulation of transporter genes in clinical isolates 
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Table 5-12 Down-regulation of transporter genes in clinical isolates 
5.4.6 Global transcriptomic profiles of clinical BMD761 strain and induced LD2 
strain are different from those of self-induced LD2 and naive LD2 strains 
I used principle component analysis (PCA) to analyse clustering of clinical isolates 
(BMD761), environmental isolates (LD2), Induced LD2 and Self-induced LD2 strains. 
PC1 (principle component 1) explains 64% of variance in transcriptional profiles 
between samples (Figure 5-11).  
The majority of replicates clustered according to their experimental isolates. Some 
outlier replicates were somewhat intermingled including three BMD761, one 
induced LD2 and two naive LD2 replicates. The emergence of outliers may reflect 
technical variations and/or population heterogeneity. Technical variation is 
inevitable in any complex experiment and in this case, this may have arisen from 
library preparation or sequencing (lane effect, flow cell effect) or both. Biological 
variation is intrinsic to all organisms. Even genetically identical isolates exposed to 
the same environment can exhibit phenotypic variations279. I removed these outliers 
for subsequent analyses in line with technical norms and because my work is 
exploratory, aiming to identify candidates for further investigation that may explain 
differences in pathogenicity.  
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Figure 5-11 Principle component analysis of transcriptional profiles of 24 replicates. 
4 isolates with 6 biological replicates each are included: environmental LD2, clinical 
BMD761 (derived from HIV uninfected patient), Induced LD2 (grown in culture 
filtrate from BMD761) and Self-induced LD2 (grown in culture filtrate from naive 
LD2). 
After removal of 6 outliers, clustering was maintained by experimental group (Figure 
5-12). PC1 increased in effect size explaining 72% of the variance in transcriptome 
profiles between samples. Replicates were grouped by experimental state. Strikingly, 
replicates of induced LD2 and BMD761 clustered closely to each other and separate 
from other isolates (naive and self-induced LD2), suggesting they had similar 
transcriptome profiles.  
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Figure 5-12 Principle component analysis of transcriptional profiles of 18 replicates 
after removal of 6 outliers. Replicates are separated by their corresponding isolates 
5.4.7 Comparative analysis of transcriptome of clinical BMD761, induced LD2, self-
induced LD2 relative to naive LD2 strains 
Comparative analysis of 4 isolates (BMD761, Induced LD2, Self-Induced LD2 and LD2) 
was performed to test for differentially expressed genes. A total of 1604 genes were 
differentially expressed between BMD761, induced LD2, and self-induced LD2 
relative to naive LD2 (Wald test, Benjamini-Hochberg adjusted P value < 0.05, log2 
fold change  1 and  -1). A hierarchical clustering of 1604 differentially expressed 
genes based on normalised read count per gene reveals two isolate-specific clusters 
(Figure 5-13). The transcriptional patterns of BMD761 and the induced LD2 cluster 
were similar and different from that of self-induced LD2 and naive LD2, with 1002 
genes induced and 602 genes repressed in BMD761, induced LD2 and self-induced 
LD2 relative to LD2. The clustering of BMD761 and Induced LD2 in the heat map is 
consistent with the PCA plot, which also shows the proximity of BMD761 to Induced 
LD2 replicates.  
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Figure 5-13 Hierarchical cluster analysis of gene expression based on normalised 
read counts per gene. The heat map displays expression patterns for 14 samples. 
Each sample corresponds to one column and each single gene to a single row. The 
colour key ranges from red for up-regulated gene to green for down-regulated genes 
across samples.  
Pairwise comparisons of differentially expressed genes (Wald test, Benjamini-
Hochberg adjusted P value <0.05, log2 fold change 1 and -1) were made between 
four isolate groups (Figure 5-14). BMD761 and Induced LD2 had highly similar 
expression profiles, exhibiting the fewest number of differentially expressed genes, 
indicating they had similar transcriptome profiles and were different to the other 
experimental states. In contrast, Induced LD2 and Self-Induced LD2 had the least 
similarity, reflecting the role of Self-induced LD2 strain as control of induction effect. 
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Figure 5-14 Pairwise comparison of differentially expressed genes for 4 isolates 
groups: BMD761 relative to Self-induced LD2 or Induced LD2, Induced LD2 relative to 
LD2 or Self-induced LD2 (Wald test, Benjamini-Hochberg adjusted P value < 0.05, 
log2 fold change  1 and  -1). Numbers in stacked bars represent up- or down-
regulated genes for pairwise comparison in each stacked bar. 
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5.4.8 Functional analysis using gene ontology 
5.4.8.1 Biological process terms relevant to metabolism and cellular biosynthesis 
were enriched in BMD761 and Induced LD2 strains relative to naive LD2 
 
 
 
 
 
 
 
 
Table 5-13 Enriched biological process–associated GO terms of exclusively 
upregulated genes in BMD761 and Induced LD2 relative to naive LD2 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-15 Biological process–associated GO terms of upregulated genes in 
BMD761/Induced LD2 relative to naive LD2. Bubble size represents frequency of GO 
terms in the GO annotation database (UniProt). Colour indicates significant level. 
Bubble proximity implies their semantic similarity 
Cellular macromolecule biosynthesis Cell cycle 
DNA recombination 
Purine ribonucleoside triphosphate 
metabolism 
Purine ribonucleotide metabolism 
DNA metabolism 
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Of 1604 genes which were differentially expressed between BMD761, induced LD2, 
and self-induced LD2 relative to LD2, I curated 384 genes which were upregulated, 
and 349 genes which were down-regulated exclusively in BMD761 and induced LD2 
(Wald test, Benjamini-Hochberg adjusted P value < 0.05, log2 fold change  1 and  -
1). The differentially expressed genes that were common to BMD761, Induced LD2 
and Self-induced LD2 relative to LD2 were likely to be ‘background’ gene expression, 
perhaps driven by relative nutrient deprivation (since they were grown in only 75% 
fresh medium). I excluded this background ‘noise’ from the analysis. A list of 
significantly enriched GO terms of biological processes was summarised and 
visualised using semantic similarity REVIGO scatterplot (Figure 5-15 & Table 5-13).  
GO terms related to cell metabolism were significantly enriched: purine 
ribonucleotide metabolism and DNA metabolism Moreover, upregulated genes 
involved in biosynthesis and cell cycle were frequently enriched including cellular 
macromolecule biosynthesis, and cell cycle (Table 5-13). Cell cycle involves 
separation of genetic material equally to daughter cells followed by cell division. 
5.4.8.2 Molecular function GO terms related to protein synthesis and cell division 
were enriched in BMD761 and Induced LD2 
Figure 5-16 displays enriched GO terms associated with molecular function. The 
most significantly enriched GO term was related to protein synthesis machinery: 
structural constituent of ribosome (Table 5-14). Other GO terms relevant to protein 
synthesis includes rRNA binding and translation elongation factor activity. Moreover, 
significantly enriched GO terms involved in cell division were identified: microtubule 
motor activity and microtubule binding.  
I also analysed enrichment of GO terms for the cellular component domain. Only one 
GO term involved in cell division was significantly enriched: GO:0000922 spindle 
pole. 
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Table 5-14 Enriched molecular function GO terms of upregulated genes in 
BMD761/Induced LD2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-16 Molecular function–associated GO terms of upregulated genes in 
BMD761/Induced LD2. Bubble size represents frequency of GO terms in the GO 
annotation database (UniProt). Colour indicates significant level. Bubble proximity 
implies their semantic similarity 
5.4.8.3 Gene ontology analysis of down-regulated genes in BMD761 and Induced 
LD2 strains relative to naive LD2 
Only one GO term related to biological process was enriched in naive LD2 strains: 
oxidation-reduction process. 
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 For GO terms associated with molecular function, genes relevant to oxidation-
reduction were also enriched in naive LD2: oxidoreductase activity and protein 
disulfide oxidoreductase activity. Other GO terms include transporter activity: amino 
acid transmembrane transporter activity and substrate-specific transmembrane 
transporter activity (Table 15 & Figure 5-17). 
Table 5-15 Enriched molecular function GO terms of downregulated genes in 
BMD761 and Induced LD2. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-17 Molecular function–associated GO terms of down-regulated genes in 
BMD761 and Induced LD2. Bubble size represents frequency of GO terms in the GO 
annotation database (UniProt). Colour indicates significant level. Bubble proximity 
implies their semantic similarity 
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5.4.9 Differentially expressed genes associated with virulence in BMD761 and 
Induced LD2 relative to naive LD2 
I screened 733 genes exclusively differentially regulated in BMD761 and Induced LD2 
strains for virulence potential by excluding genes commonly regulated in Self-
induced LD2 strains relative to naive LD2 strains. 
5.4.9.1 Regulation of kinase genes in BMD761 and Induced LD2  
Four out of five kinase genes were up-regulated in BMD761 and induced LD2 (Table 
5-16) 
Table 5-16 Regulation of virulence-related kinase genes in BMD761 and Induced LD2 
strains relative to naive LD2 
5.4.9.2 Regulation of GAT201 target genes in BMD761 and Induced LD2 relative to 
LD2 
Table 5-17 displays Gat201-bound genes that were differentially regulated in 
BMD761/Induced LD2 relative to naive LD2. Of 15 Gat201 target genes, only one was 
upregulated in BMD761/Induced LD2 strains. 
 203 
 
Table 5-17 Gat201 target genes differentially expressed in BMD761 and Induced LD2 
strains relative to naive LD2 
5.4.9.3 Regulation of genes associated with murine lung infectivity in BMD761 and 
Induced LD2 relative to naive LD2 
Mutations in a number of genes have been associated virulence attenuation in a 
mouse lung infectivity model226. Infectivity in this context refers to ability of 
pathogens to proliferate within mouse lung tissue. Table 5-18 displays genes 
previously associated with defects in in vivo lung infectivity, which are potential 
virulence factors. I found only one of these was induced in BMD761 and Induced LD2 
strains. 
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Table 5-18 Regulation of genes associated with murine lung infectivity in BMD761 
/Induced LD2 strains relative to naive LD2. 
5.4.9.4 Regulation of transcription factors in BMD761/Induced LD2 relative to 
naive LD2 
 
 
 
 
 
Table 5-19 Differential expression of transcription factors in BMD761 and 
Induced LD2 relative to naive LD2 
Table 5-19 displays differential expression of gene encoding transcription factors (TF) 
of BMD761 and Induced LD2 relative to naive LD2. Mutants of these TF were 
attenuated in G. mellonella infection model and murine inhalation model 34, 
suggesting their potential virulence factors. Only one of them was up-regulated in 
BMD761/Induced LD2 strains: cell cycle box factor subunit SWI6. 
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5.4.9.5 Multiple established virulence-associated genes were upregulated in 
BMD761 and Induced LD2 
I retrieved a list of 186 genes encoding established virulence factors (available at 
http://www.phidias.us/victors/index.php). Of which, 22 genes were differentially 
regulated in BMD761 and Induced LD2 strains relative to naive LD2 with 17 genes 
being upregulated (Table 5-20). 
 
Table 5-20 Regulation of virulence-associated genes in BMD761 and Induced LD2 
strains relative to naive LD2. Null means there are no function described or no 
ortholog for these genes. 
5.4.9.6 Regulation of transporter genes in BMD761 and Induced LD2 relative to 
naive LD2 
Transporters play important roles in yeast pathobiology262. For example, major 
facilitator superfamily (MFS) transporters are responsible for multiple drug 
resistance to fungus276 277. Others enable cryptococci adaptation to different 
ecological niches, such as pigeon excreta, murine lung and human CSF 259 278 201. 
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Table 5-21 shows up-regulation of gene encoding transporters as many as down-
regulated transporter genes in BMD761 and Induced LD2 strains. 
Interestingly, multiple genes encoding sugar, zinc ion, mannose and monosaccharide 
transporter were exclusively enriched in BMD761 and Induced LD2 (Table 5-21). Of 
upregulated transporters, the zinc ion transporter (CNAG_00895) was the most 
highly induced. 
 
Table 5-21 Differential regulation of transporter genes in BMD761 and Induced LD2 
strains relative to naive LD2 
5.4.9.7 Regulation of hypothetical proteins in BMD761 and Induced LD2 relative to 
naive LD2 
Of 733 differentially expressed genes, a third of them (263) are hypothetical 
proteins. I curated a list of hypothetical proteins which were highly upregulated 
(log2FoldChange greater than 3) and highly down-regulated (log2FoldChange less 
than -3 in BMD761 and Induced LD2 strains (Table 5-22 & 5-23) 
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Table 5-22 Hypothetical proteins up-regulated in BMD761 and Induced LD2 isolates 
 
Table 5-23 Hypothetical proteins down-regulated in BMD761 and Induced LD2. Null 
means there are no function described or no ortholog for these genes. 
5.5 Discussion 
5.5.1 Enrichment of biological process terms relevant to cellular biosynthesis, 
metabolism and cell cycle may be attributed to enhanced virulence of clinical 
isolates and induced LD2 strain. 
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Four out of 7 biological process GO terms were common between clinical isolates 
and Induced LD2/BMD761 relative to naive LD2 (Table 5-3 and 5-13). Enrichment of 
GO terms related to metabolism (purine ribonucleotide metabolism, coenzyme 
metabolism, carbohydrate metabolism and DNA metabolism) indicates more intense 
metabolic activity in clinical isolates (Table 5-3). Biosynthesis is more active in clinical 
isolates with enrichment of genes annotated to biosynthesis (cellular macromolecule 
biosynthesis, organic substance biosynthesis, small molecule biosynthesis and 
cellular biosynthesis). Upregulation of genes annotated to GO terms for synthesis of 
protein and DNA, including structural constituent of ribosome, translation elongation 
factor activity and DNA-directed DNA polymerase activity, is likely to contribute to 
cellular macromolecule biosynthesis. 
These induced activities (metabolism & biosynthesis) may explain for significantly 
higher burden of clinical isolates compared to environmental isolates (Figure 4-19). 
My finding is consistent with a study comparing transcriptome profiles between 
more active C. neoformans cultured in YPD and C. neoformans with less active 
growth in ex vivo CSF. Chen et al found enrichment of GO terms related to cellular 
biosynthesis and structural constituent of ribosome of active yeasts grown in YPD262. 
Steen et al used serial analysis of gene expression (SAGE) to compare transcription 
profiles of cells isolated in rabbit CSF and cells grown in vitro. They also identified 
abundance of sequences annotated to GO terms relevant to protein biosynthesis, 
carbohydrate metabolism, and DNA metabolism for cells grown in vivo255. 
Ferrareze et al compared transcriptome of C. gattii isolated in murine BAL 
(bronchoalveolar lavage) and those cultured in vitro confirmed enrichment of 
biological process terms relevant to cellular biosynthesis and metabolism in the 
former culture condition280. 
Taken together, these findings imply that C. neoformans accelerate intracellular 
growth in clinical settings by speeding up biosynthetic and metabolic processes. 
Moreover, I found upregulation of genes annotated to GO terms relevant to cell 
cycle in Induced LD2/BMD761 relative to naive LD2 (Table 5-13). Cell cycle is the 
process of cell duplication to produce two genetically identical daughter cells. There 
is evidence that throughout the cell cycle, 20% of all genes are periodically 
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transcribed. Moreover, DNA replication genes, mitosis genes and 40 genes 
associated with virulence are frequently co-expressed, suggesting a connection 
between cell cycle regulators and virulence pathways281 282. Genes involved in cell 
cycles are potential drug targets by affecting cell growth and virulence factors 
coordinated with such genes. Thus cell proliferation and greater activities of 
metabolism and biosynthesis can explain for the higher fungal burden of 
BMD761/Induced LD2 strains than naive LD2. 
Only two GO terms for biological process were enriched in environmental isolates, 
one of which was purine ribonucleotide biosynthesis (Table 5-5). This supports a 
hypothesis that biosynthetic activities in environmental isolates were much less 
active than those in clinical isolates. Enhanced virulence of Induced LD2 strains could 
be attributed to upregulation of genes involved in cellular biosynthesis and 
metabolism as well as cell cycle. 
In contrast to enrichment of multiple GO terms in BMD761 and Induced LD2, only 
one GO term for biological process was enriched in naive LD2: oxidation-reduction 
process. I am not clear why this process was induced in environmental isolates. 
5.5.2 Enrichment of molecular function terms relevant to cell division and peptide 
synthesis may be attributed to increased virulence of clinical isolates and 
BMD761/induced LD2 strains. 
Six out of 8 molecular function-associated GO terms was common between clinical 
isolates and Induced LD2/BMD761 (Table 5-4 and 5-14). They are involved in cell 
division and peptide synthesis (translation elongation factor activity, structural 
constituent of ribosome). 
Enrichment of molecular function GO terms in clinical isolates and BMD761/induced 
LD2 are related to cell division via microtubule activities: microtubule motor activity 
and microtubule binding (Table 5- 5). Microtubules are tube-like structure consisting 
of tubulin protein. Apart from composition of cytoskeleton, microtubules are integral 
to multiple cellular processes in eukaryote: transport of organelles through the 
cytoplasm, cell motility and cell division (separation of chromosome during mitosis 
and meiosis)283. Moreover, cellular component GO term exclusively enriched in 
clinical isolates and BMD761/induced LD2 is relevant to cell division too: spindle 
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pole, which is composed of microtubules. Each pole is involved in portioning 
chromosomes evenly to each daughter cell. 
Besides, I found upregulation of genes annotated to GO terms associated with rRNA 
binding in Induced LD2/BMD761. rRNA binding occur during formation of 
ribonucleo-protein complex for ribosome. Taken together, these activities may 
contribute to robust protein biosynthesis and proliferation of BMD761/Induced LD2, 
thereby promoting their faster growth inside G. mellonella. 
5.5.3 GAT201 target genes are dispensable for virulence of clinical isolates and 
BMD761/Induced LD2 strains 
I found 19 of GAT201 target genes were differentially regulated in my clinical and 
environmental C. neoformans strains in YPD culture broth (Table 5-6). The product of 
one of these,  Qsp1, was previously recognized to be an autoregulatory signaling 
factor246. The QSP1 gene encodes a peptide precursor consisting of a signal sequence 
and a 24-amino acid pro-peptide (proQsp1). proQsp1 is synthesized intracellularly. 
Once exported extracellularly, it matures through cleavage mediated by the cell-
associated protease Pqp1. The mature Qsp1 enters surrounding cells via peptide 
transporter Opt1, where it initiates morphological and virulence changes. QSP1-
deficient mutants exhibit attenuated virulence in the murine inhalational infection 
model246. The downregulation of QSP1 in my clinical isolates may be compensated by 
upregulation of other Gat201 target genes which makes clinical isolates significantly 
more virulent. The other 18 genes may be dispensable for virulence as their mutants 
did not show remarkable defects in phagocytosis by macrophage116. The limitation of 
the referenced study by Chun et al is that the H99 strain and its mutants were used 
and cultured in DMEM (tissue culture broth) while I used clinical strains of ST4 and 
ST5 and cultured them in YPD broth. 
Of 19 GAT201 target genes in Table 5-6, six were also down-regulated in 
BMD761/Induced LD2 (Table 5-17) .However, their mutants were not attenuated in 
macrophage infection model116, suggesting their dispensable role for virulence in 
clinical isolates and BMD761/Induced LD2 strains. 
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5.5.4 LIV10, gene associated with murine lung infectivity, is responsible for 
enhanced virulence of clinical isolates and BMD761/Induced LD2 
I found 6 differentially expressed genes in clinical and environmental isolates (Table 
5-7), whose mutants are known to exhibit defects in lung infectivity but have normal 
for growth at 37oC, capsule enlargement and melanin production284 285. I found 
upregulation of LIV10 gene in clinical isolates and BMD761/Induced LD2. This 
suggests contribution of this gene to enhanced virulence of such isolates in G. 
mellonella model.  
However, I detected down-regulation of LIV5 and ENA1 in clinical isolates. The LIV5–
deficient strain has exhibited increased survival in murine inhalation model226. This 
gene is homologous to one gene required for pathogenicity in the plant fungal 
pathogen Magnaporthe grisea226. ENA1 encodes a potassium/sodium ATPase 
transporter201. This gene is required for C. neoformans survival in ex vivo CSF. ENA1 
mutants fail to grow in CSF after 4 days of incubation. The mutant strain also 
displayed virulence attenuation in rabbit meningitis model 201. Down-regulation of 
LIV5 and ENA1 in clinical isolates suggests that they work independently and may be 
compensated by other virulence factors. Likewise, I found down-regulation of 
PDR802 (Table 5-18) in BMD761/Induced LD2 vs naive LD2. The DNA-binding 
regulator PDR802–deleted mutants have displayed growth defect in mouse lung 
compared to the wild-type strain, suggesting their role in pathogenicity285. The 
repression of this gene in BMD761 and Induced LD2 implies their dispensable role for 
virulence in G. mellonella. 
5.5.5 Four kinase genes contribute to increased virulence of clinical isolates and 
BMD761/Induced LD2 
Kinases play central roles in metabolic pathways and signaling cascades in C. 
neoformans227 140 155, thereby regulating its pathogenicity. For example, the protein 
kinase A catalytic subunit (Pka1) activate downstream proteins in the cAMP-PKA 
signaling pathway, governing cell wall synthesis, expression of transmembrane 
transporters, melanin formation, and stress response of C. neoformans140 155. 
Interestingly, I detected elevated expression of seven kinase genes in clinical isolates 
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(Table 5-8). Four of these kinases (BUB1, HSL101, MPS1 and SWE102) were 
commonly upregulated in clinical isolates and BMD761/Induced LD2 (Table 5-16). 
These kinase mutants have been related to pathogenicity using the G. mellonella 
infection model and murine infectivity assay227, suggesting their potential drug 
targets. The elevated expression of kinase genes suggests their involvement in 
virulence of clinical isolates and BMD761/Induced LD2 strains. 
5.5.6 Transcription factor role in pathogenicity 
Transcription factors govern general biology and pathogenicity of C. neoformans 
through activation or repression of effector proteins in signal transduction pathways 
34. I identified 6 differentially expressed genes which have been previously confirmed 
to regulate virulence of C. neoformans using the murine or insect infection model34. 
Two genes of particular note were PDR802 and GAT201 (Table 5-8), whose mutants 
exhibited reduced virulence in such models. I found down-regulation of GAT201 in 
clinical isolates. This can be associated with the down-regulation of GAT201 target 
genes that I mentioned in table 5-6. The downregulation of GAT201 may be 
compensated by upregulation of other transcription factors in clinical isolates which 
made clinical isolates significantly more virulent than environmental isolates. I 
detected upregulation of zinc-finger transcription factor PDR802, which may confer 
enhanced virulence on clinical isolates. 
Additionally, I identified upregulation of the cell cycle box factor subunit gene SWI6 
(Table 5-19) in BMD761/Induced LD2. This gene was reported to drive cell-cycle 
genes281. SWI6 mutants cause growth defect in murine lung compared to wild type 
strains, implicating their potential virulence attribute34. The presence of this gene in 
BMD761/Induced LD2 suggests its contribution to enhanced virulence of these 
strains in G. mellonella. 
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5.5.7 BMD761/Induced LD2 strains displayed upregulation of multiple virulence-
associated genes  
Cryptococcal pathogenicity is determined by composite of virulence factors, which 
are coordinately regulated286. Established virulence factors are of interest due to 
potential drug targets. I found elevated expression of multiple virulence factors in 
clinical isolates compared with environmental isolates, and in induced LD2, lending 
biological plausibility to the increased virulence observed in the Galleria model and 
potentially explaining that increased virulence (Table 5-10). Of 19 induced genes in 
clinical isolates, 15 genes were expressed in both BMD761 and Induced LD2 (Table 5-
21) 
5.5.8 Cell wall and capsule-associated genes are upregulated in hypervirulent and 
induced strains 
A number of genes relevant to synthesis of cell wall and capsule were upregulated in 
clinical isolates. These included chitin synthase (CHS2, CHS6) & capsule structure 
designer proteins (CAS4, CAS32). Chitin is indispensable to the integrity of the fungal 
cell wall. C. neoformans has 8 putative chitin synthases (CHS1 to CHS8)287. They are 
periodically induced during the C. neoformans cell cycle288. CAS genes are important 
for capsule synthesis. CAS gene-deficient mutants have resulted in capsule 
defects289. Of all elevated genes in clinical isolates, CHS6 was the most highly 
induced (Table 5-10). This gene was highly expressed in BMD761/Induced LD2 too 
(Table 5-21). Taken together, upregulation of these genes may account for 
significantly larger capsule in clinical isolates compared to environmental isolates in 
larvae (Figure 4-20).  
Apart from genes upregulated in clinical isolates, I detected upregulation of CAP64 
gene in BMD761/Induced LD2. This gene is critical to capsule formation. Deletion of 
CAP64 leads to loss of capsule as well as pathogenicity in mouse infection model290. 
Another gene involved in capsule synthesis is PBX1, parallel beta-helix repeat 
protein, participating in synthesising glucuronoxylomannan (GXM). GXM accounts 
for 88% of capsular mass. PBX1 mutants exhibit clumpy cells  and decreased capsule 
integrity, leading to virulence attenuation in mouse infection model291. I found 
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upregulation of PBX1 in clinical isolates and BMD761/Induced LD2, suggesting its 
contribution to enhanced virulence of these isolates  
The cAMP-PKA signal transduction pathway regulates capsule production and 
melanin formation. PKA1 mutants are avirulent with defects in capsule size and 
melanin formation. Pka1 activity modulates up to 302 proteins of C. neoformans292, 
including the large subunit ribosomal protein L27e encoded by RPL27 gene, which 
was upregulated in clinical and BMD761/Induced LD2 strains 
5.5.9 Oxidative stress-regulated genes 
 To manage the harsh environment in macrophages, C. neoformans elaborate 
antioxidant defense mechanisms to neutralise reactive oxygen species elicited by 
phagolysomes. The catalase gene family together with superoxide dimutase Sod1 & 
Sod2, cytochrome c peroxidase Ccp1, thioredoxin reductase Trr1,  alternative 
oxidase Aox1 contribute to resistance against oxidative stress293 284. I detected 
upregulation of CAT4 in environmental isolates (Table 5-10). However, Cat4 has not 
demonstrated detectable catalase activity in vitro 293 although its transcript was 
detected by real time quantitative PCR. Moreover, mortality of mice infected with 
CAT4 mutant was not significantly different to those infected with wild type strains. 
This suggests that CAT4 is compensated by other CAT genes (CAT1, CAT2 and CAT3) 
and other components of the antioxidant system. 
Another oxidative stress-regulated genes was highly induced in environmental 
isolates was CCP1. This gene is involved in the stress-activated HOG signaling 
pathway284 for adaptation to hostile host environment. The down-regulation of this 
gene in clinical isolates suggests that this gene works independently and can be 
compensated by other components of the antioxidant system. 
5.5.10 Other virulence genes 
 I also found induction of methionine synthase (MET6) in clinical isolates. 
Methionine-cystein biosynthesis has been extensively investigated in a number of 
fungal pathogens due to their relevance as a potential drug target. MET-deficient 
mutants lose viability due to methionine starvation. They are avirulent in the murine 
inhalation model294. Upregulation of MET6 will lead to expression of methionine. 
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This explains the enrichment of GO terms relevant to cellular biosynthesis in clinical 
isolates I mentioned above.  
In this study I detected two-fold upregulation of carbonic anhydrase gene (CAN2) in 
clinical isolates. During growth in natural habitats, such as tree hollows, soil, and 
avian excreta, C. neoformans are exposed to low ambient CO2 levels (0.033 %). 
However in mammalian hosts the CO2 concentration can rise to 5 %; C. neoformans 
adapts to such elevated levels of CO2 by inducing this enzyme to efficiently convert 
CO2 to bicarbonate (HCO3
-)295. Bicarbonate in turn stimulates Adenylyl Cyclase Cac1 
to regulate biosynthesis of capsule through the GPA1-cAMP signaling pathway139. 
Capsule confers advantage on clinical isolates for survival in mammalian hosts.  
Of down-regulated genes listed in Table 5-10 and Table 5-21, APP1 is the most down-
regulated in clinical isolates and BMD761/Induced LD2 strains. This gene encodes an 
antiphagocytic protein that is secreted to the extracellular space. However, in an 
impaired immunity mouse model (deficient for T and NK cells) the APP1 mutant 
exhibited hypervirulence and dissemination with increased number of fungal cells 
recovered from the brain113. The down regulation of APP1 in hypervirulent strains 
suggests that phagocytosis may infect be beneficial for the survival of these strains, 
perhaps through providing an environment for replication and dissemination.  
In my study, expression of BWC1 was elevated in environmental isolates. Light is 
known to regulate cryptococcal development through inhibition of mating mediated 
by the gene BWC1296. In addition, the BWC1 gene protects cells from UV radiation. 
Its disruption results in hypersensitivity to ultraviolet light compared with wild type 
strains. However, it likely has a role in virulence – mutants also appear significantly 
less pathogenic in murine inhalation model than the wild type strain. Down-
regulation of BWC1 in clinical isolates suggests that any role in virulence is secondary 
to other functions. 
Another gene exhibited elevated expression in clinical isolates and BMD761/Induced 
LD2 is the translation elongation factor TUF1 responsible for mitochondrial protein 
synthesis. Production of mitochondrial protein is indispensable for ATP generation 
through oxidative phosphorylation286. 
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The calcium-dependent protein kinase 2 (CPK2) was upregulated in 
BMD761/Induced LD2 strains. CPK2-deficient strains were involved in cell cycle 
regulation and attenuated in murine infectivity model227. The presence of this gene 
can explain for higher fungal burden of these strains compared to naive LD2 in G. 
mellonella. 
I screened 19 virulence-associated genes, 9 of which were down-regulated in clinical 
isolates. This can be explainable by the fact that cryptococcal pathogenicity is related 
to virulence composite. Virulence factors (capsule size, melanin formation, 
phospholipase activity, protease activity) partially contribute to overall pathogenicity 
of C. neoformans 275 274. Litvintseva et al found clinical and environmental C. 
neoformans with identical MLST profile. They exhibited similarity of such virulence 
traits but differed in murine virulence62. Non-capsular C. neoformans can cause 
cryptococcal meningitis and pulmonary cryptococcosis in HIV patient and HIV-
uninfected patients, respectively 297 298. Multiple genes have overlapping functions in 
response to genetic perturbation, so lacking of a virulence attribute can be 
compensated by others288. For instance, C. neoformans utilise redundant systems to 
neutralise superoxide radicals. Superoxide dimutase (SOD) detoxifies such radicals 
through the conversion of them into hydrogen peroxide and oxygen. However, SOD1 
mutants maintain virulence in the mouse model, suggesting other radical quenchers 
compensate for loss of SOD1. Such quenchers could include mannitol and melanin299 
5.5.11 Upregulation of transporter genes involved in nutrient transportion and 
capsule components  
Transporters were frequently identified in transcriptional analyses, implicating their 
role in regulating fungal physiology. The two superfamilies MFS transporters and 
sugar transporters were the most abundant in the Cryptococcus genome259. 
Overexpression of MFS transporter was discovered in Fluconazole-resistant clinical 
isolates276. In this study, I detected a number of transporters belonging to these two 
families that were differentially expressed in clinical versus environmental isolates. 
Notably, the expression of six sugar transporters and two monosaccharide 
transporter genes were elevated in clinical isolates. Expression of these genes may 
facilitate nutrient uptake of C. neoformans inside the phagosome. Moreover, I 
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detected enrichment of two genes encoding myo-inositol transporters belonging to 
the sugar transporter family. Inositol is abundant in human CSF (25 mg/L compared 
to an average of 4.3 mg/L in plasma)300. C. neoformans can utilize myo-inositol as a 
sole carbon source through the myo-inositol transporter gene family during their 
survival in environmental niches and  the human host300. Therefore this may confer a 
growth advantage in CSF. Differential expression of myo-inositol transporter genes 
between clinical and environmental isolates could be validated by culturing these 
isolates in CSF known as ex vivo CSF survival testing. 
I also detected up-regulation of the ATP-binding cassette transporter gene PDR5 
(Table 5-11). This gene is highly induced in response to osmotic stress. PDR5 mutants 
are more susceptible to fluconazole than wild type strains, suggesting its potential 
role in efflux of antifungals for detoxification. In S. cerevisiae PDR5 is responsible for 
cellular detoxification and has been associated with multiple drug resistance284. 
Upregulation of this gene may explain for fluconazole heteroresistance inherent to 
clinical isolates301. 
Two zinc transporters were upregulated in clinical isolates (Table 5-11) but either of 
them was expressed in BMD761/Induced LD2 (Table 5-21). Zinc is a vital 
micronutrient for all organisms. Many enzymes require zinc for catalysis. In yeast 
cells, zinc is required for optimal function of approximately 3% of the proteome 302. 
In C. gattii, sibling species of C. neoformans, it has been shown that zinc deprivation 
leads to increase transcript levels of zinc transporters ZIP1 and ZIP2 302. Zinc is co-
factor of carbonic anhydrase303. Expression of zinc transporters facilitate utilization 
of zinc for functional carbonic anhydrase, whose gene CAN2 was also highly induced 
(Table 5-10). 
Taken together, the elevated expression of nutrient-related transporters (sugar, zinc, 
iron, amino acid) likely represents a growth advantage within the host, and may 
account for the higher fungal burdens seen in Galleria when infected with clinical 
isolates (Figure 4-20). 
Cryptococcal capsule is composed of glucuronoxylomannan (GXM) and 
galactoxylomannan, as well as mannoproteins. Mannose acts as backbone of GXM 
accounting for the majority of capsule mass. To produce manosylated compounds, 
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the nucleotide sugar GDP-mannose is required as a donor for enzymes to synthesize 
GXM. C. neoformans has at least two GDP-transporters to transport mannose donors 
to the Golgi apparatus: GTM1 and GTM2. I detected upregulation of GTM2 in clinical 
isolates and BMD761/Induced LD2. Under capsule-inducing condition, GTM1 
mutants have striking defects in capsule size, but capsule of GTM2 mutants was 
similar to that of wild type strain304. However, this finding is based on serotype D 
strain JEC21 and reference strain H99. My finding suggests a potential role for GTM2 
in the virulence of C. neoformans. 
I also found upregulation of the glycerol symporter STL1 in BMD761/Induced LD2. 
This gene was induced in response to osmotic stress by transporting osmolytes to 
counteract external osmotic change.284 
I detected down-regulation of polyol transporter protein 1 (PTP1) in 
BMD761/Induced LD2.  This is responsible for cryptococcal growth in media 
containing 5- or 6- carbon polyols, such as mannitol, sorbitol and arabitol. Upon 
internalization by amoeba and murine macrophage, PTP1 has been highly induced. 
However, the PTP1 mutant has not exhibited defects in in vitro phenotypes 
implicated for virulence (growth at 37oC, melanin production, phospholipase activity) 
and survival of this strain has not been significantly different from the wild type 
strains in mouse and G. mellonella infection model.33 This supports the notion that 
transcriptional response to phagocytosis activates many genes but not all of them 
are essential for virulence. Thus down-regulation of PTP1 may not affect virulence of 
BMD761 and Induced LD2 strains 
5.5.12 Differential expression of hypothetical proteins 
Interestingly, I found that upregulated hypothetical proteins outnumber down-
regulated hypothetical proteins (22 vs 5) in BMD761 and Induced LD2. Some are 
potential metallopeptidases, proteases and kinases (Table 5-22 & 5-23). Others 
involve transport from the Endoplasmic Reticulum to the Golgi apparatus, 
endocytosis, cell wall synthesis and phosphorylation of signaling proteins. Notably, 
there was an upregulated gene (CNAG_02235) encoding one enzyme involving 
stabilization of tRNA structure for efficient protein synthesis (tRNA 
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methylatransferase) and another upregulated gene (CNAG_03037) responsible for 
cell division mediated by chromatid segregation. 
 
5.6 Conclusion 
 I detected 1700 genes which were differentially expressed between clinical and 
environmental isolates. A number of GO terms relevant to metabolism and cellular 
biosynthesis were enriched in clinical isolates. Besides metabolism and cellular 
biosynthesis, enriched GO terms relevant to cell cycle and cell division can explain 
for enhanced virulence of BMD761/Induced LD2. 
I found similarity of transcriptome profiles between clinical BMD761 and Induced 
LD2. This may explain the enhanced virulence of Induced LD2 compared to naive 
LD2. I also identified a number of genes which were previously confirmed as 
virulence factors that were upregulated in clinical isolates and BMD761/Induced 
LD2. A third of differentially expressed genes between BMD761/Induced LD2 and 
naive LD2 were hypothetical proteins (263 genes). This implies the importance of 
uncharacterized genes responsible for enhanced virulence of these strains. 
 
 
 
 
 
 
 
 
 
 
  
 220 
 
Chapter 6  
General discussion 
6.1 Introduction 
My research was driven by the compelling biological observation that it is a single 
lineage of C. neoformans (VNIa-5) that is responsible for the vast majority of 
cryptococcal disease in immunocompetent patients in Vietnam, whereas HIV 
infected patients are infected by a diverse population of C. neoformans. 
The specific aims of my thesis were to: 
1.  To determine whether there is temporal-spatial clustering of C. neoformans 
by genetic lineage and HIV status in Vietnam,  
2. To identify the ecological niche of particular lineages of C. neoformans,  
3. To define the diversity of the Vietnamese C. neoformans population in the 
environment and prevalence of particular lineages,  
4. To characterise the pathogenic phenotypes of the environmental isolates,  
5. To compare the virulence between and within different genotypes and 
sources using the G. mellonella model,  
6. To define the transcriptional differences associated with variability in 
virulence and  
7. To identify gene candidates associated with variability in virulence between 
isolates.  
 
First, I mapped clinical cases of meningitis and used clustering analysis in an attempt 
to identify the broad ecological niche of C. neoformans isolates of different lineages. 
To better understand the diversity of the C. neoformans population, their relative 
prevalence and ecological niches I then used randomized environmental sampling, 
supplemented by targeted sampling (because of low yield). It must be said in this 
aim I was not as successful as I hoped, although I have to some extent characterized 
the population distribution at the genus level. Using ITS barcoding for speciation I 
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identified that the species most commonly recovered are rarely (or not at all) 
pathogenic to humans.  
Given the difficulty I had in isolating the well-recognized human pathogenic forms of 
Cryptococcus from the environment (C. neoformans or C. gattii), I decided to define 
the virulence-associated traits of the environmental isolates in an attempt to 
understand why, while they are prevalent, they are not causing disease in the local 
population. I described the thermotolerance, melanin production, capsule 
enlargement, ex vivo CSF survival and survival in the Galleria infection model. 
I had developed the Galleria model to enable me to define differences between the 
virulence of clinical isolates of different lineages, because of the association of VNIa-
5 with immunocompetence. I was able to show that this model of innate immunity 
could distinguish differences in virulence between VNIa-5 and other lineages. 
However, the use of the model led to the interesting observation of my thesis that 
isolates have an ‘ecological imprint’ – their source (environmental/HIV—infected 
patient/immunocompetent patient) determines the virulence phenotype in Galleria. 
However, the most exciting result of my thesis is the observation that there is 
intercellular signaling that can lead to upregulation of virulence of naive isolates by 
‘hyperpathogenic’ isolates (by which I mean they can cause disease in 
immunocompetent patients). I then used RNAseq and validated the upregulated 
virulence phenotype by showing it was associated with upregulation of previously 
identified virulence associated genes, and identified a number of hypothetical 
proteins that are potential drivers of the induction phenomenon and virulence itself.   
6.2 Summary of principal findings 
1. I detected temporal-spatial clustering of cases of cryptococcal in Ho Chi Minh city 
and bordering well-industrialised provinces (Ba Ria-Vung Tau and Dong Nai). The 
temporal signal has to be interpreted in the face of gaps in the accumulation of cases 
due to lack of trial activity in HIV associated cases between 2011 and 2012. 
2. I found the VNIa-5 lineage was more widely dispersed in Vietnam than the other 6 
lineages. 
3. I found there was clustering of 3 lineages: VNIa-4, VNIa-5 and VNIa-32.  
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4. I found Cryptococcus neoformans to be elusive in the environment – I isolated 
many other cryptococcal species, but only 3 Cryptococcus neoformans.  
5. Environmental non-neoformans cryptococci were more frequently isolated around 
the spatial cluster of cryptococcal meningitis ST5 cases. 
6. ST5 strains from HIV uninfected patients are more virulent than non-ST5 strains in 
the G. mellonella infection model. 
7. Clinical isolates (ST4&ST5) are significantly more virulent than environmental 
isolates (ST4&ST5) 
8. The virulence of naive environmental isolates can be up-regulated by a 
protein/peptide based inter-yeast signaling system derived from virulent isolates. 
9. Virulence of such induced isolates is stable over generations. 
10. The induced isolate can in turn up-regulate the virulence of the naive isolate. 
11. The enhanced virulence of clinical and induced isolates seen in Galleria is 
associated with significantly higher fungal loads in the larvae. 
12. 1700 genes were differentially expressed between clinical and environmental 
isolates. The transcriptional profile of the induced LD2 isolate resembles that of the 
highly virulent BMD761 strain. 
14. Genes annotated to metabolism and cellular biosynthesis were enriched in 
clinical isolates 
15. Besides metabolism and cellular biosynthesis, genes annotated to cell cycle and 
cell division were enriched in the induced LD2 relative to the naive LD2. 
16. Multiple genes associated with virulence factors were up-regulated in clinical and 
induced environmental isolates. 
17. A third of differentially expressed genes between BMD761/Induced LD2 and 
naive LD2 were hypothetical proteins. 
6.3 Discussion  
6.3.1 Aim 1: To determine whether there is temporal-spatial clustering of C. 
neoformans by genetic lineage and HIV status in Vietnam 
Understanding cryptococcal adaptation to its ecological niche may give insight into 
how particular lineages can cause disease in immunocompetent humans. As a first 
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step, I investigated whether there was clustering of cryptococcal meningitis cases. 
Evidence of disease clusters could provide insight into the ecological habitat of C. 
neoformans in Southern Vietnam where the vast majority of cryptococcal meningitis 
occurs. I found a spatial cluster spanning Ho Chi Minh city, Dong Nai and Ba Ria-Vung 
Tau. This clustering is likely driven by HCMC and Ba Ria-Vung Tau, these cities having 
the highest prevalence of HIV infection in southern Vietnam (1.25% as opposed to 
0.5% for the country183). HCMC, Dong Nai and Ba Ria-Vung Tau constitute an 
industrial hub in Vietnam which attracts youths seeking career opportunities. Youths 
(26-36 years-old) account for 50% of patients infected with cryptococcosis. I do not 
have the internal migration histories of the cases of cryptococcal meningitis, which, 
together with the probably prolonged incubation period/latency of cryptococcal 
infection, confers a complication in interpreting the significance of these clusters.  
Thus it is possible that the clustering I identified in clinical cases is artefactual. 
Nonetheless, to my knowledge this is the first study to map and investigate the 
temporal-spatial clustering of cryptococcal meningitis due to C. neoformans, and the 
first to attempt to determine clustering by genetic lineage. Previously, the ecological 
niche of the sibling species C. gattii causing the outbreak in Vancouver Islands in 
Canada was modeled. They clustered along the central and southeastern coast of 
Vancouver Island170. 
I also found spatial clustering of meningitis by infecting lineage. Lineage VNIa-5 
infections clustered to the south-west of Ho Chi Minh City. I found clustering of the 
VNIa-4 lineage to the west alongside the Cambodian border. This is consistent with 
our understanding of the wider population structure of C. neoformans in southeast 
Asia – this lineage dominates infection in Thailand and Laos305.  
 
Interestingly, the VNIa-5 lineage had the widest geographical dispersal compared 
with the other 6 lineages (Figure 2-10). Its expanded range could be explained by its 
adaptation to multiple different ecosystems in Viet Nam, driven by its phenotypic 
heterogeneity - Thanh et al found VNIa-5 strains to have marked variation within 
virulence-associated phenotypes 247. Phenotypic heterogeneity in other yeasts (S. 
cerevisae) facillitates survival in the face of environmental stresses by generating 
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outliers with exceptionally high fitness306. Ecosystems in Viet Nam differ by region at 
least in terms of tree abundance, elevation, rain fall, temperature and seasonality. 
There are also significant differences in land use - the Mekong delta is divided by a 
net of rivers and covered in lush vegetation, mostly rice fields. The neighbouring 
Southeast is home to industrial tree plantations (rubber, acacia, cassava & cashew). 
The central highlands, located between 500 and 1500 meters, is famous for 
cultivation of coffee, tea, white mulberry, and black pepper. The south central coast 
is a harsh region which suffers storms frequently, and is characterized by the 
presence of fish farms and culture of non-indigenous animals including sheep, goat 
and ostrich. However, to determine that the expanded distribution of VNIa-5 that I 
found through analysis of human cases is real would need environmental sampling. 
A further option that might provide insight, and be more successful than tree, air and 
soil sampling, would be analysis of cases derived from veterinary infection. The 
shorter lifecycles and reduced mobility of animals would negate some of the 
complications (latency and migration) that interfere with the interpretation of data 
from humans. However, veterinary medicine is poorly developed in Vietnam and 
while cryptococcosis in animals is well described, there are currently no 
epidemiological data from Vietnam.  
 
Interestingly, I did not find clustering of non-HIV associated cryptococcosis cases. 
This could be explained by the widespread dispersal of VNIa-5 C. neoformans isolates 
(which causes the majority of disease in HIV uninfected patients) or lack of power 
due to the relatively low number of non-HIV cases available to analyse (59 non-HIV 
vs 350 HIV). However, since I was able to show clustering of the VNIa-32 lineage with 
only 12 cases, I think the low power explanation is unlikely, (Figure 2-15), and believe 
the widespread distribution of VNIa-5 is a more likely explanation. The cluster of HIV-
associated cryptococcal meningitis that I identified spanning the whole Mekong 
River delta and half of Ho Chi Minh city from 2004 to 2006 may be driven by the 
highest prevalance of people living with HIV in these region in 2005183.  
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6.3.2 Aim 2: To identify ecological niches associated with C. neoformans lineages 
As mentioned above, the movement of people and likely variable latency period of 
cryptococcal infection are significant complications when trying to understand the 
ecology and biology of C. neoformans. Environmental sampling, which is not 
complicated by these factors, has the potential to allow a more accurate 
understanding of spatial distribution, population structure and ecology. I used 
randomized environmental sampling to ensure that my environmental isolate 
collection would be representative of the wider population. In particular, I was 
interested in the relative prevalence of different lineages in relation to their 
prevalence in clinical isolates, since this ratio could be considered a marker of their 
relative pathogenicity. Randomized sampling would allow this inference to be drawn 
robustly. However, I had extremely low rates of isolation of C. neoformans using the 
randomized approach, with recovery rates of 0.06%. Remarkably, I found the 
recovery rate of non-neoformans cryptococci in cluster sites of clinical C. neoformans 
to be five times higher than with random sampling. Morever non-neoformans 
isolates from air were only recovered in the cluster sites of clinical isolates. The high 
rate of isolation of non-neoformans isolates from around cases of human C. 
neoformans disease suggests that, prolonged incubation and latency 
notwithstanding, there is much in common in the general ecological niches of 
Cryptococcus species. However, the extremely low rate of isolation of pathogenic 
forms suggests that Cryptococcus neoformans may usually be in a state of 
quiescence in the environment. Such possible quiescent states include spores, 
desiccated yeasts and the recently discovered novel and quiescent ‘viable but non-
culturable) forms described by Hommel and colleagues 
(https://www.biorxiv.org/content/10.1101/552836v1). More intenstive longitudinal 
sampling, particularly around sites of cases, could be more successful in isolating 
environmental examples and confirming the ecological niche of C. neoformans, as 
has been done in India and Colombia where an association was found for C. gattii 
with the Syzygium cumini and Terminalia catappa tree species172 26. 
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6.3.3 Aim 4: To characterize the virulence phenotypes of environmental 
Cryptococcus isolates.  
I was interested in potential virulence of environmental isolates, so I characterize 
their phenotypes using conventional virulence factors including temperature-
dependent growth, melanin production, melanin production, capsule size, and ability 
to survive ex vivo CSF. As expected, C. neoformans exhibited the most robust 
expression of such attributes particularly thermotolerance. All Cryptococcus can 
grow at 30oC but only C. neoformans can survive human physiological temperature 
(37oC) and elevated temperature (39oC). This suggested adaptation to human host’s 
physical temperature is the critical virulence attribute for cryptococcal infection. I 
also challenged G. mellonella larvae with these isolates at 30 and 37oC. Surprisngly 
Cryptococcus spp exhibited no significant difference in virulence at 30oC. However C. 
neoformans was significantly more virulent than C. laurentii at 37oC given that they 
grew equally well at this temperature. This implied that thermotolerance is not 
solely responsible for infection. The finding that only 47% of C. laurentii isolates in 
my study can grow at 37oC agree with rare report of C. laurentii infection. 
C. laurentii rarely cause opportunistic disease involving skin, lung, bloodstream and 
the central nervous system211. Infection in humans caused by other cryptococcal 
species (C. heveanensis, C. rajasthanensis and unidentified Cryptococcus) has not 
been reported. 
My phenotypic assays suggest that larva infection model with exposure at 37oC could 
be used to investigate potential pathogenicity of environmental fungal pathogens 
instead of relying on individual virulence factors. 
6.3.4 Aim 5: To compare the virulence between and within different genotypes 
using the G. mellonella model. 
Two decades ago, G. mellonella emerged as an alternative infection model to study 
microbial pathogenesis. The insect immune response shares functional and 
structural homology to the innate immune response of vertebrates, with insect 
hemolymph containing at least six types of hemocytes which function similarly to 
mammalian phagocytes229. G. mellonella has been shown to  provide comparable 
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data to murine models of infection for a number of microbial species including 
Pseudomonas aeruginosa 163, Bacillus cereus and B. thuringiensis229. With fungi, the 
G. mellonella infection model can distinguish pathogenic and non-pathogenic 
Candida albicans isolates and there is a positive correlation between the 
pathogenicity of C. albicans in mice and larvae. Subsequently, an association 
between toxin production and the virulence of Aspergillus fumigatus was established 
in the model165. 
Day et al previously found that C. neoformans ST5 isolates cause cryptococcal 
infection in immunocompetent individuals more frequently than non-ST5 isolates86. 
The lineage ST5 is of great interest because it predominates in China and 
neighbouring countries in north eastern Asia (Japan, Korea) where disease in HIV-
uninfected patients has been frequently reported. Given this host distribution, I 
hypothesized that ST5 strains have increased pathogenicity – ability to cause disease 
- compared with non-ST5 strains. Using the Galleria infection model, I found ST5 
isolates derived from HIV-uninfected patients were significantly more virulent than 
ST4 isolates derived from HIV-patients. Moreover, this model can differentiate naive 
environmental isolates from virulent clinical isolates (ST4 and ST5). The difference in 
virulence between clinical and environmental C. neoformans isolates (serotype A) 
has previously been demonstrated in the mouse infection model62. The most exciting 
part of my work was the finding of an ‘ecological imprint’ on strains. Strains derived 
from HIV uninfected apparently immunocompetent patients are more virulent than 
those from HIV infected (immunosuppressed) patients, which are in turn more 
virulent than strains derived from the environment. This virulence phenotype is 
extremely stable and fixed over generations of infection and purification. Moreover, 
while increased virulence is not ‘learnt’ by repeated infection in the model, it can be 
‘taught’ by hypervirulent, lineage 5, strains to less virulent strains. Once upregulated, 
that virulence phenotype is again fixed over generations, and the upregulated strain 
itself can now upregulate the virulence of other strains – i.e the effect is 
transmissible. My experiments suggest that the phenomenon is driven by secreted 
peptides/proteins. The phenomenon offers a fascinating avenue of research to take 
forward, with the potential identification of novel drug targets. Interrupting inter-
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yeast communication that is at the heart of regulation of virulence is an exciting 
prospect for the control of infection.  
The whole genome sequence-derived phylogeny of C. neoformans generated within 
our research group at OUCRU (Appendix B) shows that VNIa-5 strains from 
immuncompetent patients, that have the hypervirulent phenotype, are dispersed 
throughout the phylogeny of that lineage. This suggests that all VNIa-5 isolates have 
the potential to cause disease in immunocompetent hosts.  
Differences in the virulence of clinical isolates versus environmental isolates of 
strains of the same molecular type has been described before in the mouse infection 
model62. Litvintseva et al found the vast majority of environmental strains to be 
avirulent, whereas 70% of clinical strains were virulent. Together with my data, this 
begs the big question regarding how do naive environmental isolates become 
pathogenic in the environment, in order to cause human infection. Do they evolve to 
become pathogenic through their interaction with natural predators (amoeba, 
nematode, etc.) or through incubation in human (or other mammalian) hosts? I 
proved that passage of naive C. neoformans through six generations of larvae did not 
enhance virulence of passaged isolates, suggesting at least that it is not the innate 
immune system that drives virulence up-regulation. However, in my experiments, 
yeasts extracted from larval hemolymph were cultured on Sabouraud agar before 
infecting the next batch of larvae. It could be argued that this ‘interruption’, outside 
the immune environment, may result in a reversion of virulence. An alternative 
approach that would mitigate this potential effect would be to perform in vivo 
passage. In this case, yeasts extracted from larval hemolymph are injected directly 
into the next batch of larvae without prior culture, so they would in theory maintain 
virulence acquired during interaction with hemocytes. However, the fact that the 
upregulated virulence following growth in culture filtrate from a hypervirulent strain 
is also fixed despite growth on agar plates between larvae infections, and even 
following freezing, suggests that this ‘interruption-reversion’ hypothesis is wrong. In 
fact, the durability of virulence upregulation is intriguing, suggesting epigenetic 
effect such as chromatin remodeling, and is an additional opportunity for research in 
the future, alongside elucidating the mechanics of inter-yeast signaling itself.  
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A further explanation for discrepancy in virulence between clinical and 
environmental isolates is that pathogenicity/virulence is primarily a quality of spores 
rather than yeast cells, and a ‘pathogenicity’ switch is thrown when a spore ends in a 
host-like environment. An obvious trigger for this could be thermotolerance in 
mammals. It would be interesting to induce sporulation in clinical and environmental 
isolates and see whether there is variability in the virulence in infection models 
where the spore is used as the inoculum. 
6.3.5 Aims 6 and 7: To define transcriptional pathways and to identify genes 
associated with variability in virulence between isolates 
I found infection with clinical isolates and induced environmental isolates led to 
moderately higher fungal burdens in the Galleria model compared with infections 
due to the environmental strain. Whether this higher fungal burden is an expression 
of higher virulence, or the cause of increased virulence (presumably as a function of 
an increased rate of growth), is not clear. Higher fungal burdens could be due to 
greater rates of proliferation or could reflect better survival/evasion of the host 
immune response in the Galleria compared with naive isolates. However, there was 
no change in in vitro growth rates of the environmental strain following induction 
(appendix C). The higher fungal burden of the BMD761 and induced C. neoformans 
isolates seen in larvae was associated with upregulation of virulence-associated 
genes (virulence factors, kinases, transporters, transcription factors) and enrichment 
of genes annotated to metabolism, cellular biosynthesis, and cell cycle, consistent 
with higher growth rates. Around 260 hypothetical proteins were differentially 
regulated in induced LD2 and naive LD2. Presumably, somewhere within this set of 
genes is a single gene or group of genes that function as intercellular signals to 
upregulate virulence. It is possible that some of these upregulated genes I observed 
are artefactual – I sequenced RNA from C. neoformans cells which had been revived 
in YPD rather than C. neoformans cells extracted directly from larvae. However, 
virulence induction did appear to be an extremely robust in vitro phenomenon. 
RNAseq on yeast cells derived directly from hemolymph might provide cleaner 
transcriptional data, but separating yeast cells without contamination of hemocyte 
debris is challenging. It is an experiment I would consider taking forward in the 
 230 
 
future. However, a more fruitful approach is likely to be a proteomic approach, 
particularly since the relationship between protein/peptide expression and 
trsncription is not necessarily linear. Following the identification of protein/peptide 
candidates, the advent of CRISPR technology, reliably deliverable for C. neoformans 
using electroporation, delivers the tools to allow further interrogation of my isolates 
and gene candidates.  
6.4 Future directions 
If I were to take my work on Cryptococcus further forward, I would be most 
interested in better understanding the mechanism of inter-yeast signaling, and how 
this upregulates pathogenesis. 
My works suggest that inter-yeast signaling is certainly in someway mediated 
through secreted proteins, and as discussed in chapter 4 recent work suggests that 
extracellular vesicles may facilitate inter-yeast communication in C. neoformans and 
may have a role in the regulation of virulence of the related species C. gattii. I would 
be interested in determining whether vesicles are mediating the effect I have 
described in my isolates, which I believe is plausible based on the following evidence. 
First, the constituency of vesicles is complex. They contain cell membrane, proteins, 
which may be either within the membrane or cross the membrane, and they may 
also contain small RNAs. Rodrigues et al reported C. neoformans extracellular 
vesicles containing plentiful protein components associated with virulence119.  
Second, Bielska et al found C. gattii extracellular vesicles can mediate intercellular 
communication between outbreak and non-outbreak strains, resulting in probable 
up-regulation of virulence. They found that the intracellular proliferation rate (IPR) 
of non-outbreak strains in murine macrophages was significantly enhanced when 
these strains was co-cultured with outbreak strains230. They went on to show that 
this is regulated by extracellular vesicles (EV) derived from the outbreak strain. They 
believed that the mechanism was mediated through the uptake of EVs by the host 
macrophage, with transport to the fungal phagosome where they triggered 
proliferation of non-outbreak cells. The two EV components essential for inducing 
virulence of non-outbreak strains were reported as protein and RNA230.  
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My work differs in that it shows that macrophages are not essential to the inter-
yeast communication – I demonstrate up-regulation occurring in in vitro culture. 
However, I have not demonstrated the presence of extracellular vesicles, but could 
gather some supporting information for this with some fairly simple experiments.  
Wolf et al found albumin disrupts bacterial and fungal vesicles307. Therefore, as a 
first step, I would destabilize EV in culture filtrate by adding albumin to the culture 
filtrate and test whether this disrupts the induction of virulence in the Galleria 
model. 
A second experiment would be to use ultracentrifugation to separate the potential 
vesicle containing fraction from the culture filtrate (CF). Then I would use the (EV-
containing) pellet and (EV-free) supernatant and determine which of these has the 
ability to induce virulence in naive LD2, again testing the phenotype using the 
Galleria model. Finally, I could determine the presence of EVs in culture filtrate (and 
in ultracentrifuged CF) using transmission electron microscopy. However, I do not 
have this last facility in Vietnam. 
Having demonstrated that vesicles are implicated in the phenomenon, I would then 
wish to purify and fractionate them, and use mass spectrometry to define the 
proteins present. If I could fractionate vesicles by size, which can be done with 
filtration columns, then I would be able to test the effect of individual fractions on 
induction.  
Of note, when I treated culture filtrate with nucleases, there was no effect on its 
ability to upregulate virulence. EVs can contain small RNAs, and even DNA. I did not 
find any evidence that nucleic acids mediate the induction effect of culture filtrate. 
However, it may be that small RNAs, contained within vesicles, are somewhat 
protected against the action of nucleases. Therefore, having purified EVs (assuming 
they underly the phenomenon) I would be interested in small RNA-seq to determine 
whether RNA is present and what form it takes. 
In Chapter 5, I found a large number of virulence-associated genes that were 
upregulated when the environmental isolate was induced to become more virulent. I 
have discussed the biological plausibility of this differential expression in the 
discussion of chapter 5. Differentially expressed genes between clinical/induced 
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isolates and environmental isolates could also be validated by quantification of their 
expression using real-time reverse-transcription PCR.  
To test whether my inferences are correct, I would need to set up knock-out 
experiments. The advent of CRISPR-Cas9 system for Cryptococcus enables the 
precise development of relevant knockouts308. The challenge would be identifying 
which genes to knockout first. Here, because it is increasingly clear that the 
relationship between gene expression and phenotype is not simply linear, I would be 
guided by the results of the proteomic analyses of the culture filtrate/EVs as 
described above, in choosing which genes to knock-out. Having made knockouts of 
the BMD761 hypervirulent isolate, I would then use the Galleria model to evaluate 
the effect of mutant BMD761 culture filtrate on the naive LD2 isolate.  Further 
experiments to define the exact mechanism through which increased virulence is 
mediated would have to be guided by the genes implicated from the knockout 
experiments. If, for example, these were genes involved in sugar transport (as 
described in chapter 5), then simple experiments looking at growth efficiency in 
differing relevant sugar concentrations might be informative. 
6.5 Conclusion 
In summary, I found some evidence of clustering of Cryptococcus species within the 
wider environment, but was unable to identify specific niches associated with 
particular lineages because of poor recovery rates. The increased isolation rates of 
any Cryptococcus species from around clinical cases indicates that the ecological 
niches are highly similar and likely differ at the micro- rather than macro- level.  
The identification of a phenomenon suggestive of inter-yeast signaling that leads to 
upregulation of virulence is an exciting therapeutic prospect and something I would 
be interested to take forward in the future. 
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Appendix A 
List of environmental isolates in Vietnam 
 
Isolate 
ID Source 
Type of 
sample 
Place of 
sampling Method Species 
NT466 Delonix regia swab 
Nhon 
Trach random C. heveanensis 
15438 Hopea odorata swab HCMC random C. heveanensis 
VAT550 
Khaya 
senegalensis swab HCMC random 
C. 
rajasthanensis 
NT4419 Mimosa pigra swab 
Nhon 
Trach 
random 
Undetermined  
cryptococcus 
NT6628 Cassia fistula swab 
Nhon 
Trach random C. heveanensis 
NT1112
7 
Tamarindus 
indica swab 
Nhon 
Trach random C. heveanensis 
NT6620 
Lagerstroemia 
speciosa swab 
Nhon 
Trach random C. heveanensis 
17479 unidentified swab HCMC random C. heveanensis 
GD299 
Khaya 
senegalensis swab HCMC random C. laurentii 
6776 
Tamarindus 
indica 
rotten 
wood HCMC random C. laurentii 
599 
Dipterocarpus 
alatus swab HCMC random C. heveanensis 
4367 
Terminalia 
catappa 
rotten 
wood HCMC random C. heveanensis 
25663 
Lagerstroemia 
speciosa soil HCMC random C. laurentii 
2563 
Alstonia 
scholaris swab HCMC random C. heveanensis 
3602 Delonix regia swab HCMC random C. heveanensis 
NT3039 
Peltophorum 
pterocarpum swab 
Nhon 
Trach random C. laurentii 
NT1213 Cassia fistula swab 
Nhon 
Trach random C. heveanensis 
NT1153
4 
Hevea 
brasiliensis swab 
Nhon 
Trach random C. laurentii 
GeckoJ
D Guano 
gecko 
guano HCMC target C. heveanensis 
AirconJ
D 
air conditioner 
filter swab HCMC target 
C. 
rajasthanensis 
WallJD wall swab HCMC target C. laurentii 
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NT7533 
Acacia 
auriculiformis swab 
Nhon 
Trach random C. neoformans 
6338 
Dipterocarpus 
alatus swab HCMC random C. laurentii 
6350 Delonix regia swab HCMC random C. heveanensis 
2697 
Samanea 
saman swab HCMC random C. heveanensis 
11336 Delonix regia swab HCMC random C. heveanensis 
11516 
Artocarpus 
altilis swab HCMC random C. heveanensis 
SS153 
Mimusops 
elengi swab HCMC target C. laurentii 
SS41 
Artocarpus 
heterophyllus air HCMC target C. laurentii 
SS37 
Peltophorum 
pterocarpum  air HCMC target C. heveanensis 
SS67 Ficus rumphii swab HCMC target C. heveanensis 
SS97 Delonix regia swab HCMC target C. heveanensis 
SS105 unidentified swab HCMC target C. heveanensis 
SS118 
Rhizophora 
apiculata  swab HCMC target C. heveanensis 
SS77 
Bougainvillea 
spectabilis swab HCMC target C. laurentii 
SS54 
Pterocarpus 
macrocarpus swab HCMC target C. heveanensis 
NT4268 Cassia fistula swab 
Nhon 
Trach random C. heveanensis 
NT3960 tree stump swab 
Nhon 
Trach random C. laurentii 
NT3176 tree stump swab 
Nhon 
Trach random C. laurentii 
LTR82 Hopea odorata swab HCMC random C. heveanensis 
LTR73A Cassia fistula swab HCMC random C. heveanensis 
LTR73B Cassia fistula swab HCMC random 
C. 
rajasthanensis 
LD1 Hopea odorata swab HCMC random C. neoformans 
LD2 Hopea odorata swab HCMC random C. neoformans 
7908 Hopea odorata swab HCMC random C. heveanensis 
5309 
Khaya 
senegalensis swab HCMC random C. heveanensis 
5521 Hopea odorata swab HCMC random C. heveanensis 
24326 
Peltophorum 
pterocarpum swab HCMC random C. heveanensis 
4918 
Dipterocarpus 
alatus swab HCMC random C. heveanensis 
1295 unidentified soil HCMC random C. heveanensis 
10127 Dipterocarpus swab HCMC random C. heveanensis 
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alatus 
9940 
Cinnamomum 
camphora swab HCMC random C. heveanensis 
12896 
Azadirachta 
indica swab HCMC random C. heveanensis 
14300 
Mimusops 
elengi swab HCMC random C. heveanensis 
11888 Delonix regia swab HCMC random C. heveanensis 
4917 
Samanea 
saman swab HCMC random C. heveanensis 
10126 
Dipterocarpus 
alatus swab HCMC random C. heveanensis 
14482 Delonix regia swab HCMC random C. laurentii 
15077 Delonix regia swab HCMC random C. heveanensis 
19104 Delonix regia swab HCMC random C. heveanensis 
TD135 unidentified swab HCMC random C. heveanensis 
6865 Delonix regia swab HCMC random C. heveanensis 
9658 Delonix regia swab HCMC random C. heveanensis 
5063 
Acacia 
mangium swab HCMC random C. heveanensis 
1021 Cassia fistula swab HCMC random C. heveanensis 
9494 
Peltophorum 
pterocarpum swab HCMC random C. heveanensis 
5052 
Samanea 
saman swab HCMC random C. heveanensis 
853 
Peltophorum 
pterocarpum swab HCMC random C. heveanensis 
661 Cassia fistula swab HCMC random C. heveanensis 
1266 
Mimusops 
elengi swab HCMC random C. heveanensis 
1419 Cassia fistula swab HCMC random C. heveanensis 
3657 
Samanea 
saman swab HCMC random C. heveanensis 
4827 
Peltophorum 
pterocarpum soil HCMC random C. heveanensis 
13118 Delonix regia swab HCMC random C. heveanensis 
39469 Hopea odorata swab HCMC random C. heveanensis 
258 
Eucalyptus 
globulus swab HCMC random C. heveanensis 
15091 Delonix regia swab HCMC random C. heveanensis 
11873 unidentified swab HCMC random C. heveanensis 
1810 
Pterocarpus 
macrocarpus swab HCMC random C. heveanensis 
6252 Cassia fistula swab HCMC random C. heveanensis 
23478 
Muntingia 
calabura swab HCMC random C. heveanensis 
25498 Lagerstroemia soil HCMC random C. heveanensis 
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speciosa 
27498 
Peltophorum 
pterocarpum swab HCMC random C. heveanensis 
37969 
Muntingia 
calabura swab HCMC random C. laurentii 
40147 
Ravenala 
madagascariens
is swab HCMC random C. heveanensis 
NT2975 
Manihot 
esculenta 
swab 
Nhon 
Trach 
random 
Undetermined  
cryptococcus 
1077 
Pterocarpus 
macrocarpus swab HCMC random C. heveanensis 
1474 
Samanea 
saman swab HCMC random C. heveanensis 
5092 
Peltophorum 
pterocarpum swab HCMC random C. heveanensis 
5486 Hopea odorata swab HCMC random C. heveanensis 
6285 Cassia fistula swab HCMC random C. heveanensis 
8870 Delonix regia soil HCMC random C. heveanensis 
6495 Hopea odorata swab HCMC random C. laurentii 
38262 
Acacia 
auriculiformis swab HCMC random C. heveanensis 
37796 Delonix regia swab HCMC random C. heveanensis 
1673 
Samanea 
saman swab HCMC random 
C. 
rajasthanensis 
35178 Delonix regia swab HCMC random C. heveanensis 
32766 Delonix regia swab HCMC random C. heveanensis 
VAT tree stump swab HCMC random C. laurentii 
SS160a 
Lagerstroemia 
speciosa swab Vung Tau target C. heveanensis 
SS160b Plumeria rubra swab Vung Tau target C. heveanensis 
31049 
Khaya 
senegalensis swab HCMC random C. laurentii 
27450 
Lagerstroemia 
speciosa swab HCMC random C. heveanensis 
34467 
Muntingia 
calabura swab HCMC random C. heveanensis 
39328 
Tamarindus 
indica swab HCMC random C. laurentii 
38296 
Peltophorum 
pterocarpum soil HCMC random C. heveanensis 
14797 
Mimusops 
elengi swab HCMC random C. laurentii 
4067 
Dipterocarpus 
alatus swab HCMC target C. heveanensis 
10771 
Pterocarpus 
macrocarpus swab HCMC random C. heveanensis 
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NT4243 
Peltophorum 
pterocarpum swab 
Nhon 
Trach random C. heveanensis 
TXS377 
Peltophorum 
pterocarpum swab HCMC random C. heveanensis 
SS74 Hopea odorata swab 
 Tien 
Giang target 
C. 
rajasthanensis 
35244 
Peltophorum 
pterocarpum soil HCMC random C. heveanensis 
36053 
Peltophorum 
pterocarpum swab HCMC random C. heveanensis 
33388 
Tamarindus 
indica swab HCMC random C. heveanensis 
26977 Delonix regia swab HCMC random C. heveanensis 
25340 Cassia fistula swab HCMC random C. heveanensis 
23747 Delonix regia swab HCMC random C. heveanensis 
18740 Delonix regia swab HCMC random C. heveanensis 
NT6004 
Lagerstroemia 
speciosa swab 
Nhon 
Trach random 
C. 
rajasthanensis 
SG1868
0 
Melia 
azedarach swab HCMC random C. heveanensis 
35386 unidentified swab HCMC random C. heveanensis 
6289 unidentified swab HCMC random C. heveanensis 
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Appendix B 
A whole genome SNP phylogeny of 679 C. neoformans VNI isolates 
(https://www.biorxiv.org/content/biorxiv/early/2018/06/28/356816.full.pdf) 
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Appendix C 
Growth curves of strains used in the chapter 5 
In vitro growth rates (from 0-20 hours) at 30oC were similar between isolates 
(P=0.26, Kruskal-Wallis rank sum test). 
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Appendix D 
Protocol for G. mellonella infection model 
1. Purpose 
This protocol describes the usage of Galleria mellonella larvae as infection 
model to study pathogenicity of Cryptococcus species. 
2. Principle 
Cryptococcus species vary in their pathogenicity between species and even 
between different genotypes. Insect larvae can play as a host to study 
pathogenicity of Cryptococcus pathogen. Larvae will be infected with the 
same inoculum of Cryptococcus species/genotypes of interest. All infected 
larvae are incubated for ten days at the same temperature. Larvae survival is 
observed daily using death as an endpoint. Survival curves plotted after 10 
days could tell if the pathogens of interest significantly differ in their 
pathogenicity. 
3. Scope and responsibilities 
This procedure will be carried out within the BSL2 cabinet of mycology lab, 
OUCRU, HCMC. Only trained staff members of the CNS/HIV group are allowed to 
perform the procedure. 
4. Reference  
Mylonakis E, Moreno R, El JB, Idnurm A, Heitman J, Stephen B, et al. Galleria 
mellonella as a model system to study Cryptococcus neoformans pathogenesis. 
Infect Immun. 2005;73(7):3842–2850. 
Website: https://www.jove.com/video/50964/use-galleria-mellonella-as-model-
organism-to-study-legionella 
5. Specimens 
o Galleria mellonella larvae (250-300 mg) 
o Cryptococcus species 
6. Materials/ Equipments used  
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o 1x PBS (phosphate-buffered saline) 
o Light microscope fitted with 40x objective 
o  Forceps 
o Glass slide & slide cover 
o 10 micrometer Hamilton syringe 
o Petri dish 
o Rubber and leather gloves 
o YPD broth (1% yeast extract, 2%peptone and 2% dextrose) 
o Sabouraud and BHI (brain heart infusion) agar plates 
o 0.2 micrometer pore size filter 
o 10 mL syringes 
o 10 micromiter loop 
o 70 % alcohol 
o Bleach (chlorine-based) 
o Cellometer (Nexcelom) 
o 1.5 mL microtube 
o Centrifuge  
7. Procedures 
Prepare larvae  
1) Larvae, kept in 16 oC cooler, are taken out and left at room temperature for 
at least 2 hours before infection. 
2) Larvae are dispensed into petri dishes (20 larva/dish) prior to injection 
3) Discard any larvae with grey markings (indicator for ill larvae) 
Fungal inoculum preparation 
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4) Fungi are cultured in YPD broth between 24 to 48 hours in shaking incubator 
(150-200 rpm) at 30 oC 
5)  Spin the culture at 8000 rpm for 1 minute 
6) Wash the pellet with PBS and then resuspend pellet in PBS 
7) Quantitate fungal cells using the cellometer. 
8) Adjust a density of 108 cells/mL, then 10 μL of inoculum (106 cells/larva) is 
ready for injection 
Sterility test 
Sterility of culture and PBS can be checked by inoculating 10 μL of culture into 
Sabouraud and BHI. Incubate plates at 30 oC for 3 days. 
Infection 
9) Clean Hamilton syringes using 10% bleach by drawing and pushing out for 
3 times followed by 100% ethanol and 1X PBS.  
10) The needle and syringe are cleaned between fungal strains 
11) Use a cotton bud soaked in 70 % ethanol to swab the larva pro-legs prior 
to injection. 
12) Inject 10 μL of inoculum (1.0x106 cells per larvae) into the last left pro-leg. 
If there is tension then adjust the position slightly. It should enter the 
larvae easily. Don’t push hard and fast, needle is sharp and easy to go 
through the larvae body. 
13) After injection, put larva into a petri dish covered with tissue for a few 
minute to stop hemolymph leakage 
14) Also inject 10 μL  PBS as control 
15) Transfer infected larvae into a new petri dish (maximum 20 larvae/plate). 
Use tape to fasten both sides of petri dishes to prevent larvae from 
escaping. 
16) Put petri dishes in perforated platic boxes or plastic box covered with 
aluminum foil and incubate at 37 oC incubator for 10 days 
17) NOTE: a leather glove must be worn during injection 
Observation after injection 
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18) Larvae are checked daily for survival by physical stimuli with forceps. 
Remove cocoons if the larvae can't be observed. Normally they start make 
a little silk immediately after injection.  
19) Dead larvae are removed from petri dish. Put them in ziplock bags and 
discard in a biological harzard bin.  The number of dead larvae is recorded.  
20) Analyse result by plotting survival curves  
8. Quality control 
o Quantitate inoculum after infection by inoculating onto Sabouraud agar 
o All petri dishes are encoded by another labmate to avoid bias 
9. Safety 
o PPE should be worn at all times while working (a minimum of lab coats, 
closed shoes,  gloves)  
o Place any waste from the procedure in the appropriate hazardous waste 
bins. 
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Appendix E 
Survival curves derived from pooled data from 6 independent Galleria mellonella 
larva infection experiments. Larvae were infected with one of 3 Cryptococcus 
neoformans isolates: BMD 761, naive LD2 or induced LD2. Survival data were pooled 
by infecting isolate. BMD761 is an isolate derived from an HIV uninfected and 
apparently immunocompetent human patient; LD2 is an environmental isolate of the 
same genetic lineage as BMD 761 (VNIa-5). Induced LD2 is the LD2 isolate following 
its culture in broth augmented with sterile culture filtrate from BMD761 culture. The 
sample size is 240 larvae per arm. Infection with the induced LD2  isolate resulted in 
a 2.5 fold increase in the hazard of death (i.e. Hazard Ratio = 2.5) compared with 
infection with naïve LD2 (Cox proportional hazards model, P <0.0001).  
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